No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d4qv4O_, 1.0000, 0.00, 1.000, 250, 250, YCP BETA5-M45T MUTANT
2, d4qv8O_, 0.9999, 0.04, 1.000, 250, 250, YCP BETA5-C52F MUTANT
3, d4qv8A_, 0.9999, 0.04, 1.000, 250, 250, YCP BETA5-C52F MUTANT
4, d4qv7O_, 0.9999, 0.04, 1.000, 250, 250, YCP BETA5-A50V MUTANT
5, d4qv7A_, 0.9999, 0.04, 1.000, 250, 250, YCP BETA5-A50V MUTANT
6, d4qv5O_, 0.9999, 0.04, 1.000, 250, 250, YCP BETA5-M45I MUTANT
7, d4qv5A_, 0.9999, 0.04, 1.000, 250, 250, YCP BETA5-M45I MUTANT
8, d4qv4A_, 0.9999, 0.00, 1.000, 250, 250, YCP BETA5-M45T MUTANT
9, d4qv3O_, 0.9999, 0.05, 1.000, 250, 250, YCP BETA5-M45V MUTANT
10, d4qv3A_, 0.9999, 0.05, 1.000, 250, 250, YCP BETA5-M45V MUTANT
11, d4qv1O_, 0.9999, 0.03, 1.000, 250, 250, YCP BETA5-M45A MUTANT
12, d4qv1A_, 0.9999, 0.03, 1.000, 250, 250, YCP BETA5-M45A MUTANT
13, d4qv0O_, 0.9999, 0.06, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT
14, d4qv0A_, 0.9999, 0.06, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT
15, d5lttO_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
16, d5lttA_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
17, d5l6cO_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
18, d5l6cA_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
19, d5l6bO_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
20, d5l6bA_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
21, d5l6aO_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
22, d5l6aA_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
23, d5l67O_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
24, d5l67A_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
25, d5l65O_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
26, d5l65A_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
27, d5l64O_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
28, d5l64A_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
29, d5l63O_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
30, d5l63A_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
31, d5l62O_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
32, d5l62A_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
33, d5l61O_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
34, d5l61A_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
35, d5l5wO_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
36, d5l5wA_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
37, d5l5uO_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
38, d5l5uA_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
39, d5l5sO_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
40, d5l5sA_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
41, d5l5qO_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
42, d5l5qA_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
43, d5l5pO_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
44, d5l5pA_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
45, d5l5oO_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
46, d5l5oA_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
47, d5l5hO_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
48, d5l5hA_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
49, d5l5fO_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
50, d5l5fA_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
51, d5l5dO_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
52, d5l5dA_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
53, d5l5aO_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
54, d5l5aA_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
55, d5fgaO_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
56, d5fgaA_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
57, d5fg7O_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T1A MUTANT
58, d5fg7A_, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T1A MUTANT
59, d5czaO_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT
60, d5czaA_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT
61, d5cz6O_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
62, d5cz6A_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
63, d5bxlA_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT
64, d4ya1O_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT
65, d4ya1A_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT
66, d4y9yO_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT
67, d4y9yA_, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT
68, d4qzzO_, 0.9998, 0.06, 1.000, 250, 250, YCP IN COMPLEX WITH OMURALIDE
69, d4qzzA_, 0.9998, 0.06, 1.000, 250, 250, YCP IN COMPLEX WITH OMURALIDE
70, d4qw1O_, 0.9998, 0.07, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
71, d4qw1A_, 0.9998, 0.07, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
72, d4qvyO_, 0.9998, 0.08, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
73, d4qvyA_, 0.9998, 0.08, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
74, d4qvwO_, 0.9998, 0.08, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
75, d4qvlO_, 0.9998, 0.07, 1.000, 250, 250, YCP IN COMPLEX WITH BORTEZOMIB
76, d4qvlA_, 0.9998, 0.07, 1.000, 250, 250, YCP IN COMPLEX WITH BORTEZOMIB
77, d4quyO_, 0.9998, 0.07, 1.000, 250, 250, YCP BETA5-A49S-MUTANT
78, d4quyA_, 0.9998, 0.07, 1.000, 250, 250, YCP BETA5-A49S-MUTANT
79, d4quxO_, 0.9998, 0.08, 1.000, 250, 250, YCP BETA5-A49T-MUTANT
80, d4quxA_, 0.9998, 0.08, 1.000, 250, 250, YCP BETA5-A49T-MUTANT
81, d5m2bO_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
82, d5m2bA_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
83, d5l68O_, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
84, d5l68A_, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
85, d5l66O_, 0.9997, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
86, d5l66A_, 0.9997, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
87, d5l5zO_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
88, d5l5zA_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
89, d5l5xO_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
90, d5l5xA_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
91, d5l5tO_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
92, d5l5tA_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
93, d5l5rO_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
94, d5l5rA_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
95, d5l5jO_, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
96, d5l5jA_, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
97, d5l5iO_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
98, d5l5iA_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
99, d5l5eO_, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
100, d5l5eA_, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
101, d5l5bO_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
102, d5l5bA_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
103, d5fg9O_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
104, d5fg9A_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
105, d5d0wO_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT
106, d5d0wA_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT
107, d5cz7O_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
108, d5cz7A_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
109, d5cgfO_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT
110, d5cgfA_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT
111, d5bxnO_, 0.9997, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
112, d5bxnA_, 0.9997, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
113, d4ya4O_, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT
114, d4ya4A_, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT
115, d4y8rO_, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT
116, d4y8rA_, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT
117, d4y8mO_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
118, d4y8mA_, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
119, d4r00O_, 0.9997, 0.09, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
120, d4r00A_, 0.9997, 0.09, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
121, d4qvwA_, 0.9997, 0.08, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
122, d4qvpO_, 0.9997, 0.09, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
123, d4qvpA_, 0.9997, 0.09, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
124, d4qvnO_, 0.9997, 0.09, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
125, d4qvnA_, 0.9997, 0.09, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
126, d4qv9O_, 0.9997, 0.10, 1.000, 250, 250, YCP BETA5-C63F MUTANT
127, d4qv9A_, 0.9997, 0.10, 1.000, 250, 250, YCP BETA5-C63F MUTANT
128, p6gopO_, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
129, d5l69O_, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
130, d5l69A_, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
131, d5l60O_, 0.9996, 0.12, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
132, d5l60A_, 0.9996, 0.12, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
133, d5l5yO_, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
134, d5l5yA_, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
135, d5l5vO_, 0.9996, 0.11, 1.000, 250, 250,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
136, d5l5vA_, 0.9996, 0.11, 1.000, 250, 250,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
137, d5bouO_, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
138, d5bouA_, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
139, d4z1lO_, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
140, d4z1lA_, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
141, d4qwuO_, 0.9996, 0.10, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
142, d4qwuA_, 0.9996, 0.10, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
143, d5dkjO_, 0.9995, 0.13, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
144, d5dkjA_, 0.9995, 0.13, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
145, d5d0tO_, 0.9995, 0.13, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
146, d5d0tA_, 0.9995, 0.13, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
147, p4y6vO_, 0.9995, 0.12, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
148, d4rurO_, 0.9995, 0.12, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
149, d4rurA_, 0.9995, 0.12, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
150, d4qvqO_, 0.9995, 0.12, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
151, d4qvqA_, 0.9995, 0.12, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
152, d4qv6O_, 0.9995, 0.13, 1.000, 250, 250, YCP BETA5-A49V MUTANT
153, d4qv6A_, 0.9995, 0.13, 1.000, 250, 250, YCP BETA5-A49V MUTANT
154, d5l55O_, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
155, d5l55A_, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
156, p5cghO_, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
157, p5cggO_, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
158, p4y8uO_, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
159, p4y8tO_, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
160, p4y8nO_, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
161, p4y6aO_, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
162, p4y69O_, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
163, d4qwlO_, 0.9994, 0.14, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
164, d4qwlA_, 0.9994, 0.14, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
165, d4qw0O_, 0.9994, 0.14, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
166, d4qw0A_, 0.9994, 0.14, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
167, d5lajO_, 0.9993, 0.15, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
168, d5lajA_, 0.9993, 0.15, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
169, d5l52O_, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
170, d5l52A_, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
171, d5jhrO_, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
172, d5jhrA_, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
173, d5d0xO_, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
174, d5d0xA_, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
175, d5d0vO_, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
176, d5d0vA_, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
177, d5d0sO_, 0.9993, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
178, d5d0sA_, 0.9993, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
179, d5bxlO_, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT
180, p4y8pO_, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
181, p4y75O_, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
182, d4r18O_, 0.9993, 0.15, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
183, d4r18A_, 0.9993, 0.15, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
184, d4qz7O_, 0.9993, 0.14, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
185, d4qz7A_, 0.9993, 0.15, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
186, d4qz6O_, 0.9993, 0.15, 1.000, 250, 250, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
187, d4qz6A_, 0.9993, 0.15, 1.000, 250, 250, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
188, d4qz4O_, 0.9993, 0.15, 1.000, 250, 250, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
189, d4qz4A_, 0.9993, 0.15, 1.000, 250, 250, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
190, d4qz3O_, 0.9993, 0.16, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
191, d4qz3A_, 0.9993, 0.16, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
192, d4qwxO_, 0.9993, 0.16, 1.000, 250, 250, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
193, d4qw6O_, 0.9993, 0.15, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
194, d4qw6A_, 0.9993, 0.16, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
195, d4qvmO_, 0.9993, 0.14, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
196, d4qvmA_, 0.9993, 0.14, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
197, d4jsqO_, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
198, d4jsqA_, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
199, d5laiO_, 0.9992, 0.16, 1.000, 250, 250, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
200, d5laiA_, 0.9992, 0.16, 1.000, 250, 250, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
201, d5fggO_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
202, d5fggA_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
203, d5d0zO_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
204, d5d0zA_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
205, d5ahjO_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
206, d5ahjA_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
207, p4ya9O_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
208, p4ya7O_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
209, p4ya5O_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
210, p4y9zO_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
211, p4y8sO_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
212, p4y77O_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
213, d4qz5O_, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
214, d4qz5A_, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
215, d4qz0O_, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
216, d4qz0A_, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
217, d4qwxA_, 0.9992, 0.16, 1.000, 250, 250, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
218, d4qw7O_, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
219, d4qw7A_, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
220, d4qw5O_, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
221, d4qw5A_, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
222, d4no1O_, 0.9992, 0.16, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
223, d4no1A_, 0.9992, 0.16, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
224, d4jsuO_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
225, d4jsuA_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
226, d4inrA_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
227, d3un8O_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
228, d3un8A_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
229, p3un4O_, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
230, d3nzxA_, 0.9992, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
231, d3nzjO_, 0.9992, 0.16, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
232, d3nzjA_, 0.9992, 0.16, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
233, d5l54O_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
234, d5l54A_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
235, d5jhsO_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
236, d5jhsA_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
237, p5fghO_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
238, d5fgfO_, 0.9991, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
239, d5fgfA_, 0.9991, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
240, d5cz9O_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
241, d5cz9A_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
242, p5cgiO_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
243, p4y8kO_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
244, d4r02O_, 0.9991, 0.18, 1.000, 250, 250, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
245, d4qzwO_, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
246, d4qzwA_, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
247, d4qwfO_, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
248, d4qwfA_, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
249, d4qltO_, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
250, d4qltA_, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
251, d4qlsO_, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
252, d4qlsA_, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
253, d4no8O_, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
254, d4no8A_, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
255, d4nnnO_, 0.9991, 0.18, 1.000, 250, 250, YCP IN COMPLEX WITH MG132
256, d4nnnA_, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH MG132
257, d4ltcO_, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
258, d4ltcA_, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
259, d4jt0O_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
260, d4jt0A_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
261, d4inuO_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
262, d4inuA_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
263, d4intO_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
264, d4intA_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
265, d4inrO_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
266, d3nzxO_, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
267, d3nzwO_, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
268, d3nzwA_, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
269, d3hyeA_, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
270, d3gpwO_, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
271, d3gpwA_, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
272, d3gptO_, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
273, d3gptA_, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
274, d2fakO_, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
275, d2fakA_, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
276, p4ya2O_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
277, p4y8lO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
278, p4y8hO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
279, p4y8gO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
280, p4y82O_, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
281, d4qz2O_, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
282, d4qz2A_, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
283, d4qw4O_, 0.9990, 0.19, 1.000, 250, 250, YCP IN COMPLEX WITH CARFILZOMIB
284, d4qw4A_, 0.9990, 0.19, 1.000, 250, 250, YCP IN COMPLEX WITH CARFILZOMIB
285, d4qlqO_, 0.9990, 0.18, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
286, d4qlqA_, 0.9990, 0.18, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
287, d4lqiO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
288, d4lqiA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
289, d3mg0A_, 0.9990, 0.18, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
290, d3hyeO_, 0.9990, 0.18, 1.000, 250, 250, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
291, d5fgeO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
292, d5fgeA_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
293, d5cz8O_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
294, d5cz8A_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
295, d5cz4O_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
296, d5cz4A_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
297, p4y8qO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
298, p4y8jO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
299, p4y74O_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
300, p4y70O_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
301, d4r02A_, 0.9989, 0.19, 1.000, 250, 250, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
302, d4qwrO_, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
303, d4qwrA_, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
304, d4qvvO_, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
305, d4qvvA_, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
306, d3tddO_, 0.9989, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
307, d3tddA_, 0.9989, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
308, d3shjO_, 0.9989, 0.19, 1.000, 250, 250, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
309, d3shjA_, 0.9989, 0.19, 1.000, 250, 250, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
310, d3okjO_, 0.9989, 0.19, 1.000, 250, 250, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
311, d3okjA_, 0.9989, 0.19, 1.000, 250, 250, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
312, d2gplO_, 0.9989, 0.19, 1.000, 250, 250, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
313, d2gplA_, 0.9989, 0.19, 1.000, 250, 250, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
314, d2fnyA_, 0.9989, 0.19, 1.000, 250, 250,  
315, d5fhsO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
316, d5fhsA_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
317, d5dkiO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
318, d5dkiA_, 0.9988, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
319, p4y8iO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
320, p4y84O_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
321, p4y81O_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
322, p4y7yO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
323, p4y7xO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
324, p4y7wO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
325, d4qzxA_, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
326, d4qluO_, 0.9988, 0.20, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
327, d4qluA_, 0.9988, 0.20, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
328, d3e47O_, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
329, d3e47A_, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
330, d2fnyO_, 0.9988, 0.20, 1.000, 250, 250,  
331, d2f16O_, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
332, d2f16A_, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
333, p4ya3O_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
334, p4y8oO_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
335, p4y80O_, 0.9987, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
336, d4qzxO_, 0.9987, 0.20, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
337, d4qz1O_, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
338, d4qz1A_, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
339, d4qwiO_, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
340, d4qwiA_, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
341, d4qlvA_, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
342, d4q1sA_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
343, d4no9O_, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
344, d4no9A_, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
345, d4j70A_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
346, d3mg0O_, 0.9987, 0.20, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
347, d5fgdO_, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
348, d5fgdA_, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
349, d5cz5O_, 0.9986, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
350, d5cz5A_, 0.9986, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
351, d4qxjO_, 0.9986, 0.22, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
352, d4qxjA_, 0.9986, 0.22, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
353, d4qw3O_, 0.9986, 0.21, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
354, d4qw3A_, 0.9986, 0.21, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
355, d4qlvO_, 0.9986, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
356, p4gk7O_, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
357, d3dy3O_, 0.9986, 0.21, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
358, d3dy3A_, 0.9986, 0.21, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
359, d3d29O_, 0.9986, 0.22, 1.000, 250, 250, PROTEASOME INHIBITION BY FELLUTAMIDE B
360, d3d29A_, 0.9986, 0.21, 1.000, 250, 250, PROTEASOME INHIBITION BY FELLUTAMIDE B
361, p4ya0O_, 0.9985, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
362, p4y6zO_, 0.9985, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
363, d4qwkO_, 0.9985, 0.23, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
364, d4qwkA_, 0.9985, 0.23, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
365, d4no6O_, 0.9985, 0.22, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
366, d4no6A_, 0.9985, 0.22, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
367, d4nnwO_, 0.9985, 0.23, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
368, d4nnwA_, 0.9985, 0.23, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
369, d4j70O_, 0.9985, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
370, d3dy4A_, 0.9985, 0.23, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
371, d2zcyO_, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
372, d2zcyA_, 0.9985, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
373, d4fzcO_, 0.9984, 0.23, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
374, d4fzcA_, 0.9984, 0.23, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
375, d3gpjA_, 0.9984, 0.23, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
376, d3dy4O_, 0.9984, 0.23, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
377, p4y78O_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
378, d4qwjO_, 0.9983, 0.24, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
379, d4qwjA_, 0.9983, 0.24, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
380, d3gpjO_, 0.9983, 0.23, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
381, d4fzgO_, 0.9982, 0.24, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
382, d4fzgA_, 0.9982, 0.24, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
383, p4qbyO_, 0.9981, 0.26, 1.000, 250, 250, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
384, d4qwsO_, 0.9980, 0.26, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
385, d4qwsA_, 0.9980, 0.26, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
386, d4q1sO_, 0.9980, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
387, d3bdmO_, 0.9980, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
388, d3bdmA_, 0.9980, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
389, p5nifP_, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
390, d4hnpA_, 0.9979, 0.26, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
391, d3mg4A_, 0.9979, 0.27, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
392, p4zzgP_, 0.9978, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
393, d4hnpO_, 0.9978, 0.28, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
394, d1rypB_, 0.9978, 0.27, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
395, d4qwgO_, 0.9975, 0.30, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
396, d4hrdO_, 0.9975, 0.29, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
397, d1rypP_, 0.9975, 0.29, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
398, d4qwgA_, 0.9974, 0.30, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
399, d4hrdA_, 0.9973, 0.31, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
400, d3oevA_, 0.9973, 0.31, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
401, d3mg6A_, 0.9973, 0.31, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
402, d3oeuA_, 0.9971, 0.32, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
403, d3mg8A_, 0.9970, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
404, d1g65A_, 0.9970, 0.32, 1.000, 250, 250, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
405, p5nifB_, 0.9969, 0.33, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
406, d3sdkO_, 0.9969, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
407, d3sdkA_, 0.9969, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
408, d3oeuO_, 0.9969, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
409, d3mg7A_, 0.9969, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
410, p4zzgB_, 0.9968, 0.33, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
411, d3mg8O_, 0.9968, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
412, d3mg7O_, 0.9968, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
413, d1g65O_, 0.9967, 0.33, 1.000, 250, 250, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
414, d3oevO_, 0.9964, 0.35, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
415, d3mg6O_, 0.9964, 0.35, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
416, d3mg4O_, 0.9961, 0.37, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
417, d1jd2A_, 0.9957, 0.38, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
418, d4r17O_, 0.9955, 0.12, 1.000, 249, 249, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
419, d4r17A_, 0.9955, 0.12, 1.000, 249, 249, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
420, d1jd2V_, 0.9952, 0.41, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
421, d5fgiO_, 0.9950, 0.18, 1.000, 249, 249, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
422, d5fgiA_, 0.9950, 0.18, 1.000, 249, 249, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
423, d3wxrB_, 0.9941, 0.25, 1.000, 249, 249, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
424, p4x6zP_, 0.9935, 0.30, 0.996, 249, 249, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
425, d4hrcO_, 0.9933, 0.30, 1.000, 249, 249, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
426, d4hrcA_, 0.9931, 0.32, 1.000, 249, 249, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
427, d4eu2B_, 0.9928, 0.34, 1.000, 249, 249, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
428, d3wxrP_, 0.9923, 0.36, 1.000, 249, 249, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
429, d4eu2P_, 0.9913, 0.43, 0.996, 249, 249, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
430, p4x6zB_, 0.9897, 0.28, 1.000, 248, 248, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
431, p3jcpKA_, 0.9890, 0.62, 1.000, 250, 250, 
432, p3jcpK_, 0.9890, 0.62, 1.000, 250, 250, 
433, p5mp9B_, 0.9859, 0.70, 1.000, 250, 250, 26S PROTEASOME IN PRESENCE OF ATP (S1)
434, p3jcoKA_, 0.9829, 0.78, 1.000, 250, 250, 
435, p3jcoK_, 0.9829, 0.78, 1.000, 250, 250, 
436, d3sdiA_, 0.9826, 0.22, 1.000, 246, 246, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
437, d3sdiO_, 0.9816, 0.28, 1.000, 246, 246, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
438, p5mp9b_, 0.9813, 0.90, 1.000, 250, 250, 26S PROTEASOME IN PRESENCE OF ATP (S1)
439, d1g0uA_, 0.9810, 0.32, 1.000, 246, 246, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
440, d1g0uO_, 0.9806, 0.35, 1.000, 246, 246, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
441, d4g4sB_, 0.9794, 0.41, 1.000, 246, 246, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
442, p5mpab_, 0.9768, 1.00, 1.000, 250, 250, 26S PROTEASOME IN PRESENCE OF ATP (S2)
443, p5mpaB_, 0.9751, 0.95, 1.000, 250, 250, 26S PROTEASOME IN PRESENCE OF ATP (S2)
444, p5wvkW_, 0.9722, 1.02, 1.000, 250, 250, 
445, p5wvkP_, 0.9704, 1.05, 1.000, 250, 250, 
446, d4cr2B_, 0.9597, 1.28, 1.000, 250, 250, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
447, p5mpbB_, 0.9571, 1.33, 1.000, 250, 250, 
448, p5wviOA_, 0.9546, 1.32, 1.000, 250, 250, 
449, p5mpbP_, 0.9538, 1.35, 1.000, 250, 250, 
450, p5wviDA_, 0.9529, 1.34, 1.000, 250, 250, 
451, d1z7qP1, 0.9522, 0.94, 1.000, 249, 243, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
452, d1z7qB1, 0.9522, 0.94, 1.000, 249, 243, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
453, p1fntP_, 0.9519, 1.06, 1.000, 247, 243, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
454, p1fntB_, 0.9519, 1.06, 1.000, 247, 243, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
455, p4cr4B_, 0.9463, 1.52, 1.000, 250, 250, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
456, p5a5bB_, 0.9426, 1.52, 1.000, 250, 250, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
457, p4cr3B_, 0.9426, 1.52, 1.000, 250, 250, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
458, p5mpcB_, 0.9350, 1.41, 1.000, 250, 244, 
459, p5mpcP_, 0.9338, 1.47, 1.000, 250, 244, 
460, p6gopA_, 0.9197, 0.09, 1.000, 230, 230, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
461, p4v7oB_, 0.9168, 0.53, 1.000, 231, 231, 
462, d3l5qG_, 0.9168, 0.53, 1.000, 231, 231,  
463, p4v7oXA_, 0.9167, 0.54, 1.000, 231, 231, 
464, p4v7oP_, 0.9167, 0.54, 1.000, 231, 231, 
465, p4v7oJA_, 0.9167, 0.54, 1.000, 231, 231, 
466, d3l5qS_, 0.9167, 0.54, 1.000, 231, 231,  
467, d1vsyP_, 0.9167, 0.54, 1.000, 231, 231,  
468, d1vsyB_, 0.9167, 0.54, 1.000, 231, 231,  
469, p4y6vA_, 0.9156, 0.12, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
470, p4y8uA_, 0.9155, 0.14, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
471, p4y8tA_, 0.9155, 0.13, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
472, p5cghA_, 0.9154, 0.14, 1.000, 229, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
473, p5cggA_, 0.9154, 0.14, 1.000, 229, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
474, p4ya7A_, 0.9154, 0.15, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
475, p4y8nA_, 0.9154, 0.14, 1.000, 229, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
476, p4y69A_, 0.9154, 0.14, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
477, p4ya9A_, 0.9153, 0.15, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
478, p4ya5A_, 0.9153, 0.16, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
479, p4y9zA_, 0.9153, 0.16, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
480, p4y8sA_, 0.9153, 0.16, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
481, p4y77A_, 0.9153, 0.15, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
482, p4y75A_, 0.9153, 0.15, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
483, p5fghA_, 0.9152, 0.17, 1.000, 229, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
484, p5cgiA_, 0.9152, 0.17, 1.000, 229, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
485, p4y8hA_, 0.9152, 0.17, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
486, p4y8gA_, 0.9152, 0.17, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
487, p4ya2A_, 0.9151, 0.18, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
488, p4y8lA_, 0.9151, 0.18, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
489, p4y8jA_, 0.9151, 0.18, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
490, p4y84A_, 0.9150, 0.19, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
491, p4y70A_, 0.9150, 0.19, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
492, p4y8iA_, 0.9149, 0.20, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
493, p4y7yA_, 0.9149, 0.20, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
494, p4y7wA_, 0.9149, 0.20, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
495, p4ya3A_, 0.9148, 0.21, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
496, p4y8oA_, 0.9148, 0.21, 1.000, 229, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
497, p4ya0A_, 0.9146, 0.22, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
498, p4qbyA_, 0.9143, 0.26, 1.000, 229, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
499, p4y8pA_, 0.9114, 0.14, 1.000, 228, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
500, p4y6aA_, 0.9114, 0.14, 1.000, 228, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
501, p3un4A_, 0.9113, 0.16, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
502, p4y8kA_, 0.9112, 0.17, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
503, p4y8qA_, 0.9110, 0.19, 1.000, 228, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
504, p4y82A_, 0.9110, 0.19, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
505, p4y74A_, 0.9110, 0.19, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
506, p4y7xA_, 0.9109, 0.20, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
507, p4gk7A_, 0.9109, 0.20, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
508, p4y81A_, 0.9108, 0.21, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
509, p4y80A_, 0.9108, 0.21, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
510, p4y6zA_, 0.9107, 0.22, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
511, p4y78A_, 0.9104, 0.24, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
512, d4r3oP_, 0.9042, 1.04, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME
513, d4r3oB_, 0.9042, 1.04, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME
514, d4r67r_, 0.9033, 1.06, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
515, d4r67P_, 0.9033, 1.06, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
516, d4r67d_, 0.9033, 1.06, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
517, d4r67B_, 0.9031, 1.06, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
518, p5gjqC_, 0.9022, 1.09, 0.608, 233, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
519, p5l4gP_, 0.9020, 1.08, 0.608, 233, 232, 
520, p5gjrHA_, 0.9016, 1.00, 0.606, 231, 231, 
521, p5gjrT_, 0.9015, 1.01, 0.606, 231, 231, 
522, p5l4gB_, 0.9010, 1.16, 0.608, 233, 232, 
523, p3uneO_, 0.9008, 1.12, 0.608, 233, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
524, d1iruP_, 0.9004, 1.12, 0.608, 233, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
525, p5lezO_, 0.9003, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
526, d5lexO_, 0.9003, 0.94, 0.613, 230, 230, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
527, p5leyO_, 0.9001, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
528, d5lf1O_, 0.9000, 0.95, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
529, d5lf7O_, 0.8999, 0.95, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
530, d5lf3O_, 0.8999, 0.95, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
531, d5lf4O_, 0.8998, 0.95, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
532, p5lf6O_, 0.8997, 0.96, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
533, p5lezA_, 0.8997, 0.96, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
534, d5lexA_, 0.8997, 0.96, 0.613, 230, 230, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
535, d5le5O_, 0.8997, 0.95, 0.613, 230, 230, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
536, p3unec_, 0.8996, 1.14, 0.603, 233, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
537, d3unbq_, 0.8996, 1.05, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
538, d3unbA_, 0.8995, 1.05, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
539, p3uneq_, 0.8994, 1.16, 0.603, 233, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
540, d3unbO_, 0.8993, 1.06, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
541, d3unbc_, 0.8993, 1.06, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
542, p5lf0O_, 0.8992, 0.97, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
543, p5leyA_, 0.8990, 0.97, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
544, p5lf6A_, 0.8989, 0.98, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
545, p5gjqi_, 0.8989, 1.06, 0.602, 231, 231, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
546, d5lf4A_, 0.8988, 0.98, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
547, d5lf3A_, 0.8987, 0.98, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
548, d5lf1A_, 0.8987, 0.98, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
549, d5lf7A_, 0.8984, 0.99, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
550, d1iruB_, 0.8984, 1.19, 0.608, 233, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
551, p5lf0A_, 0.8983, 0.99, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
552, d5le5A_, 0.8983, 0.99, 0.613, 230, 230, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
553, p3uneA_, 0.8980, 1.19, 0.603, 233, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
554, p6avoP_, 0.8967, 1.01, 0.613, 230, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
555, p6avob_, 0.8967, 1.01, 0.613, 230, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
556, p3unhO_, 0.8941, 1.09, 0.609, 230, 230, MOUSE 20S IMMUNOPROTEASOME
557, p3unhA_, 0.8941, 1.09, 0.609, 230, 230, MOUSE 20S IMMUNOPROTEASOME
558, d3unfO_, 0.8934, 1.11, 0.609, 230, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
559, d3unfA_, 0.8934, 1.11, 0.609, 230, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
560, p5m32O_, 0.8923, 1.09, 0.613, 230, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
561, p5m32A_, 0.8923, 1.09, 0.613, 230, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
562, p5vfsAA_, 0.8922, 1.19, 0.610, 232, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
563, p5vfsB_, 0.8919, 1.20, 0.610, 232, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
564, p5vfoh_, 0.8912, 1.20, 0.602, 232, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
565, p5vfqAA_, 0.8910, 1.21, 0.606, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
566, p5vfpZ_, 0.8907, 1.21, 0.602, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
567, p5vfrh_, 0.8901, 1.22, 0.602, 232, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
568, p5vfuS_, 0.8898, 1.23, 0.610, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
569, p5vftH_, 0.8897, 1.23, 0.610, 232, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
570, p5t0cZA_, 0.8896, 1.24, 0.610, 232, 231, 
571, p5t0cT_, 0.8896, 1.24, 0.610, 232, 231, 
572, p5vfuGA_, 0.8863, 1.29, 0.610, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
573, p5vfth_, 0.8863, 1.29, 0.610, 232, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
574, p5t0gH_, 0.8850, 1.45, 0.608, 233, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
575, p5ln3B_, 0.8751, 1.54, 0.616, 234, 232, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
576, p5t0hH_, 0.8747, 1.50, 0.606, 232, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
577, d4r02P_, 0.8725, 2.14, 0.357, 244, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
578, d1rypQ_, 0.8714, 2.18, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
579, d4eu2Q_, 0.8712, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
580, d3unfP_, 0.8711, 1.97, 0.356, 248, 233, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
581, p3unfB_, 0.8711, 1.97, 0.356, 248, 233, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
582, d2gplP_, 0.8711, 2.20, 0.357, 244, 235, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
583, d2gplB_, 0.8710, 2.20, 0.357, 244, 235, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
584, d3nzjP_, 0.8709, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
585, d5bouP_, 0.8708, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
586, d4qluP_, 0.8708, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
587, d4q1sP_, 0.8708, 2.24, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
588, d3nzjB_, 0.8708, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
589, d3hyeP_, 0.8708, 2.20, 0.357, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
590, d5lajP_, 0.8707, 2.17, 0.353, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
591, d5fgaP_, 0.8707, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
592, d5cgfP_, 0.8707, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
593, d5bouB_, 0.8707, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
594, d4rurP_, 0.8707, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
595, d4r18P_, 0.8707, 2.17, 0.357, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
596, p4qluB_, 0.8707, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
597, d4qlqP_, 0.8707, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
598, d3wxrQ_, 0.8707, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
599, d3hyeB_, 0.8707, 2.20, 0.357, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
600, d2fakP_, 0.8707, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
601, d5lajB_, 0.8706, 2.17, 0.353, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
602, d5fgaB_, 0.8706, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
603, d5cgfB_, 0.8706, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
604, d4y9yP_, 0.8706, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
605, p4y6vP_, 0.8706, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
606, d4rurB_, 0.8706, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
607, p4r18B_, 0.8706, 2.17, 0.357, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
608, d4r17P_, 0.8706, 2.16, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
609, d4r17B_, 0.8706, 2.16, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
610, d4qltP_, 0.8706, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
611, p4qlqB_, 0.8706, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
612, d3nzwP_, 0.8706, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
613, d2fnyP_, 0.8706, 2.21, 0.362, 244, 235,  
614, d2fakB_, 0.8706, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
615, d1g65P_, 0.8706, 2.21, 0.353, 244, 235, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
616, d5lf4B_, 0.8705, 1.97, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
617, d5laiP_, 0.8705, 2.17, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
618, d5bxlP_, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
619, d5bxlB_, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
620, d4z1lP_, 0.8705, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
621, d4z1lB_, 0.8705, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
622, d4ya4P_, 0.8705, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
623, d4y9yB_, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
624, p4y8sP_, 0.8705, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
625, d4y8rP_, 0.8705, 2.15, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
626, p4y6vB_, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
627, p4y69P_, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
628, p4y69B_, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
629, d4qvyP_, 0.8705, 2.17, 0.357, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
630, p4qltB_, 0.8705, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
631, d4lqiP_, 0.8705, 2.22, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
632, p3unhP_, 0.8705, 1.98, 0.356, 248, 233, MOUSE 20S IMMUNOPROTEASOME
633, p3unhB_, 0.8705, 1.98, 0.356, 248, 233, MOUSE 20S IMMUNOPROTEASOME
634, d3nzwB_, 0.8705, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
635, d2fnyB_, 0.8705, 2.22, 0.362, 244, 235,  
636, d5le5B_, 0.8704, 1.97, 0.356, 248, 233, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
637, d5laiB_, 0.8704, 2.17, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
638, d5l54P_, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
639, d5l54B_, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
640, d5fg7P_, 0.8704, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
641, d5fg7B_, 0.8704, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
642, d5dkiP_, 0.8704, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
643, d5cz6P_, 0.8704, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
644, d5cz4P_, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
645, p4ya5P_, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
646, d4ya4B_, 0.8704, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
647, d4ya1P_, 0.8704, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
648, p4ya0P_, 0.8704, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
649, p4y8sB_, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
650, d4y8rB_, 0.8704, 2.15, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
651, p4y8nP_, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
652, d4qz2P_, 0.8704, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
653, d4qwfP_, 0.8704, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
654, d4qwfB_, 0.8704, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
655, d4qw6P_, 0.8704, 2.18, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
656, d4qw1P_, 0.8704, 2.16, 0.357, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
657, d4qw1B_, 0.8704, 2.16, 0.357, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
658, d4qvyB_, 0.8704, 2.17, 0.357, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
659, d4qvwP_, 0.8704, 2.17, 0.357, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
660, d4qvwB_, 0.8704, 2.17, 0.357, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
661, d4qvlP_, 0.8704, 2.16, 0.357, 244, 235, YCP IN COMPLEX WITH BORTEZOMIB
662, d4qlsP_, 0.8704, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
663, d4lqiB_, 0.8704, 2.22, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
664, d3tddP_, 0.8704, 2.21, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
665, d3e47P_, 0.8704, 2.22, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
666, p5lezB_, 0.8703, 1.98, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
667, p5gjqD_, 0.8703, 1.97, 0.356, 240, 233, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
668, d5fg9P_, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
669, d5fg9B_, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
670, d5dkiB_, 0.8703, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
671, d5d0wP_, 0.8703, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
672, d5d0tP_, 0.8703, 2.17, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
673, d5czaP_, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
674, d5cz6B_, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
675, d5cz4B_, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
676, p4ya5B_, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
677, d4ya1B_, 0.8703, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
678, p4ya0B_, 0.8703, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
679, p4y8uP_, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
680, p4y8nB_, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
681, d4y8mP_, 0.8703, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
682, p4y8iP_, 0.8703, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
683, d4qz2B_, 0.8703, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
684, d4qz1P_, 0.8703, 2.18, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
685, d4qw6B_, 0.8703, 2.18, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
686, d4qvmP_, 0.8703, 2.17, 0.357, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
687, d4qvmB_, 0.8703, 2.17, 0.357, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
688, d4qvlB_, 0.8703, 2.16, 0.357, 244, 235, YCP IN COMPLEX WITH BORTEZOMIB
689, p4qlsB_, 0.8703, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
690, d4intP_, 0.8703, 2.22, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
691, d3tddB_, 0.8703, 2.21, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
692, d3gpwP_, 0.8703, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
693, d3e47B_, 0.8703, 2.22, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
694, d5lf7B_, 0.8702, 1.97, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
695, d5lf3B_, 0.8702, 1.97, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
696, d5l65P_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
697, d5l65B_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
698, d5l5sP_, 0.8702, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
699, d5l5iP_, 0.8702, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
700, d5dkjP_, 0.8702, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
701, d5d0xP_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
702, d5d0xB_, 0.8702, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
703, d5d0wB_, 0.8702, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
704, d5d0tB_, 0.8702, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
705, d5czaB_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
706, d5cz8P_, 0.8702, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
707, p4ya3P_, 0.8702, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
708, p4y8uB_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
709, d4y8mB_, 0.8702, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
710, p4y8iB_, 0.8702, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
711, d4qz7P_, 0.8702, 2.17, 0.357, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
712, d4qz1B_, 0.8702, 2.18, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
713, d4qxjP_, 0.8702, 2.18, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
714, d4qwuP_, 0.8702, 2.16, 0.357, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
715, d4qwuB_, 0.8702, 2.16, 0.357, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
716, d4qw7P_, 0.8702, 2.18, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
717, d4qw4P_, 0.8702, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH CARFILZOMIB
718, d4qw0P_, 0.8702, 2.17, 0.357, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
719, d4qw0B_, 0.8702, 2.17, 0.357, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
720, d4qvpP_, 0.8702, 2.17, 0.357, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
721, d4qvpB_, 0.8702, 2.17, 0.357, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
722, d5l69P_, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
723, d5l69B_, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
724, d5l60P_, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
725, d5l5zP_, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
726, d5l5sB_, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
727, d5l5iB_, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
728, d5l5eP_, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
729, p5gjrIA_, 0.8701, 1.97, 0.356, 250, 233, 
730, p5fghP_, 0.8701, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
731, d5dkjB_, 0.8701, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
732, d5cz8B_, 0.8701, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
733, d5cz7P_, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
734, d5cz7B_, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
735, p4ya9P_, 0.8701, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
736, p4ya3B_, 0.8701, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
737, p4ya2P_, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
738, p4ya2B_, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
739, p4y8gP_, 0.8701, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
740, p4y84P_, 0.8701, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
741, p4y6aP_, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
742, d4qz7B_, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
743, d4qz5P_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
744, d4qz4P_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
745, d4qz4B_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
746, d4qz0P_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
747, d4qz0B_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
748, d4qxjB_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
749, d4qw7B_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
750, d4qw4B_, 0.8701, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH CARFILZOMIB
751, d4qvvP_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
752, d4qvvB_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
753, d4qvqP_, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
754, d4qvnP_, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
755, d4qvnB_, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
756, d4qv6P_, 0.8701, 2.16, 0.357, 244, 235, YCP BETA5-A49V MUTANT
757, d4qv6B_, 0.8701, 2.16, 0.357, 244, 235, YCP BETA5-A49V MUTANT
758, d4quxP_, 0.8701, 2.18, 0.357, 244, 235, YCP BETA5-A49T-MUTANT
759, d4quxB_, 0.8701, 2.18, 0.357, 244, 235, YCP BETA5-A49T-MUTANT
760, d4nnwP_, 0.8701, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
761, d4nnwB_, 0.8701, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
762, d4ltcP_, 0.8701, 2.19, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
763, d3gpwB_, 0.8701, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
764, d5m2bP_, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
765, d5lttP_, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
766, p5lf0B_, 0.8700, 1.98, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
767, p5lezP_, 0.8700, 2.00, 0.356, 247, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
768, p5leyB_, 0.8700, 1.98, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
769, d5l60B_, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
770, d5l5zB_, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
771, d5l5tP_, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
772, d5l5tB_, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
773, d5l5hP_, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
774, d5l5fP_, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
775, d5l5fB_, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
776, d5l5eB_, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
777, d5l5aP_, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
778, d5fgiP_, 0.8700, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
779, p5fghB_, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
780, d5bxnP_, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
781, d5bxnB_, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
782, p4ya9B_, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
783, p4y9zP_, 0.8700, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
784, p4y8lP_, 0.8700, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
785, p4y8gB_, 0.8700, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
786, p4y84B_, 0.8700, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
787, p4y6aB_, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
788, d4qz6P_, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
789, d4qz6B_, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
790, d4qz5B_, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
791, d4qwiP_, 0.8700, 2.19, 0.353, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
792, d4qw5P_, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
793, d4qw5B_, 0.8700, 2.19, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
794, d4qvqB_, 0.8700, 2.17, 0.357, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
795, d4quyP_, 0.8700, 2.16, 0.357, 244, 235, YCP BETA5-A49S-MUTANT
796, d4hrdP_, 0.8700, 2.19, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
797, d3nzxP_, 0.8700, 2.22, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
798, d3mg4P_, 0.8700, 2.24, 0.362, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
799, p6gopP_, 0.8699, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
800, p6epfB_, 0.8699, 1.64, 0.608, 234, 232, GROUND STATE 26S PROTEASOME (GS1)
801, d5m2bB_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
802, d5lttB_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
803, d5lf1B_, 0.8699, 1.98, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
804, d5l6bP_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
805, d5l6bB_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
806, d5l68P_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
807, d5l68B_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
808, d5l66P_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
809, d5l66B_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
810, d5l63P_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
811, d5l5yP_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
812, d5l5xP_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
813, d5l5xB_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
814, d5l5uP_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
815, d5l5uB_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
816, d5l5pP_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
817, d5l5jP_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
818, d5l5jB_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
819, d5l5hB_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
820, d5l5dP_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
821, d5l5dB_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
822, d5l5aB_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
823, d5jhsP_, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
824, d5jhsB_, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
825, d5fgiB_, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
826, d5d0vP_, 0.8699, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
827, d5d0vB_, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
828, p5cgiP_, 0.8699, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
829, p5cgiB_, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
830, p4y9zB_, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
831, p4y8pP_, 0.8699, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
832, p4y8oP_, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
833, p4y8lB_, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
834, p4y8jP_, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
835, p4y8hP_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
836, p4y8hB_, 0.8699, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
837, p4y7xP_, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
838, p4y7xB_, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
839, d4qzzP_, 0.8699, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH OMURALIDE
840, d4qzzB_, 0.8699, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH OMURALIDE
841, d4qzxP_, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
842, d4qzwP_, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
843, d4qwxP_, 0.8699, 2.18, 0.353, 244, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
844, d4qwlP_, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
845, d4qwlB_, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
846, d4qwiB_, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
847, d4qw3P_, 0.8699, 2.18, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
848, d4qw3B_, 0.8699, 2.18, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
849, d4quyB_, 0.8699, 2.16, 0.357, 244, 235, YCP BETA5-A49S-MUTANT
850, d3nzxB_, 0.8699, 2.22, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
851, d3dy4P_, 0.8699, 2.24, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
852, d3dy3P_, 0.8699, 2.24, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
853, d3d29P_, 0.8699, 2.24, 0.357, 244, 235, PROTEASOME INHIBITION BY FELLUTAMIDE B
854, d3d29B_, 0.8699, 2.24, 0.357, 244, 235, PROTEASOME INHIBITION BY FELLUTAMIDE B
855, p6gopB_, 0.8698, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
856, d5lexB_, 0.8698, 1.99, 0.356, 248, 233, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
857, d5l6cP_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
858, d5l6cB_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
859, d5l67P_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
860, d5l67B_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
861, d5l64P_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
862, d5l64B_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
863, d5l63B_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
864, d5l5yB_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
865, d5l5wP_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
866, d5l5qP_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
867, d5l5qB_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
868, d5l5pB_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
869, d5l5oP_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
870, d5jhrP_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
871, p5gjrU_, 0.8698, 1.98, 0.356, 250, 233, 
872, d5fgfP_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
873, d5fgfB_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
874, d5fgdP_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
875, d5fgdB_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
876, d5d0zP_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
877, p5cghP_, 0.8698, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
878, p4y8tP_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
879, p4y8pB_, 0.8698, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
880, p4y8oB_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
881, p4y8jB_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
882, p4y7yP_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
883, p4y77P_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
884, p4y77B_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
885, d4qzxB_, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
886, d4qzwB_, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
887, d4qz3P_, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
888, d4qz3B_, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
889, d4qwxB_, 0.8698, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
890, d4qwrP_, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
891, d4qwkP_, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
892, d4qv9P_, 0.8698, 2.16, 0.357, 244, 235, YCP BETA5-C63F MUTANT
893, d4qv8P_, 0.8698, 2.18, 0.357, 244, 235, YCP BETA5-C52F MUTANT
894, d4qv7P_, 0.8698, 2.18, 0.357, 244, 235, YCP BETA5-A50V MUTANT
895, d3mg0P_, 0.8698, 2.26, 0.357, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
896, d3gptP_, 0.8698, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
897, d3dy4B_, 0.8698, 2.24, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
898, d3dy3B_, 0.8698, 2.24, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
899, d2f16P_, 0.8698, 2.22, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
900, d5l62P_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
901, d5l5wB_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
902, d5l5vP_, 0.8697, 2.18, 0.357, 244, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
903, d5l5rP_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
904, d5l5oB_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
905, d5l55P_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
906, d5l52P_, 0.8697, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
907, d5l52B_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
908, d5jhrB_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
909, d5d0zB_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
910, d5cz9P_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
911, d5cz5P_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
912, p5cghB_, 0.8697, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
913, p4ya7P_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
914, p4ya7B_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
915, p4y8tB_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
916, p4y8qP_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
917, p4y82P_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
918, p4y81P_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
919, p4y80P_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
920, p4y80B_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
921, p4y7yB_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
922, p4y78P_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
923, p4y78B_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
924, d4r00P_, 0.8697, 2.18, 0.357, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
925, d4qwrB_, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
926, d4qwkB_, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
927, d4qwjP_, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
928, d4qwjB_, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
929, d4qv9B_, 0.8697, 2.17, 0.357, 244, 235, YCP BETA5-C63F MUTANT
930, d4qv8B_, 0.8697, 2.18, 0.357, 244, 235, YCP BETA5-C52F MUTANT
931, d4qv7B_, 0.8697, 2.18, 0.357, 244, 235, YCP BETA5-A50V MUTANT
932, d4qv0P_, 0.8697, 2.17, 0.357, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
933, d4intB_, 0.8697, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
934, d4inrP_, 0.8697, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
935, p4gk7P_, 0.8697, 2.22, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
936, d3gptB_, 0.8697, 2.22, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
937, d5l6aP_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
938, d5l62B_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
939, d5l61P_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
940, d5l5vB_, 0.8696, 2.18, 0.357, 244, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
941, d5l5rB_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
942, d5l5bP_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
943, d5l55B_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
944, d5fhsP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
945, d5fhsB_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
946, d5fgeP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
947, d5fgeB_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
948, d5d0sP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
949, d5cz9B_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
950, d5cz5B_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
951, p5cggP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
952, p4y8qB_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
953, p4y8kP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
954, p4y82B_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
955, p4y81B_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
956, p4y7wP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
957, p4y75P_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
958, p4y75B_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
959, p4y74P_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
960, p4y70P_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
961, p4y70B_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
962, d4r00B_, 0.8696, 2.18, 0.357, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
963, d4qv1P_, 0.8696, 2.18, 0.357, 244, 235, YCP BETA5-M45A MUTANT
964, d4qv1B_, 0.8696, 2.18, 0.357, 244, 235, YCP BETA5-M45A MUTANT
965, d4qv0B_, 0.8696, 2.17, 0.357, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
966, d4jsuP_, 0.8696, 2.21, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
967, d4hnpP_, 0.8696, 2.24, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
968, p4gk7B_, 0.8696, 2.22, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
969, d2f16B_, 0.8696, 2.23, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
970, p5lf6B_, 0.8695, 1.99, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
971, d5l6aB_, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
972, d5l61B_, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
973, d5l5bB_, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
974, d5fggP_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
975, d5fggB_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
976, d5d0sB_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
977, p5cggB_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
978, p4y8kB_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
979, p4y7wB_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
980, p4y74B_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
981, d4qwsP_, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
982, d4qwsB_, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
983, d4qv4P_, 0.8695, 2.18, 0.357, 244, 235, YCP BETA5-M45T MUTANT
984, d4jsuB_, 0.8695, 2.21, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
985, d3okjP_, 0.8695, 2.23, 0.357, 244, 235, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
986, d3gpjP_, 0.8695, 2.23, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
987, d3gpjB_, 0.8695, 2.23, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
988, p4y6zP_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
989, d4qv4B_, 0.8694, 2.18, 0.357, 244, 235, YCP BETA5-M45T MUTANT
990, d4qlvP_, 0.8694, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
991, p4qlvB_, 0.8694, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
992, p4qbyP_, 0.8694, 2.17, 0.353, 244, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
993, d4no9P_, 0.8694, 2.21, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
994, d4nnnP_, 0.8694, 2.20, 0.357, 244, 235, YCP IN COMPLEX WITH MG132
995, d4nnnB_, 0.8694, 2.20, 0.357, 244, 235, YCP IN COMPLEX WITH MG132
996, d4fzcP_, 0.8694, 2.24, 0.357, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
997, p3unbB_, 0.8694, 2.01, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
998, d3okjB_, 0.8694, 2.23, 0.357, 244, 235, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
999, p5t0iH_, 0.8693, 1.58, 0.609, 233, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1000, d5lf4P_, 0.8693, 1.99, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1001, d5le5P_, 0.8693, 1.99, 0.356, 247, 233, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1002, d5ahjP_, 0.8693, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1003, p4y6zB_, 0.8693, 2.20, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1004, d4qv5P_, 0.8693, 2.19, 0.357, 244, 235, YCP BETA5-M45I MUTANT
1005, d4qv3P_, 0.8693, 2.18, 0.357, 244, 235, YCP BETA5-M45V MUTANT
1006, p4qbyB_, 0.8693, 2.17, 0.353, 244, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1007, d4no9B_, 0.8693, 2.21, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1008, d4j70P_, 0.8693, 2.26, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1009, d4inrB_, 0.8693, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1010, d4fzcB_, 0.8693, 2.25, 0.357, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1011, d3bdmP_, 0.8693, 2.26, 0.362, 244, 235, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1012, d3bdmB_, 0.8693, 2.26, 0.362, 244, 235, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1013, d1g65B_, 0.8693, 2.22, 0.357, 244, 235, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1014, d5lf1P_, 0.8692, 2.00, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1015, d5ahjB_, 0.8692, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1016, d4r02B_, 0.8692, 2.20, 0.357, 244, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1017, d4qv5B_, 0.8692, 2.19, 0.357, 244, 235, YCP BETA5-M45I MUTANT
1018, d4qv3B_, 0.8692, 2.19, 0.357, 244, 235, YCP BETA5-M45V MUTANT
1019, d3unfC_, 0.8692, 1.51, 0.336, 238, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1020, d1rypC_, 0.8692, 2.21, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1021, d4no6P_, 0.8691, 2.20, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1022, d4no1P_, 0.8691, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1023, d4no1B_, 0.8691, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1024, d4inuP_, 0.8691, 2.24, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1025, d3unfQ_, 0.8691, 1.51, 0.336, 238, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1026, d4no6B_, 0.8690, 2.20, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1027, d4jsqP_, 0.8690, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1028, p3unhQ_, 0.8690, 1.52, 0.336, 238, 229, MOUSE 20S IMMUNOPROTEASOME
1029, p3unbP_, 0.8690, 2.02, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1030, p3unbd_, 0.8690, 2.02, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1031, d2zcyP_, 0.8690, 2.25, 0.357, 244, 235, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1032, d2zcyB_, 0.8690, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1033, p5nifS_, 0.8689, 1.64, 0.329, 236, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1034, d5lf7P_, 0.8689, 2.00, 0.356, 247, 233, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1035, p4zzgS_, 0.8689, 1.64, 0.329, 236, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1036, d4jsqB_, 0.8689, 2.24, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1037, p3unhC_, 0.8689, 1.52, 0.336, 238, 229, MOUSE 20S IMMUNOPROTEASOME
1038, p3un4P_, 0.8689, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1039, d3shjP_, 0.8689, 2.24, 0.362, 244, 235, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1040, p5lf6P_, 0.8688, 2.01, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1041, d4qwgP_, 0.8688, 2.21, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1042, d4qwgB_, 0.8688, 2.21, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1043, d4no8P_, 0.8688, 2.20, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1044, d4hrcP_, 0.8688, 2.26, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1045, d3un8P_, 0.8688, 2.24, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1046, p3un4B_, 0.8688, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1047, d5lf3P_, 0.8687, 2.01, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1048, p5lf0P_, 0.8687, 2.01, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1049, p4x6zQ_, 0.8687, 2.22, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1050, d4no8B_, 0.8687, 2.20, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1051, d4jt0P_, 0.8687, 2.23, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1052, d4j70B_, 0.8687, 2.26, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1053, d3shjB_, 0.8687, 2.24, 0.362, 244, 235, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1054, d3dy3R_, 0.8687, 1.60, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1055, d3dy3D_, 0.8687, 1.60, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1056, p5lezC_, 0.8686, 1.45, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1057, d5lexP_, 0.8686, 2.02, 0.356, 247, 233, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1058, p4q1sB_, 0.8686, 2.20, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1059, d4jt0B_, 0.8686, 2.23, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1060, d4inuB_, 0.8686, 2.25, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1061, d4hnpB_, 0.8686, 2.23, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1062, d4eu2S_, 0.8686, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1063, d4j70D_, 0.8685, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1064, d4fzgP_, 0.8685, 2.26, 0.357, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1065, d4ltcB_, 0.8684, 2.21, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1066, d4j70R_, 0.8684, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1067, p3unbr_, 0.8684, 2.03, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1068, d3mg0R_, 0.8684, 1.60, 0.329, 242, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1069, p5leyP_, 0.8683, 2.01, 0.356, 247, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1070, d4fzgB_, 0.8683, 2.26, 0.357, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1071, d3mg0D_, 0.8682, 1.61, 0.329, 242, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1072, d2gplR_, 0.8682, 1.60, 0.329, 242, 228, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1073, d2gplD_, 0.8682, 1.60, 0.329, 242, 228, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1074, d2fakR_, 0.8682, 1.60, 0.329, 242, 228, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1075, d2fakD_, 0.8682, 1.60, 0.329, 242, 228, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1076, d3tddD_, 0.8681, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1077, d3mg0B_, 0.8681, 2.28, 0.357, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1078, d3dy4R_, 0.8681, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1079, d3dy4D_, 0.8681, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1080, p5l4gQ_, 0.8680, 2.00, 0.356, 240, 233, 
1081, d4lqiR_, 0.8680, 1.60, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1082, d4lqiD_, 0.8680, 1.60, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1083, d3tddR_, 0.8680, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1084, d3nzjR_, 0.8680, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1085, d3nzjD_, 0.8680, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1086, d2zcyR_, 0.8680, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1087, d2zcyD_, 0.8680, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1088, p5nifQ_, 0.8679, 2.00, 0.361, 242, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1089, p5mp9c_, 0.8679, 2.15, 0.353, 244, 235, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1090, d5lf7C_, 0.8679, 1.45, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1091, p4zzgQ_, 0.8679, 2.01, 0.361, 242, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1092, d4hrdB_, 0.8679, 2.23, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1093, d4eu2E_, 0.8679, 1.65, 0.329, 242, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1094, d5le5C_, 0.8678, 1.46, 0.338, 236, 228, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1095, p5gjqj_, 0.8678, 2.00, 0.356, 240, 233, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1096, p4gk7D_, 0.8677, 1.60, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1097, p4fzgD_, 0.8677, 1.61, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1098, d3un8B_, 0.8677, 2.26, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1099, d3gpwD_, 0.8677, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1100, d3d29D_, 0.8677, 1.61, 0.329, 242, 228, PROTEASOME INHIBITION BY FELLUTAMIDE B
1101, d2f16R_, 0.8677, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1102, d2f16D_, 0.8677, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1103, d1jd2W_, 0.8677, 2.25, 0.353, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1104, d5lf4C_, 0.8676, 1.46, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1105, p5leyC_, 0.8676, 1.46, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1106, d4q1sD_, 0.8676, 1.66, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1107, d4intR_, 0.8676, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1108, p4gk7R_, 0.8676, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1109, p4fzgR_, 0.8676, 1.61, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1110, p3unbe_, 0.8676, 1.53, 0.332, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1111, p3un4R_, 0.8676, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1112, p3un4D_, 0.8676, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1113, d3gpwR_, 0.8676, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1114, d3gptR_, 0.8676, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1115, d3gptD_, 0.8676, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1116, d3gpjD_, 0.8676, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1117, p3e47D_, 0.8676, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1118, d3d29R_, 0.8676, 1.61, 0.329, 242, 228, PROTEASOME INHIBITION BY FELLUTAMIDE B
1119, d5lf1C_, 0.8675, 1.47, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1120, d5lexC_, 0.8675, 1.46, 0.338, 236, 228, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1121, p4jt0R_, 0.8675, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1122, p4jt0D_, 0.8675, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1123, d4inrD_, 0.8675, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1124, d3okjR_, 0.8675, 1.62, 0.329, 242, 228, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1125, d3okjD_, 0.8675, 1.62, 0.329, 242, 228, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1126, d3hyeR_, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1127, d3hyeD_, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1128, d3gpjR_, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1129, p3e47R_, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1130, d5lf3C_, 0.8674, 1.46, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1131, d4q1sR_, 0.8674, 1.64, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1132, d4jsuR_, 0.8674, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1133, d4jsuD_, 0.8674, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1134, p4inuD_, 0.8674, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1135, d3nzwR_, 0.8674, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1136, d3nzwD_, 0.8674, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1137, p5lf6C_, 0.8673, 1.47, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1138, d4inrR_, 0.8673, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1139, d4hrcB_, 0.8673, 2.28, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1140, d3nzxD_, 0.8673, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1141, p5lf0C_, 0.8672, 1.47, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1142, d4intD_, 0.8672, 1.68, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1143, d3shjD_, 0.8672, 1.61, 0.329, 242, 228, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1144, d3nzxR_, 0.8672, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1145, d4jsqR_, 0.8671, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1146, d4jsqD_, 0.8671, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1147, d4fzcR_, 0.8671, 1.61, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1148, d4fzcD_, 0.8671, 1.61, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1149, d4eu2C_, 0.8671, 2.26, 0.357, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1150, p3uneP_, 0.8671, 2.04, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1151, d3shjR_, 0.8671, 1.61, 0.329, 242, 228, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1152, d4r67Q_, 0.8670, 2.03, 0.356, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1153, d4ltcR_, 0.8670, 1.64, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1154, p4inuR_, 0.8670, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1155, p4r67s_, 0.8669, 2.03, 0.356, 240, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1156, p4r67e_, 0.8669, 2.03, 0.356, 239, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1157, d4r67C_, 0.8669, 2.03, 0.356, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1158, d4r3oQ_, 0.8669, 2.03, 0.356, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME
1159, d4r3oC_, 0.8669, 2.03, 0.356, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME
1160, d4ltcD_, 0.8669, 1.64, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1161, d3wxrS_, 0.8669, 1.47, 0.330, 238, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1162, d3un8D_, 0.8669, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1163, d1g65D_, 0.8668, 1.64, 0.329, 242, 228, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1164, d4hrcD_, 0.8667, 1.65, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1165, p3unbQ_, 0.8667, 1.54, 0.336, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1166, p3unbs_, 0.8666, 1.54, 0.336, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1167, d3mg8R_, 0.8666, 1.47, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1168, d1jd2B_, 0.8666, 2.26, 0.353, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1169, d5lttR_, 0.8665, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1170, d5lttD_, 0.8665, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1171, d5l60R_, 0.8665, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1172, d5l60D_, 0.8665, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1173, p5l4gC_, 0.8665, 2.03, 0.356, 240, 233, 
1174, p3unbC_, 0.8665, 1.56, 0.328, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1175, d3un8R_, 0.8665, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1176, d3mg7R_, 0.8665, 1.46, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1177, d5l62R_, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1178, d5l62D_, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1179, d5l5zR_, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1180, d5l5zD_, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1181, d5l5yR_, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1182, d5l5yD_, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1183, d5l5xD_, 0.8664, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1184, p4ya0R_, 0.8664, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1185, p4ya0D_, 0.8664, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1186, d3oeuD_, 0.8664, 1.47, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1187, d3bdmD_, 0.8664, 1.45, 0.330, 242, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1188, d5l61R_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1189, d5l61D_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1190, d5l5xR_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1191, d5l5wR_, 0.8663, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1192, d5l5wD_, 0.8663, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1193, d5l5vR_, 0.8663, 1.58, 0.330, 235, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1194, d5l5vD_, 0.8663, 1.58, 0.330, 235, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1195, d5l5sR_, 0.8663, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1196, d5l5sD_, 0.8663, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1197, d5cz4R_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1198, d5cz4D_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1199, p4ya3R_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1200, p4ya3D_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1201, p4y8uR_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1202, p4y8uD_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1203, p4y69R_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1204, p4y69D_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1205, d4qw3R_, 0.8663, 1.58, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1206, d4qw3D_, 0.8663, 1.58, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1207, d4qvvR_, 0.8663, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1208, d4qvvD_, 0.8663, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1209, d4hrdD_, 0.8663, 1.48, 0.330, 242, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1210, d4hrcR_, 0.8663, 1.68, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1211, d3mg8D_, 0.8663, 1.48, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1212, d3dy4C_, 0.8663, 1.54, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1213, d3bdmR_, 0.8663, 1.45, 0.330, 242, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1214, d1rypE_, 0.8663, 1.46, 0.330, 242, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1215, d5l6cR_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1216, d5l6cD_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1217, d5l64R_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1218, d5l64D_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1219, d5l63R_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1220, d5l63D_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1221, d5l5tR_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1222, d5l5tD_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1223, d5l5pD_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1224, d5l5iR_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1225, d5l5iD_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1226, d5l5eR_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1227, d5l5eD_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1228, d5l5aD_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1229, p5fghR_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1230, p5fghD_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1231, d5dkiR_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1232, d5dkiD_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1233, p4zzgD_, 0.8662, 1.55, 0.362, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1234, p4ya5R_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1235, p4ya5D_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1236, d4q1sC_, 0.8662, 1.55, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1237, d4hnpR_, 0.8662, 1.46, 0.330, 242, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1238, p3uner_, 0.8662, 2.06, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1239, d3oevR_, 0.8662, 1.47, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1240, d3mg6R_, 0.8662, 1.47, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1241, d3mg4B_, 0.8662, 2.33, 0.357, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1242, d3dy4Q_, 0.8662, 1.54, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1243, d2zcyC_, 0.8662, 1.54, 0.367, 241, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1244, p5nifD_, 0.8661, 1.55, 0.362, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1245, d5l68R_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1246, d5l68D_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1247, d5l67R_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1248, d5l67D_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1249, d5l65R_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1250, d5l65D_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1251, d5l5qR_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1252, d5l5qD_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1253, d5l5pR_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1254, d5l5jR_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1255, d5l5jD_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1256, d5l5fR_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1257, d5l5fD_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1258, d5l5aR_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1259, d5d0xR_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1260, d5d0xD_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1261, p4y8nR_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1262, p4y8nD_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1263, p4y6vR_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1264, p4y6vD_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1265, d4rurD_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1266, d4hnpD_, 0.8661, 1.46, 0.330, 242, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1267, d3mg4R_, 0.8661, 1.47, 0.330, 242, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1268, d2zcyQ_, 0.8661, 1.54, 0.367, 241, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1269, d5lajR_, 0.8660, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1270, d5lajD_, 0.8660, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1271, d5l6bR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1272, d5l6bD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1273, d5l69R_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1274, d5l69D_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1275, d5l5oR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1276, d5l5oD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1277, d5l5hR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1278, d5l5hD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1279, d5dkjR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1280, d5dkjD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1281, d5d0tD_, 0.8660, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1282, d5cz7R_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1283, d5cz7D_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1284, d5bouR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1285, d5bouD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1286, p4y6aR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1287, p4y6aD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1288, d4rurR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1289, d4qwjR_, 0.8660, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1290, d4qwjD_, 0.8660, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1291, d4qw0R_, 0.8660, 1.58, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1292, d4qw0D_, 0.8660, 1.58, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1293, d4qvmR_, 0.8660, 1.58, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1294, d4qvmD_, 0.8660, 1.58, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1295, p3jcpLA_, 0.8660, 2.21, 0.362, 244, 235, 
1296, p3jcpL_, 0.8660, 2.21, 0.362, 244, 235, 
1297, d1g65R_, 0.8660, 1.65, 0.329, 242, 228, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1298, p6avoZ_, 0.8659, 2.04, 0.356, 240, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1299, p6avoO_, 0.8659, 2.04, 0.356, 240, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1300, d5m2bR_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1301, d5m2bD_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1302, d5l66R_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1303, d5l66D_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1304, d5l5uR_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1305, d5l5uD_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1306, d5fgaD_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1307, d5fg9R_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1308, d5fg9D_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1309, d5d0tR_, 0.8659, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1310, d4y9yD_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1311, p4quxR_, 0.8659, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT
1312, p4quxD_, 0.8659, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT
1313, d4hrdR_, 0.8659, 1.49, 0.330, 242, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1314, d3mg6D_, 0.8659, 1.48, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1315, d3dy3C_, 0.8659, 1.54, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1316, d5laiR_, 0.8658, 1.58, 0.330, 235, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1317, d5laiD_, 0.8658, 1.58, 0.330, 235, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1318, d5l5rD_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1319, d5fgdR_, 0.8658, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1320, d5fgdD_, 0.8658, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1321, d5fgaR_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1322, d5cz6R_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1323, d5cz6D_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1324, d5cgfR_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1325, d5cgfD_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1326, d4z1lR_, 0.8658, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1327, d4z1lD_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1328, d4y9yR_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1329, d4y8mD_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1330, p4y8iR_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1331, p4y8iD_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1332, p4y78R_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1333, p4y78D_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1334, p4x6zC_, 0.8658, 2.30, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1335, d4qwiR_, 0.8658, 1.58, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1336, d4qwiD_, 0.8658, 1.58, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1337, p3uned_, 0.8658, 2.07, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1338, d3oevD_, 0.8658, 1.48, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1339, d3oeuR_, 0.8658, 1.53, 0.330, 236, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1340, d3mg4D_, 0.8658, 1.51, 0.330, 242, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1341, d3dy3Q_, 0.8658, 1.54, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1342, d1rypS_, 0.8658, 1.46, 0.330, 242, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1343, d5l6aR_, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1344, d5l6aD_, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1345, d5l5rR_, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1346, d5l5dR_, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1347, d5l5dD_, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1348, d5fg7R_, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1349, p4y8oR_, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1350, p4y8oD_, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1351, d4y8mR_, 0.8657, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1352, d4r18R_, 0.8657, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1353, d4r18D_, 0.8657, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1354, d4r00R_, 0.8657, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1355, d4r00D_, 0.8657, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1356, d4qwkR_, 0.8657, 1.58, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1357, d4qwkD_, 0.8657, 1.58, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1358, d4qvyR_, 0.8657, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1359, d4qvyD_, 0.8657, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1360, p4qvwR_, 0.8657, 1.58, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1361, p4qvwD_, 0.8657, 1.58, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1362, d4q1sQ_, 0.8657, 1.54, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1363, d3mg7D_, 0.8657, 1.48, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1364, d1iruQ_, 0.8657, 2.03, 0.356, 250, 233, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1365, d1iruC_, 0.8657, 2.03, 0.356, 250, 233, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1366, d5l5bR_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1367, d5l5bD_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1368, d5fg7D_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1369, d5bxlR_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1370, d5bxlD_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1371, d4ya1R_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1372, d4ya1D_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1373, p4y8tR_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1374, p4y8tD_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1375, p4y8qR_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1376, p4y8qD_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1377, p4y8jR_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1378, p4y8jD_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1379, p4y80R_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1380, p4y80D_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1381, p4y7yR_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1382, p4y7yD_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1383, p4y7xR_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1384, p4y7xD_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1385, p4y7wR_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1386, p4y7wD_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1387, p4r67t_, 0.8656, 1.56, 0.336, 232, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1388, p4r67f_, 0.8656, 1.56, 0.336, 232, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1389, p4r3oR_, 0.8656, 1.56, 0.341, 231, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
1390, d4qzxR_, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1391, d4qzxD_, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1392, d4qz7R_, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1393, d4qz7D_, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1394, d4qz5R_, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1395, d4qz5D_, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1396, p4qz1R_, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1397, p4qz1D_, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1398, p4qwsR_, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1399, p4qwsD_, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1400, d4qw4R_, 0.8656, 1.58, 0.330, 235, 227, YCP IN COMPLEX WITH CARFILZOMIB
1401, d4qw4D_, 0.8656, 1.58, 0.330, 235, 227, YCP IN COMPLEX WITH CARFILZOMIB
1402, d4qvqR_, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1403, d4qvqD_, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1404, d4qvlR_, 0.8656, 1.58, 0.330, 235, 227, YCP IN COMPLEX WITH BORTEZOMIB
1405, d4qvlD_, 0.8656, 1.58, 0.330, 235, 227, YCP IN COMPLEX WITH BORTEZOMIB
1406, d4qv8D_, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT
1407, d5czaR_, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1408, d5czaD_, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1409, p4y8lR_, 0.8655, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1410, p4y8lD_, 0.8655, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1411, p4y81R_, 0.8655, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1412, p4y81D_, 0.8655, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1413, p4y70R_, 0.8655, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1414, p4y70D_, 0.8655, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1415, p4r67D_, 0.8655, 1.56, 0.336, 232, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1416, p4r3oD_, 0.8655, 1.56, 0.341, 231, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
1417, d4qzzR_, 0.8655, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH OMURALIDE
1418, d4qzzD_, 0.8655, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH OMURALIDE
1419, p4qzwR_, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1420, p4qzwD_, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1421, d4qz3R_, 0.8655, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1422, d4qz3D_, 0.8655, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1423, d4qxjR_, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1424, d4qxjD_, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1425, d4qwgD_, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1426, d4qw1R_, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1427, d4qw1D_, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1428, d4qvpR_, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1429, d4qvpD_, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1430, d4qv8R_, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT
1431, d4qv7R_, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT
1432, d4qv7D_, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT
1433, d5jhsR_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1434, d5jhsD_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1435, d5cz9R_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1436, d5cz9D_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1437, p5cgiR_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1438, p5cgiD_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1439, p4zzgR_, 0.8654, 1.56, 0.362, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1440, p4y9zR_, 0.8654, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1441, p4y9zD_, 0.8654, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1442, p4y8sR_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1443, p4y8sD_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1444, d4y8rR_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1445, d4y8rD_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1446, p4y82R_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1447, p4y82D_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1448, d4qz6R_, 0.8654, 1.58, 0.330, 235, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1449, d4qz6D_, 0.8654, 1.58, 0.330, 235, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1450, d4qwgR_, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1451, d4qw7D_, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1452, d4qv4R_, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT
1453, d4qv4D_, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT
1454, p4qv3D_, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-M45V MUTANT
1455, p4qv0R_, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1456, p4qv0D_, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1457, d4quyD_, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-A49S-MUTANT
1458, d3wxrE_, 0.8654, 1.68, 0.329, 239, 228, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1459, d3wxrC_, 0.8654, 2.09, 0.361, 242, 233, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1460, p6gopQ_, 0.8653, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1461, p6gopC_, 0.8653, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1462, p5nifR_, 0.8653, 1.57, 0.362, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1463, p5mp9C_, 0.8653, 2.22, 0.353, 244, 235, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1464, d5d0wR_, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1465, d5d0wD_, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1466, d4ya4R_, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1467, d4ya4D_, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1468, p4y74R_, 0.8653, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1469, p4y74D_, 0.8653, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1470, p4y6zR_, 0.8653, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1471, p4y6zD_, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1472, p4r67R_, 0.8653, 1.56, 0.336, 232, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1473, d4r17D_, 0.8653, 1.59, 0.330, 235, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1474, p4qwuR_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1475, p4qwuD_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1476, p4qwfR_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1477, p4qwfD_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1478, d4qw7R_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1479, d4qv5R_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45I MUTANT
1480, d4qv5D_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45I MUTANT
1481, p4qv3R_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45V MUTANT
1482, d4qv1R_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT
1483, d4qv1D_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT
1484, d4quyR_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A49S-MUTANT
1485, p6gopD_, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1486, d5lajC_, 0.8652, 1.55, 0.367, 240, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1487, d5bxnD_, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1488, p4y8pR_, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1489, p4y8pD_, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1490, p4y77D_, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1491, d4r17R_, 0.8652, 1.59, 0.330, 235, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1492, d4r02C_, 0.8652, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1493, p4qz4R_, 0.8652, 1.58, 0.330, 235, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1494, p4qz4D_, 0.8652, 1.58, 0.330, 235, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1495, d4qwxR_, 0.8652, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1496, d4qwxD_, 0.8652, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1497, d4qw6R_, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1498, d4qw6D_, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1499, d4qvvC_, 0.8652, 1.55, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1500, p6gopR_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1501, d5lajQ_, 0.8651, 1.56, 0.367, 240, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1502, d5d0zR_, 0.8651, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1503, d5d0zD_, 0.8651, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1504, d5d0vR_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1505, d5d0vD_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1506, d5d0tQ_, 0.8651, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1507, d5d0tC_, 0.8651, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1508, d5bxnR_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1509, p4zzgC_, 0.8651, 2.04, 0.362, 241, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1510, p4ya9R_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1511, p4ya9D_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1512, p4ya7R_, 0.8651, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1513, p4ya7D_, 0.8651, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1514, p4y77R_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1515, p4y75D_, 0.8651, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1516, p4qw5D_, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1517, d4qvvQ_, 0.8651, 1.55, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1518, d4qv9R_, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-C63F MUTANT
1519, d4qv9D_, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-C63F MUTANT
1520, d4qv6Q_, 0.8651, 1.56, 0.367, 240, 229, YCP BETA5-A49V MUTANT
1521, d4qv6D_, 0.8651, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT
1522, d4qv6C_, 0.8651, 1.56, 0.367, 240, 229, YCP BETA5-A49V MUTANT
1523, d3d29Q2, 0.8651, 1.55, 0.367, 234, 229, PROTEASOME INHIBITION BY FELLUTAMIDE B
1524, d3d29C2, 0.8651, 1.55, 0.367, 234, 229, PROTEASOME INHIBITION BY FELLUTAMIDE B
1525, p5nifC_, 0.8650, 2.04, 0.362, 241, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1526, d5l52R_, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1527, d5l52D_, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1528, d5jhrR_, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1529, d5jhrD_, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1530, p4y75R_, 0.8650, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1531, p4x6zR_, 0.8650, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1532, p4x6zE_, 0.8650, 1.54, 0.330, 242, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1533, d4qwuQ_, 0.8650, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1534, d4qwuC_, 0.8650, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1535, d4qwlD_, 0.8650, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1536, d4qv6R_, 0.8650, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT
1537, d4qv0Q_, 0.8650, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1538, d4qv0C_, 0.8650, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1539, d4qlsD_, 0.8650, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1540, d4nnnR_, 0.8650, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH MG132
1541, d4nnnD_, 0.8650, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH MG132
1542, d4eu2D_, 0.8650, 1.56, 0.362, 241, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1543, p3uneB_, 0.8650, 2.08, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1544, d3sdkC_, 0.8650, 1.56, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1545, d3mg6C_, 0.8650, 1.56, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1546, d5fgfD_, 0.8649, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1547, d5dkjQ_, 0.8649, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1548, d5dkjC_, 0.8649, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1549, d5dkiQ_, 0.8649, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1550, d5dkiC_, 0.8649, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1551, p5cggR_, 0.8649, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1552, p5cggD_, 0.8649, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1553, d4r00Q_, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1554, d4r00C_, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1555, d4qzzQ_, 0.8649, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH OMURALIDE
1556, d4qzzC_, 0.8649, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH OMURALIDE
1557, p4qz0R_, 0.8649, 1.60, 0.330, 235, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1558, p4qz0D_, 0.8649, 1.60, 0.330, 235, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1559, d4qwlR_, 0.8649, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1560, d4qw1Q_, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1561, d4qw1C_, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1562, d4qvpQ_, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1563, d4qvpC_, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1564, d4qvnR_, 0.8649, 1.60, 0.330, 235, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1565, d4qvnD_, 0.8649, 1.60, 0.330, 235, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1566, d4qlsR_, 0.8649, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1567, d4hrcC_, 0.8649, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1568, d5l54R_, 0.8648, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1569, d5l54D_, 0.8648, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1570, d5fggR_, 0.8648, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1571, d5fggD_, 0.8648, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1572, d5fgfR_, 0.8648, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1573, d5d0xC_, 0.8648, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1574, d5cz8Q_, 0.8648, 1.56, 0.362, 240, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1575, d5cz8C_, 0.8648, 1.56, 0.362, 240, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1576, d5cgfC_, 0.8648, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1577, p4x6zD_, 0.8648, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1578, d4qz6Q_, 0.8648, 1.57, 0.367, 240, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1579, d4qz6C_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1580, d4qz5Q_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1581, d4qz5C_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1582, d4qwjQ_, 0.8648, 1.56, 0.362, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1583, d4qwjC_, 0.8648, 1.56, 0.362, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1584, d4qw0Q_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1585, d4qw0C_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1586, d4qv8Q_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT
1587, d4qv8C_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT
1588, d4qv7Q_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT
1589, d4qv7C_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT
1590, d4fzcC_, 0.8648, 1.56, 0.367, 241, 229, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1591, d3gpjQ_, 0.8648, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1592, d3gpjC_, 0.8648, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1593, d5l55R_, 0.8647, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1594, d5l55D_, 0.8647, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1595, p5gjrJA_, 0.8647, 1.57, 0.341, 231, 229, 
1596, d5fhsR_, 0.8647, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1597, d5fhsD_, 0.8647, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1598, d5fgeR_, 0.8647, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1599, d5fgeD_, 0.8647, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1600, d5fgaQ_, 0.8647, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1601, d5fgaC_, 0.8647, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1602, d5d0xQ_, 0.8647, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1603, d5cz5R_, 0.8647, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1604, d5cz5D_, 0.8647, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1605, d5cgfQ_, 0.8647, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1606, d4r18C_, 0.8647, 1.56, 0.367, 240, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1607, d4r02R_, 0.8647, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1608, d4qzwQ_, 0.8647, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1609, d4qzwC_, 0.8647, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1610, d4qz3C_, 0.8647, 1.57, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1611, d4qvqC_, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1612, d4qv9Q_, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT
1613, d4qv9C_, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT
1614, d4qlvR_, 0.8647, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1615, d4qlvD_, 0.8647, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1616, d4no8D_, 0.8647, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1617, d4nnwR_, 0.8647, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1618, d4nnwD_, 0.8647, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1619, d4fzcQ_, 0.8647, 1.56, 0.367, 241, 229, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1620, p3uneQ_, 0.8647, 1.56, 0.341, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
1621, d3mg0C_, 0.8647, 1.57, 0.367, 241, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1622, d1rypD_, 0.8647, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1623, d1g65C_, 0.8647, 1.56, 0.362, 241, 229, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1624, p5gjrV_, 0.8646, 1.57, 0.341, 231, 229, 
1625, d5fgiR_, 0.8646, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1626, d5fgiD_, 0.8646, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1627, d5cz8R_, 0.8646, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1628, d5cz8D_, 0.8646, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1629, d5cz7Q_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1630, d5cz7C_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1631, d4z1lQ_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1632, d4z1lC_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1633, d4y9yC_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1634, d4r18Q_, 0.8646, 1.56, 0.367, 240, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1635, d4qz3Q_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1636, d4qxjC_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1637, d4qwrR_, 0.8646, 1.41, 0.332, 235, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1638, d4qwrD_, 0.8646, 1.40, 0.332, 235, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1639, d4qwlQ_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1640, d4qwlC_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1641, d4qwkC_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1642, d4qw7Q_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1643, d4qw7C_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1644, d4qw6Q_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1645, d4qw6C_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1646, d4qvwC_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1647, d4qvqQ_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1648, d4qvmQ_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1649, d4qvmC_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1650, d4qvlQ_, 0.8646, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH BORTEZOMIB
1651, d4qvlC_, 0.8646, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH BORTEZOMIB
1652, d4qv3C_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-M45V MUTANT
1653, d4quyQ_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49S-MUTANT
1654, d4quyC_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49S-MUTANT
1655, d4qlqR_, 0.8646, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1656, d4qlqD_, 0.8646, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1657, d4no8R_, 0.8646, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1658, d3oeuC_, 0.8646, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1659, d3bdmQ_, 0.8646, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1660, d3bdmC_, 0.8646, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1661, d5l52C_, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1662, d5jhsQ_, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1663, d5jhsC_, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1664, p5fghQ_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1665, p5fghC_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1666, d5fg7Q_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1667, d5fg7C_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1668, p5cgiQ_, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1669, p5cgiC_, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1670, p5cghR_, 0.8645, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1671, p5cghD_, 0.8645, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1672, p4ya2R_, 0.8645, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1673, p4ya2D_, 0.8645, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1674, d4y9yQ_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1675, p4y8uQ_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1676, p4y8uC_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1677, d4y8rQ_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1678, d4y8rC_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1679, p4y84R_, 0.8645, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1680, p4y84D_, 0.8645, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1681, d4r02D_, 0.8645, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1682, d4qzxC_, 0.8645, 1.57, 0.362, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1683, d4qz4Q_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1684, d4qz4C_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1685, d4qz2C_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1686, d4qxjQ_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1687, d4qwkQ_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1688, d4qw5Q_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1689, d4qw5C_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1690, d4qvyQ_, 0.8645, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1691, d4qvyC_, 0.8645, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1692, d4qvwQ_, 0.8645, 1.56, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1693, d4qv3Q_, 0.8645, 1.56, 0.367, 240, 229, YCP BETA5-M45V MUTANT
1694, d4qltR_, 0.8645, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1695, d4qltD_, 0.8645, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1696, d4hnpC_, 0.8645, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1697, d3shjQ_, 0.8645, 1.56, 0.362, 241, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1698, d3shjC_, 0.8645, 1.56, 0.362, 241, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1699, d3hyeC_, 0.8645, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1700, d5l52Q_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1701, p5gjqE_, 0.8644, 1.58, 0.341, 231, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1702, d5fhsC_, 0.8644, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1703, d5fggQ_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1704, d5fggC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1705, d5fg9Q_, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1706, d5fg9C_, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1707, d5d0zQ_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1708, d5d0zC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1709, d5d0wQ_, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1710, d5d0wC_, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1711, d5d0vQ_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1712, d5d0vC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1713, d5d0sQ_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1714, d5d0sC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1715, d5czaQ_, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1716, d5czaC_, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1717, d5cz5Q_, 0.8644, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1718, d5cz5C_, 0.8644, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1719, p4y8sC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1720, p4y8iC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1721, d4qzxQ_, 0.8644, 1.57, 0.362, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1722, d4qz2R_, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1723, d4qz2Q_, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1724, d4qz2D_, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1725, d4qz0C_, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1726, d4qwiQ_, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1727, d4qwiC_, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1728, d4qwfQ_, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1729, d4qwfC_, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1730, d4qw4C_, 0.8644, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH CARFILZOMIB
1731, d4qv1Q_, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT
1732, d4qv1C_, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT
1733, p4no6R_, 0.8644, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1734, p4no6D_, 0.8644, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1735, d4eu2R_, 0.8644, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1736, d3hyeQ_, 0.8644, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1737, d1rypR_, 0.8644, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1738, d5lttQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1739, d5lttC_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1740, d5l5sC_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1741, d5l55Q_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1742, d5l55C_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1743, d5fhsQ_, 0.8643, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1744, d5fgiQ_, 0.8643, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1745, d5fgiC_, 0.8643, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1746, d5fgfQ_, 0.8643, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1747, d5fgfC_, 0.8643, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1748, d5cz9Q_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1749, d5cz9C_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1750, d5bxnQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1751, d5bxnC_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1752, d5bxlQ_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1753, d5bxlC_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1754, d4ya4Q_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1755, d4ya4C_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1756, p4ya0Q_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1757, p4ya0C_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1758, p4y9zC_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1759, p4y8sQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1760, p4y8lQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1761, p4y8lC_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1762, p4y8iQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1763, p4y7yQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1764, p4y7yC_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1765, d4qz7Q_, 0.8643, 1.58, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1766, d4qz7C_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1767, d4qz0Q_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1768, d4qwrC_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1769, p4qw5R_, 0.8643, 1.41, 0.332, 235, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1770, d4qw4Q_, 0.8643, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH CARFILZOMIB
1771, d4qw3Q_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1772, d4qw3C_, 0.8643, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1773, d4qvnQ_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1774, d4qvnC_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1775, d4qv4Q_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT
1776, d4qv4C_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT
1777, d4quxC_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-A49T-MUTANT
1778, d4no1R_, 0.8643, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1779, d4no1D_, 0.8643, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1780, d2fnyC_, 0.8643, 1.56, 0.367, 241, 229,  
1781, d5l60C_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1782, d5l5xQ_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1783, d5l5xC_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1784, d5l5uQ_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1785, d5l5uC_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1786, d5l5sQ_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1787, d5fgdC_, 0.8642, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1788, d5cz6Q_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1789, d5cz6C_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1790, p5cggC_, 0.8642, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1791, p4y9zQ_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1792, p4y8kR_, 0.8642, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1793, p4y8kD_, 0.8642, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1794, p4y8jQ_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1795, p4y8jC_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1796, p4y8hR_, 0.8642, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1797, p4y8gR_, 0.8642, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1798, p4y8gD_, 0.8642, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1799, p4y69Q_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1800, d4qwrQ_, 0.8642, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1801, d4qv5Q_, 0.8642, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT
1802, d4qv5C_, 0.8642, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT
1803, d4quxQ_, 0.8642, 1.57, 0.367, 240, 229, YCP BETA5-A49T-MUTANT
1804, d4lqiQ_, 0.8642, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1805, d4lqiC_, 0.8642, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1806, d4j70C_, 0.8642, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1807, d3nzwC_, 0.8642, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1808, d3gpwC_, 0.8642, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1809, d3gptC_, 0.8642, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1810, d3e47C_, 0.8642, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1811, d2fnyQ_, 0.8642, 1.56, 0.367, 241, 229,  
1812, p5nifE_, 0.8641, 1.42, 0.332, 236, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1813, d5l65Q_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1814, d5l65C_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1815, d5l60Q_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1816, d5l5zC_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1817, d5l5vC_, 0.8641, 1.57, 0.367, 240, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1818, d5l5eQ_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1819, d5l5eC_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1820, d5jhrQ_, 0.8641, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1821, d5jhrC_, 0.8641, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1822, d5fgdQ_, 0.8641, 1.58, 0.362, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1823, d5d0sR_, 0.8641, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1824, d5d0sD_, 0.8641, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1825, p5cggQ_, 0.8641, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1826, p4ya3Q_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1827, p4ya3C_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1828, d4ya1Q_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1829, d4ya1C_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1830, p4y8hD_, 0.8641, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1831, p4y78C_, 0.8641, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1832, p4y69C_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1833, p4x6zS_, 0.8641, 1.56, 0.330, 242, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1834, d4qz1Q_, 0.8641, 1.58, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1835, d4qz1C_, 0.8641, 1.58, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1836, d4qwxQ_, 0.8641, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1837, d4qwxC_, 0.8641, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1838, d4qluR_, 0.8641, 1.62, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1839, d4qluD_, 0.8641, 1.62, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1840, d4fzgC_, 0.8641, 1.57, 0.367, 241, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1841, d3nzwQ_, 0.8641, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1842, d3gpwQ_, 0.8641, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1843, d3gptQ_, 0.8641, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1844, d3e47Q_, 0.8641, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1845, d5l67Q_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1846, d5l67C_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1847, d5l64Q_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1848, d5l64C_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1849, d5l62Q_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1850, d5l62C_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1851, d5l61Q_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1852, d5l61C_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1853, d5l5zQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1854, d5l5vQ_, 0.8640, 1.57, 0.367, 240, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1855, d5l5qQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1856, d5l5qC_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1857, d5l5hQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1858, d5l5hC_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1859, d5fgeQ_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1860, d5fgeC_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1861, d5cz4Q_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1862, d5cz4C_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1863, p4ya9Q_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1864, p4ya9C_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1865, p4ya7Q_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1866, p4ya7C_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1867, p4ya5Q_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1868, p4ya5C_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1869, p4ya2Q_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1870, p4ya2C_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1871, p4y8qC_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1872, p4y8pQ_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1873, p4y8pC_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1874, d4y8mQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1875, d4y8mC_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1876, p4y80C_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1877, p4y78Q_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1878, d4rurQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1879, d4rurC_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1880, d4no9R_, 0.8640, 1.62, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1881, d4no9D_, 0.8640, 1.62, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1882, d4inrQ_, 0.8640, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1883, d4fzgQ_, 0.8640, 1.57, 0.367, 241, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1884, d3un8Q_, 0.8640, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1885, d3un8C_, 0.8640, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1886, d3tddC_, 0.8640, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1887, d3oeuP_, 0.8640, 1.83, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1888, d3nzjQ_, 0.8640, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1889, d3nzjC_, 0.8640, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1890, d3mg0Q_, 0.8640, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1891, p5mpaC_, 0.8639, 2.27, 0.353, 244, 235, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1892, d5l6cQ_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1893, d5l6cC_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1894, d5l6bQ_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1895, d5l6bC_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1896, d5l63Q_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1897, d5l63C_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1898, d5l5yQ_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1899, d5l5yC_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1900, d5l5wQ_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1901, d5l5wC_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1902, d5l5iQ_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1903, d5l5iC_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1904, d5l5fQ_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1905, d5l5fC_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1906, p5cghQ_, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1907, p5cghC_, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1908, d5bouQ_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1909, d5bouC_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1910, p4y8qQ_, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1911, p4y8nQ_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1912, p4y8nC_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1913, p4y80Q_, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1914, p4y7xQ_, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1915, p4y7xC_, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1916, p4y7wQ_, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1917, p4y7wC_, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1918, p4y70Q_, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1919, p4y70C_, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1920, p4y6vQ_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1921, p4y6vC_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1922, d4qwsC_, 0.8639, 1.58, 0.362, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1923, d4inrC_, 0.8639, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1924, d3tddQ_, 0.8639, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1925, d3oevC_, 0.8639, 1.59, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1926, d3nzxQ_, 0.8639, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1927, d3nzxC_, 0.8639, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1928, d3mg8C_, 0.8639, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1929, d5l66Q_, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1930, d5l66C_, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1931, d5l5tQ_, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1932, d5l5tC_, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1933, p4zzgE_, 0.8638, 1.43, 0.332, 236, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1934, p4y6aQ_, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1935, p4y6aC_, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1936, d4qwsQ_, 0.8638, 1.58, 0.362, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1937, p4qbyR_, 0.8638, 1.62, 0.330, 235, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1938, p4qbyD_, 0.8638, 1.62, 0.330, 235, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1939, d4nnnQ_, 0.8638, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH MG132
1940, d4ltcC_, 0.8638, 1.59, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1941, d4j70Q_, 0.8638, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1942, p4gk7Q_, 0.8638, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1943, p4gk7C_, 0.8638, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1944, p3un4Q_, 0.8638, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1945, p3un4C_, 0.8638, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1946, d2fakQ_, 0.8638, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1947, d2fakC_, 0.8638, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1948, d2f16C_, 0.8638, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1949, d1g65Q_, 0.8638, 1.58, 0.362, 241, 229, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1950, d5l69Q_, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1951, d5l69C_, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1952, d5l5pQ_, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1953, d5l5pC_, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1954, d5l5jQ_, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1955, d5l5jC_, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1956, d5l54Q_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1957, d5l54C_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1958, d5ahjQ_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1959, d5ahjC_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1960, p4y8oQ_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1961, p4y8oC_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1962, p4y82C_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1963, p4y77Q_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1964, p4y77C_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1965, d4nnnC_, 0.8637, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH MG132
1966, d4ltcQ_, 0.8637, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1967, d4jsuQ_, 0.8637, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1968, d4jsuC_, 0.8637, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1969, d4intC_, 0.8637, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1970, d4hrdC_, 0.8637, 1.59, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1971, p3uneC_, 0.8637, 1.58, 0.336, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
1972, d2f16Q_, 0.8637, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1973, d5l6aQ_, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1974, d5l6aC_, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1975, d5l68Q_, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1976, d5l68C_, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1977, d5l5oQ_, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1978, d5l5oC_, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1979, p4y8tQ_, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1980, p4y8tC_, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1981, p4y82Q_, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1982, d3mg8Q_, 0.8636, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1983, d1z7qQ1, 0.8636, 1.88, 0.355, 243, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1984, d1z7qC1, 0.8636, 1.88, 0.355, 243, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1985, d5l5aQ_, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1986, d5l5aC_, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1987, p4y81Q_, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1988, p4y81C_, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1989, p4y75Q_, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1990, p4y75C_, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1991, d4r17C_, 0.8635, 1.57, 0.367, 240, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1992, d4qltQ_, 0.8635, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1993, d4qltC_, 0.8635, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1994, d4no6Q_, 0.8635, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1995, d4no6C_, 0.8635, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1996, d4jt0Q_, 0.8635, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1997, d4jt0C_, 0.8635, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1998, d4inuC_, 0.8635, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1999, d4intQ_, 0.8635, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2000, d3wxrD_, 0.8635, 1.60, 0.362, 241, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2001, p1fntC_, 0.8635, 2.02, 0.358, 241, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2002, d5m2bQ_, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2003, d5m2bC_, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2004, d5laiQ_, 0.8634, 1.57, 0.367, 240, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2005, d5laiC_, 0.8634, 1.57, 0.367, 240, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2006, d5l5rQ_, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2007, d5l5rC_, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2008, d5l5dQ_, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2009, d5l5dC_, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2010, d5l5bQ_, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2011, d5ahjR_, 0.8634, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2012, d5ahjD_, 0.8634, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2013, p4y74Q_, 0.8634, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2014, p4y74C_, 0.8634, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2015, d4r17Q_, 0.8634, 1.57, 0.367, 240, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2016, d4jsqQ_, 0.8634, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2017, d4jsqC_, 0.8634, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2018, d4inuQ_, 0.8634, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2019, d3oevP_, 0.8634, 1.84, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2020, p1fntQ_, 0.8634, 2.02, 0.358, 241, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2021, d5l5bC_, 0.8633, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2022, p4y8kQ_, 0.8633, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2023, p4y8kC_, 0.8633, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2024, d4qlsQ_, 0.8633, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2025, d4qlsC_, 0.8633, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2026, p4qbyQ_, 0.8633, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2027, p4qbyC_, 0.8633, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2028, p3unee_, 0.8633, 1.58, 0.341, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
2029, d3okjQ_, 0.8633, 1.58, 0.367, 241, 229, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2030, d3okjC_, 0.8633, 1.58, 0.367, 241, 229, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2031, d4no9Q_, 0.8632, 1.59, 0.362, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2032, d4no9C_, 0.8632, 1.59, 0.362, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2033, d4hrcQ_, 0.8632, 1.59, 0.362, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2034, d3oevQ_, 0.8632, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2035, d3oeuB_, 0.8632, 1.76, 0.365, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2036, d3mg7C_, 0.8632, 1.60, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2037, d2gplC_, 0.8632, 1.58, 0.367, 241, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2038, p4y8hQ_, 0.8631, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2039, p4y8hC_, 0.8631, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2040, p4y84Q_, 0.8631, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2041, p4y6zQ_, 0.8631, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2042, p4y6zC_, 0.8631, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2043, d4qlqC_, 0.8631, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2044, d4hnpQ_, 0.8631, 1.59, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2045, d3mg7P_, 0.8631, 1.85, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2046, d3mg6Q_, 0.8631, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2047, d3mg6P_, 0.8631, 1.86, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2048, d2gplQ_, 0.8631, 1.58, 0.367, 241, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2049, p4y8gQ_, 0.8630, 1.60, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2050, p4y8gC_, 0.8630, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2051, p4y84C_, 0.8630, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2052, d4r02Q_, 0.8630, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2053, d4qlqQ_, 0.8630, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2054, d4no1Q_, 0.8630, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2055, d4no1C_, 0.8630, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2056, d3sdkQ_, 0.8630, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2057, d4qwgQ_, 0.8629, 1.59, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2058, d4qwgC_, 0.8629, 1.59, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2059, d4qluC_, 0.8629, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2060, d4hrdQ_, 0.8629, 1.60, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2061, d3mg4Q_, 0.8629, 1.59, 0.367, 241, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2062, d1jd2D_, 0.8629, 1.52, 0.330, 242, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2063, d4qluQ_, 0.8628, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2064, d3sdiP_, 0.8628, 1.86, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2065, p5vfqB_, 0.8627, 1.36, 0.609, 230, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2066, p5mpad_, 0.8627, 1.59, 0.362, 240, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2067, d3oeuQ_, 0.8627, 1.60, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2068, p1fntS_, 0.8626, 1.58, 0.330, 244, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2069, d4qlvQ_, 0.8625, 1.61, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2070, d4qlvC_, 0.8625, 1.61, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2071, d4no8Q_, 0.8625, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2072, d4no8C_, 0.8625, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2073, d3mg4C_, 0.8625, 1.60, 0.367, 241, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2074, d3mg8P_, 0.8624, 1.87, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2075, d1jd2Y_, 0.8624, 1.52, 0.330, 242, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2076, d1g0uP_, 0.8624, 1.86, 0.357, 235, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2077, p1fntE_, 0.8624, 1.59, 0.330, 244, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2078, p5l4gR_, 0.8623, 1.62, 0.341, 232, 229, 
2079, d4r3oS_, 0.8623, 1.74, 0.322, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
2080, d4r3oE_, 0.8623, 1.74, 0.322, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
2081, d3mg8B_, 0.8623, 1.80, 0.365, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2082, d1jd2C_, 0.8623, 1.59, 0.362, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2083, p5l4gD_, 0.8622, 1.61, 0.332, 231, 229, 
2084, d4nnwQ_, 0.8622, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2085, d4nnwC_, 0.8622, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2086, p3unes_, 0.8622, 1.59, 0.341, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
2087, d1z7qS1, 0.8622, 1.55, 0.330, 242, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2088, d1z7qE1, 0.8622, 1.55, 0.330, 242, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2089, d1jd2X_, 0.8622, 1.59, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2090, p5m32P_, 0.8621, 2.06, 0.356, 244, 233, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2091, d3sdkP_, 0.8621, 1.89, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2092, d3mg7Q_, 0.8621, 1.60, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2093, d3mg7B_, 0.8620, 1.80, 0.365, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2094, d4g4sC_, 0.8619, 1.87, 0.357, 237, 230, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2095, d3oevB_, 0.8617, 1.81, 0.361, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2096, d3mg6B_, 0.8617, 1.83, 0.361, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2097, d3sdkB_, 0.8616, 1.81, 0.361, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2098, p5mp9d_, 0.8615, 1.61, 0.362, 240, 229, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2099, p3jcpMA_, 0.8614, 1.60, 0.367, 241, 229, 
2100, p3jcpM_, 0.8614, 1.60, 0.367, 241, 229, 
2101, d1iruR_, 0.8613, 1.61, 0.336, 243, 229, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2102, d1iruD_, 0.8613, 1.61, 0.336, 243, 229, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2103, p4r67u_, 0.8612, 1.77, 0.326, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2104, d4r67S_, 0.8612, 1.77, 0.326, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2105, p4r67g_, 0.8612, 1.77, 0.326, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2106, p5vfoH_, 0.8611, 1.39, 0.609, 230, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2107, p5gjqk_, 0.8611, 1.62, 0.336, 231, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2108, d4r67E_, 0.8611, 1.77, 0.326, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2109, d1g0uB_, 0.8611, 1.88, 0.357, 235, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2110, p5mpac_, 0.8610, 2.21, 0.355, 244, 234, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2111, p6avoN_, 0.8609, 1.61, 0.336, 232, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2112, p5mp9D_, 0.8608, 1.63, 0.362, 240, 229, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2113, p5gjrW_, 0.8608, 1.76, 0.322, 234, 227, 
2114, p5gjrKA_, 0.8608, 1.78, 0.322, 234, 227, 
2115, d1iruS_, 0.8607, 1.77, 0.322, 234, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2116, d1iruE_, 0.8607, 1.77, 0.322, 234, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2117, p5wvkY_, 0.8606, 1.58, 0.362, 241, 229, 
2118, p5vfpB_, 0.8605, 1.41, 0.609, 230, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2119, p5vfrH_, 0.8604, 1.40, 0.609, 230, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2120, p5lf6Q_, 0.8603, 1.59, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2121, d5lexR_, 0.8603, 1.75, 0.326, 233, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2122, d3wxrR_, 0.8603, 1.67, 0.367, 241, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2123, p3jcoLA_, 0.8602, 2.27, 0.362, 244, 235, 
2124, p3jcoL_, 0.8602, 2.27, 0.362, 244, 235, 
2125, d5lf1Q_, 0.8601, 1.59, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2126, p6avoI_, 0.8599, 1.63, 0.336, 232, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2127, d5lf4Q_, 0.8599, 1.60, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2128, d5le5R_, 0.8598, 1.59, 0.327, 233, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2129, p5gjql_, 0.8598, 1.60, 0.323, 234, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2130, d4g4sE_, 0.8598, 1.57, 0.330, 249, 227, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2131, p5mp9E_, 0.8597, 1.65, 0.330, 242, 227, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2132, p5lf0Q_, 0.8597, 1.60, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2133, d5lexD_, 0.8597, 1.77, 0.326, 233, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2134, p3uneD_, 0.8597, 1.62, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2135, p5gjqF_, 0.8596, 1.61, 0.323, 234, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2136, d5lf7Q_, 0.8594, 1.60, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2137, p5leyQ_, 0.8594, 1.61, 0.338, 239, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2138, d3unbD_, 0.8594, 1.61, 0.323, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2139, d3sdiB_, 0.8594, 1.95, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2140, d5lf3Q_, 0.8592, 1.61, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2141, d3sdkD_, 0.8591, 1.36, 0.335, 233, 224, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2142, p3uneR_, 0.8590, 1.62, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2143, p5mp9e_, 0.8589, 1.61, 0.330, 242, 227, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2144, p5lf6R_, 0.8589, 1.61, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2145, p5l4gE_, 0.8589, 1.81, 0.326, 234, 227, 
2146, p3unhR_, 0.8589, 1.60, 0.327, 233, 226, MOUSE 20S IMMUNOPROTEASOME
2147, p3unhD_, 0.8589, 1.60, 0.327, 233, 226, MOUSE 20S IMMUNOPROTEASOME
2148, d3unfR_, 0.8589, 1.60, 0.327, 233, 226, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2149, p5mpaE_, 0.8588, 1.59, 0.330, 242, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2150, d5lf1R_, 0.8588, 1.61, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2151, p5lezD_, 0.8588, 1.78, 0.326, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2152, d3unfD_, 0.8588, 1.60, 0.327, 233, 226, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2153, p3unet_, 0.8588, 1.81, 0.326, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2154, p5lezR_, 0.8587, 1.78, 0.326, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2155, p5l4gS_, 0.8587, 1.63, 0.327, 234, 226, 
2156, p3unbf_, 0.8587, 1.62, 0.323, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2157, p3jcpNA_, 0.8587, 1.57, 0.330, 242, 227, 
2158, p3jcpN_, 0.8587, 1.57, 0.330, 242, 227, 
2159, d5le5D_, 0.8586, 1.62, 0.327, 233, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2160, d5lf3R_, 0.8585, 1.61, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2161, p3unef_, 0.8584, 1.62, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2162, p5lf6D_, 0.8583, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2163, d3unbR_, 0.8583, 1.81, 0.326, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2164, d5lf7R_, 0.8582, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2165, d5lf7D_, 0.8581, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2166, d5lf4R_, 0.8581, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2167, d5lf3D_, 0.8581, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2168, p5lf0R_, 0.8581, 1.61, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2169, d5lf1D_, 0.8580, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2170, p5leyR_, 0.8578, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2171, p5lf0D_, 0.8577, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2172, p5leyD_, 0.8577, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2173, p6avoM_, 0.8576, 1.60, 0.327, 233, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2174, p3unbt_, 0.8575, 1.82, 0.326, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2175, p6avoH_, 0.8574, 1.61, 0.327, 233, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2176, d3sdkR_, 0.8574, 1.29, 0.336, 232, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2177, d5lf4D_, 0.8573, 1.63, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2178, d1j2qB_, 0.8573, 1.70, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2179, d1g0uD_, 0.8573, 1.24, 0.341, 230, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2180, p3jcoMA_, 0.8572, 1.67, 0.362, 241, 229, 
2181, p3jcoM_, 0.8572, 1.67, 0.362, 241, 229, 
2182, d1j2qD_, 0.8569, 1.71, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2183, d1j2qF_, 0.8568, 1.71, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2184, d1j2qC_, 0.8568, 1.71, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2185, d1j2qA_, 0.8568, 1.71, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2186, d1j2qG_, 0.8567, 1.71, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2187, d1j2qE_, 0.8567, 1.71, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2188, d1g0uR_, 0.8565, 1.26, 0.341, 230, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2189, p5mpcC_, 0.8559, 2.14, 0.352, 244, 233, 
2190, p5mpae_, 0.8559, 1.74, 0.330, 242, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2191, p5m32C_, 0.8557, 1.77, 0.341, 234, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2192, d4cr2C_, 0.8557, 2.23, 0.362, 245, 235, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2193, d3sdiR_, 0.8556, 1.20, 0.338, 229, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2194, d3sdiC_, 0.8555, 1.53, 0.367, 238, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2195, p5mpaD_, 0.8551, 1.74, 0.362, 240, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2196, d1g0uC_, 0.8548, 1.54, 0.367, 238, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2197, p5wvkR_, 0.8546, 1.75, 0.358, 241, 229, 
2198, p5mpbQ_, 0.8545, 2.10, 0.352, 244, 233, 
2199, p5wvkZ_, 0.8543, 1.70, 0.330, 242, 227, 
2200, d1g0uQ_, 0.8540, 1.55, 0.367, 238, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2201, d3sdiQ_, 0.8535, 1.56, 0.367, 238, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2202, p3jcoNA_, 0.8530, 1.65, 0.330, 242, 227, 
2203, p3jcoN_, 0.8530, 1.65, 0.330, 242, 227, 
2204, d3unbG_, 0.8529, 1.81, 0.360, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2205, p5m32Q_, 0.8528, 1.80, 0.341, 235, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2206, d3sdiD_, 0.8523, 1.19, 0.339, 228, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2207, p5mpbS_, 0.8520, 1.94, 0.325, 242, 228, 
2208, p3unbw_, 0.8520, 1.83, 0.360, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2209, d3unbU_, 0.8520, 1.82, 0.360, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2210, p3unbi_, 0.8519, 1.83, 0.360, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2211, p6epcB_, 0.8518, 1.93, 0.608, 234, 232, GROUND STATE 26S PROTEASOME (GS2)
2212, p4cr4C_, 0.8516, 2.39, 0.357, 245, 235, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2213, d3unfU_, 0.8515, 1.82, 0.360, 243, 228, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2214, d3unfG_, 0.8515, 1.82, 0.360, 243, 228, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2215, p5a0qQ_, 0.8514, 1.96, 0.368, 237, 228, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2216, p5a0qC_, 0.8514, 1.96, 0.368, 237, 228, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2217, p4v7oQ_, 0.8514, 1.87, 0.357, 232, 227, 
2218, d4cr2E_, 0.8514, 1.92, 0.329, 243, 228, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2219, d3l5qT_, 0.8514, 1.87, 0.357, 232, 227,  
2220, d1vsyQ_, 0.8514, 1.87, 0.357, 232, 227,  
2221, p4v7oKA_, 0.8513, 1.88, 0.357, 232, 227, 
2222, p4v7oC_, 0.8513, 1.88, 0.357, 232, 227, 
2223, d3l5qH_, 0.8513, 1.88, 0.357, 232, 227,  
2224, d1vsyC_, 0.8513, 1.88, 0.357, 232, 227,  
2225, p3uneG_, 0.8509, 1.83, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2226, d4r3oO_, 0.8507, 1.85, 0.360, 244, 228, HUMAN CONSTITUTIVE 20S PROTEASOME
2227, p5vfsC_, 0.8506, 2.22, 0.352, 250, 233, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2228, d1iruO_, 0.8506, 1.86, 0.360, 244, 228, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2229, d4r3oA_, 0.8505, 1.86, 0.360, 244, 228, HUMAN CONSTITUTIVE 20S PROTEASOME
2230, d1iruA_, 0.8505, 1.86, 0.360, 244, 228, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2231, p5vfqC_, 0.8504, 1.86, 0.352, 248, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2232, p5vfoI_, 0.8504, 1.86, 0.352, 248, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2233, p5vfsD_, 0.8503, 1.78, 0.341, 239, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2234, p4r67q_, 0.8503, 1.85, 0.360, 244, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2235, d4r67O_, 0.8503, 1.85, 0.360, 244, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2236, p4r67c_, 0.8503, 1.85, 0.360, 244, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2237, d4r67A_, 0.8503, 1.85, 0.360, 244, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2238, p5wvkS_, 0.8499, 1.73, 0.330, 242, 227, 
2239, p3uneU_, 0.8498, 1.84, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2240, p5vfrI_, 0.8495, 1.86, 0.352, 248, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2241, p5a5bD_, 0.8495, 1.80, 0.358, 242, 229, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2242, p4cr3D_, 0.8495, 1.80, 0.358, 242, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2243, p3unew_, 0.8495, 1.85, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2244, p5vfsBA_, 0.8494, 2.23, 0.352, 240, 233, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2245, p5ln3E_, 0.8494, 1.66, 0.327, 232, 226, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2246, p5gjqn_, 0.8492, 1.84, 0.295, 243, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2247, p3unei_, 0.8490, 1.86, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2248, p5vfpC_, 0.8489, 1.87, 0.352, 248, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2249, d4cr2D_, 0.8488, 1.77, 0.362, 242, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2250, p5mpbC_, 0.8485, 2.35, 0.359, 244, 234, 
2251, p5vfuU_, 0.8483, 1.81, 0.336, 239, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2252, p5vftJ_, 0.8483, 1.81, 0.336, 239, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2253, p5gjrMA_, 0.8482, 1.70, 0.296, 243, 226, 
2254, p5gjrY_, 0.8480, 1.70, 0.296, 243, 226, 
2255, p5vfuT_, 0.8478, 2.26, 0.352, 250, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2256, p5vftI_, 0.8478, 2.26, 0.352, 250, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2257, p6avoQ_, 0.8477, 1.71, 0.296, 239, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2258, p6avoJ_, 0.8477, 1.71, 0.296, 239, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2259, p5vfrK_, 0.8474, 1.55, 0.321, 228, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2260, p5vfok_, 0.8473, 1.57, 0.321, 228, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2261, p5vfsCA_, 0.8472, 1.82, 0.336, 239, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2262, d1j2pF_, 0.8472, 1.72, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2263, p5l4gU_, 0.8471, 1.86, 0.295, 241, 227, 
2264, p3uneF_, 0.8471, 1.73, 0.296, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2265, d1j2pG_, 0.8470, 1.72, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2266, d1j2pE_, 0.8470, 1.72, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2267, d1j2pD_, 0.8470, 1.72, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2268, d1j2pC_, 0.8470, 1.72, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2269, d1j2pA_, 0.8470, 1.72, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2270, p5mpcQ_, 0.8469, 2.28, 0.356, 244, 233, 
2271, d1j2pB_, 0.8469, 1.72, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2272, p5vfqDA_, 0.8468, 1.57, 0.321, 228, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2273, p5vfsDA_, 0.8467, 1.56, 0.326, 228, 224, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2274, p5vfrk_, 0.8467, 1.57, 0.321, 228, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2275, d3unbT_, 0.8467, 1.74, 0.296, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2276, p5vfqE_, 0.8466, 1.56, 0.321, 228, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2277, p5l4gG_, 0.8466, 2.14, 0.284, 242, 229, 
2278, p3unbv_, 0.8466, 1.74, 0.296, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2279, p5vfsE_, 0.8465, 1.70, 0.324, 228, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2280, p5t0cU_, 0.8465, 2.25, 0.352, 250, 233, 
2281, p5t0cAB_, 0.8465, 2.25, 0.352, 250, 233, 
2282, p3unev_, 0.8464, 1.75, 0.296, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2283, p3uneh_, 0.8464, 1.74, 0.296, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2284, p5vfpE_, 0.8462, 1.57, 0.321, 228, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2285, p5vfoK_, 0.8462, 1.70, 0.320, 228, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2286, p5vfpCA_, 0.8460, 1.59, 0.321, 228, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2287, d2ku2A1, 0.8460, 1.85, 0.390, 233, 228, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2288, p5t0cV_, 0.8459, 1.83, 0.336, 239, 229, 
2289, p5t0cBB_, 0.8459, 1.83, 0.336, 239, 229, 
2290, d5lf3F_, 0.8457, 1.74, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2291, d5lexT_, 0.8457, 1.74, 0.296, 240, 226, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2292, d5lexF_, 0.8456, 1.74, 0.296, 239, 226, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2293, p5gjqX_, 0.8456, 1.85, 0.288, 243, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2294, d5le5F_, 0.8455, 1.75, 0.296, 239, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2295, p5vfuHA_, 0.8454, 2.29, 0.352, 240, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2296, p5vfti_, 0.8454, 2.29, 0.352, 240, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2297, d5lf7F_, 0.8454, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2298, d5lf1F_, 0.8454, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2299, d3unbF_, 0.8454, 1.76, 0.296, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2300, d5lf4F_, 0.8453, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2301, p5lf0F_, 0.8453, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2302, p5lezT_, 0.8453, 1.74, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2303, p5lezF_, 0.8453, 1.74, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2304, p5leyF_, 0.8453, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2305, d2ku1A1, 0.8452, 1.94, 0.395, 233, 228, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2306, p5lf6F_, 0.8451, 1.76, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2307, d5lf1T_, 0.8451, 1.75, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2308, d5le5T_, 0.8451, 1.75, 0.296, 240, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2309, p5lf6T_, 0.8449, 1.75, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2310, d4r3oG_, 0.8449, 1.88, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
2311, d5lf7T_, 0.8448, 1.75, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2312, d5lf3T_, 0.8448, 1.75, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2313, p5lf0T_, 0.8447, 1.75, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2314, d4r3oU_, 0.8447, 1.88, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
2315, d5lf4T_, 0.8446, 1.76, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2316, p5leyT_, 0.8446, 1.76, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2317, p5mpcS_, 0.8444, 1.90, 0.335, 242, 227, 
2318, p5m32R_, 0.8442, 1.93, 0.310, 233, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2319, p5m32D_, 0.8441, 1.93, 0.310, 233, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2320, p5lezQ_, 0.8439, 1.55, 0.345, 234, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2321, d5lexQ_, 0.8439, 1.55, 0.345, 233, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2322, d5le5Q_, 0.8438, 1.55, 0.345, 233, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2323, p4r67w_, 0.8438, 1.89, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2324, d4r67U_, 0.8438, 1.89, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2325, p4r67i_, 0.8438, 1.89, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2326, d4r67G_, 0.8437, 1.89, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2327, d1iruU_, 0.8437, 1.78, 0.296, 245, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2328, d1iruG_, 0.8437, 1.78, 0.296, 245, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2329, p3h4pH_, 0.8435, 1.68, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2330, d3h4pD_, 0.8435, 1.68, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2331, p5vftK_, 0.8434, 1.76, 0.329, 228, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2332, p3uneT_, 0.8433, 1.92, 0.288, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2333, p3h4pJ_, 0.8432, 1.68, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2334, d3h4pF_, 0.8431, 1.68, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2335, p5vfuV_, 0.8430, 1.77, 0.329, 228, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2336, p4cr4E_, 0.8430, 1.83, 0.330, 243, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2337, p3unhF_, 0.8430, 1.92, 0.288, 244, 226, MOUSE 20S IMMUNOPROTEASOME
2338, d3h4pA_, 0.8430, 1.68, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2339, p5vftk_, 0.8429, 1.63, 0.326, 228, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2340, p3unhT_, 0.8429, 1.92, 0.288, 244, 226, MOUSE 20S IMMUNOPROTEASOME
2341, p3unbh_, 0.8429, 1.91, 0.288, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2342, p3h4pI_, 0.8429, 1.69, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2343, p3h4pN_, 0.8425, 1.69, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2344, d3h4pE_, 0.8425, 1.70, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2345, d3h4pC_, 0.8425, 1.69, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2346, p3h4pL_, 0.8424, 1.69, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2347, d3unfT_, 0.8423, 1.92, 0.288, 244, 226, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2348, d3unfF_, 0.8423, 1.92, 0.288, 244, 226, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2349, d3h4pB_, 0.8423, 1.70, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2350, p3h4pM_, 0.8422, 1.70, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2351, p3h4pK_, 0.8422, 1.70, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2352, d1z7qD1, 0.8422, 1.80, 0.360, 241, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2353, p5mpcE_, 0.8421, 2.00, 0.329, 242, 228, 
2354, d1z7qR1, 0.8421, 1.80, 0.360, 241, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2355, d3h4pG_, 0.8419, 1.70, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2356, p5t0cW_, 0.8418, 1.77, 0.329, 228, 225, 
2357, p5t0cCB_, 0.8418, 1.77, 0.329, 228, 225, 
2358, p5dsvL_, 0.8417, 1.80, 0.296, 245, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2359, p5dsvF_, 0.8417, 1.80, 0.296, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2360, d5l63T_, 0.8416, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2361, d5l63F_, 0.8416, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2362, d3sdiF_, 0.8416, 2.03, 0.335, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2363, p5t0gI_, 0.8415, 2.31, 0.352, 250, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2364, d5m2bT_, 0.8415, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2365, d5m2bF_, 0.8415, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2366, p5dsvB_, 0.8415, 1.81, 0.296, 245, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2367, p5dsvA_, 0.8415, 1.80, 0.296, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2368, d5l6aT_, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2369, d5l6aF_, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2370, d5l64T_, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2371, d5l64F_, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2372, d5l61T_, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2373, d5l61F_, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2374, d5l5rT_, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2375, d5l5rF_, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2376, d5l5dT_, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2377, d5l5dF_, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2378, d4r18F_, 0.8414, 1.88, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2379, p5vfuJA_, 0.8413, 1.67, 0.326, 228, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2380, d5l69T_, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2381, d5l69F_, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2382, d5l66T_, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2383, d5l66F_, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2384, d5l65F_, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2385, d5l5wT_, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2386, d5l5wF_, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2387, p5dsvN_, 0.8413, 1.81, 0.296, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2388, p5dsvI_, 0.8413, 1.81, 0.296, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2389, d4r18T_, 0.8413, 1.88, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2390, p5vfoj_, 0.8412, 1.90, 0.336, 239, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2391, d5l65T_, 0.8412, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2392, d5l62T_, 0.8412, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2393, d5l62F_, 0.8412, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2394, d5l5hT_, 0.8412, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2395, d5l5hF_, 0.8412, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2396, d4qv6F_, 0.8412, 1.88, 0.336, 243, 226, YCP BETA5-A49V MUTANT
2397, p1fntD_, 0.8412, 1.78, 0.364, 239, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2398, d5l6cT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2399, d5l6cF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2400, d5l5zT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2401, d5l5zF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2402, d5l5yT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2403, d5l5yF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2404, d5l5uT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2405, d5l5uF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2406, d5l5tF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2407, d5l5sT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2408, d5l5sF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2409, d5l5pT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2410, d5l5pF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2411, d5l5jT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2412, d5l5jF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2413, d5bxnT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2414, d5bxnF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2415, d4qvnT_, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2416, d4qvnF_, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2417, d4qv6T_, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-A49V MUTANT
2418, p1fntR_, 0.8411, 1.78, 0.364, 239, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2419, d5l6bT_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2420, d5l6bF_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2421, d5l60T_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2422, d5l60F_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2423, d5l5tT_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2424, d5l5qT_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2425, d5l5qF_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2426, d5l5oT_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2427, d5l5oF_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2428, d5l5iT_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2429, d5l5iF_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2430, d5l5bT_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2431, d5l5bF_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2432, p5dsvK_, 0.8410, 1.81, 0.296, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2433, p4y8tT_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2434, p4y8tF_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2435, d4r02T_, 0.8410, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2436, d4r02F_, 0.8410, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2437, d5l68T_, 0.8409, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2438, d5l68F_, 0.8409, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2439, d5l67T_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2440, d5l67F_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2441, d5l5xT_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2442, d5l5xF_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2443, d5l5fT_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2444, d5l5fF_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2445, p5dsvE_, 0.8409, 1.81, 0.296, 245, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2446, d4qvyT_, 0.8409, 1.88, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2447, d4qvyF_, 0.8409, 1.88, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2448, d5lajT_, 0.8408, 1.89, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2449, d5lajF_, 0.8408, 1.89, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2450, d5l5vT_, 0.8408, 1.89, 0.336, 243, 226,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2451, d5l5vF_, 0.8408, 1.89, 0.336, 243, 226,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2452, d5l5aT_, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2453, d5l5aF_, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2454, d5cz6T_, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2455, d5cz6F_, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2456, d5bxlF_, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2457, d4ya4T_, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2458, d4ya4F_, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2459, d4qvwT_, 0.8408, 1.89, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2460, d4qvwF_, 0.8408, 1.89, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2461, d4qvlT_, 0.8408, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH BORTEZOMIB
2462, d4qvlF_, 0.8408, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH BORTEZOMIB
2463, d5l5eT_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2464, d5l5eF_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2465, p5dsvD_, 0.8407, 1.81, 0.296, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2466, d5bxlT_, 0.8407, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2467, d5bouT_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2468, d5bouF_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2469, p4ya9T_, 0.8407, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2470, p4ya9F_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2471, d4nnwT_, 0.8407, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2472, d4nnwF_, 0.8407, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2473, d4hnpF_, 0.8407, 1.88, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2474, d4r17T_, 0.8406, 1.89, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2475, d4r17F_, 0.8406, 1.89, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2476, d4qzzT_, 0.8406, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH OMURALIDE
2477, d4qzzF_, 0.8406, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH OMURALIDE
2478, d4qw1T_, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2479, d4qw1F_, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2480, d4qvpT_, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2481, d4qvpF_, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2482, p6gopT_, 0.8405, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2483, p6gopF_, 0.8405, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2484, p5mp9g_, 0.8405, 1.87, 0.336, 243, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2485, d5lttT_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2486, d5lttF_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2487, d5fggT_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2488, d5fggF_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2489, p5dsvG_, 0.8405, 1.82, 0.296, 242, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2490, d5d0wT_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2491, d5d0wF_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2492, d5czaT_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2493, d5czaF_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2494, d5cz7T_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2495, d5cz7F_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2496, p5cghT_, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2497, p5cghF_, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2498, p4ya2T_, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2499, p4ya2F_, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2500, p4y8gT_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2501, p4y8gF_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2502, p4y75T_, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2503, p4y75F_, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2504, d4rurT_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2505, d4rurF_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2506, d4qz7T_, 0.8405, 1.90, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2507, d4qz7F_, 0.8405, 1.90, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2508, d4qvmT_, 0.8405, 1.89, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2509, d4qvmF_, 0.8405, 1.89, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2510, d4y9yT_, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2511, d4y8rF_, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2512, p4y8pT_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2513, p4y8pF_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2514, p4y6vT_, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2515, p4y6vF_, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2516, d4qvqT_, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2517, d4qvqF_, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2518, d4qv1T_, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-M45A MUTANT
2519, d4qv1F_, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-M45A MUTANT
2520, d4quyT_, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-A49S-MUTANT
2521, d4quyF_, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-A49S-MUTANT
2522, d4quxT_, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-A49T-MUTANT
2523, d4quxF_, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-A49T-MUTANT
2524, d4qlsF_, 0.8404, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2525, d4q1sF_, 0.8404, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2526, d5fg9F_, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2527, d5ahjT_, 0.8403, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2528, d5ahjF_, 0.8403, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2529, d4y9yF_, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2530, d4y8rT_, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2531, d4y8mT_, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2532, d4y8mF_, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2533, p4y6aT_, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2534, p4y6aF_, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2535, d4qz4T_, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2536, d4qz4F_, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2537, d4qwuT_, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2538, d4qwuF_, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2539, d4qv4T_, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-M45T MUTANT
2540, d4qv4F_, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-M45T MUTANT
2541, d4qv0T_, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2542, d4qv0F_, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2543, d4qltT_, 0.8403, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2544, d4qltF_, 0.8403, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2545, d4qlsT_, 0.8403, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2546, d5laiT_, 0.8402, 1.89, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2547, d5laiF_, 0.8402, 1.89, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2548, p5gjqm_, 0.8402, 1.63, 0.317, 238, 224, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2549, d5fgaT_, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2550, d5fgaF_, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2551, d5fg9T_, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2552, d4ya1T_, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2553, d4ya1F_, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2554, p4y8uT_, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2555, p4y8uF_, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2556, p4y8sT_, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2557, p4y8sF_, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2558, p4y8nT_, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2559, p4y8nF_, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2560, p4y77T_, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2561, p4y77F_, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2562, d4qz6T_, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2563, d4qz6F_, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2564, d4qwfT_, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2565, d4qwfF_, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2566, d4qw6T_, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2567, d4qw6F_, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2568, d4qw0T_, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2569, d4qw0F_, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2570, d4qv8T_, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT
2571, d4qv8F_, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT
2572, d4qv5T_, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-M45I MUTANT
2573, d4qv5F_, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-M45I MUTANT
2574, p4qbyT_, 0.8402, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2575, p4qbyF_, 0.8402, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2576, d5jhrT_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2577, d5jhrF_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2578, p5fghT_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2579, p5fghF_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2580, d5fg7T_, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2581, d5fg7F_, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2582, d5dkjF_, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2583, d5d0vT_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2584, d5d0vF_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2585, d5cz9F_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2586, p5cggT_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2587, p5cggF_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2588, p4ya7T_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2589, p4ya7F_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2590, p4ya5F_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2591, p4y84T_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2592, p4y84F_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2593, p4y69T_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2594, p4y69F_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2595, p4x6zU_, 0.8401, 1.90, 0.336, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2596, p4x6zG_, 0.8401, 1.90, 0.336, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2597, d4qwxT_, 0.8401, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2598, d4qwxF_, 0.8401, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2599, d4qv7T_, 0.8401, 1.89, 0.336, 243, 226, YCP BETA5-A50V MUTANT
2600, d4qv7F_, 0.8401, 1.89, 0.336, 243, 226, YCP BETA5-A50V MUTANT
2601, d4no1T_, 0.8401, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2602, d4no1F_, 0.8401, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2603, d3sdiT_, 0.8401, 1.90, 0.332, 242, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2604, p5t0gK_, 0.8400, 1.93, 0.327, 228, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2605, d5l54T_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2606, d5l54F_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2607, d5dkjT_, 0.8400, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2608, d5d0tT_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2609, d5d0tF_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2610, d5cz9T_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2611, p4ya5T_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2612, p4y8hT_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2613, p4y8hF_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2614, p4y74T_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2615, p4y74F_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2616, d4qz0T_, 0.8400, 1.90, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2617, d4qz0F_, 0.8400, 1.90, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2618, d4qwlT_, 0.8400, 1.90, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2619, d4qwlF_, 0.8400, 1.90, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2620, d4qw7T_, 0.8400, 1.90, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2621, d4qw7F_, 0.8400, 1.90, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2622, d4qw5T_, 0.8400, 1.90, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2623, d4qw5F_, 0.8400, 1.90, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2624, d4qw4T_, 0.8400, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH CARFILZOMIB
2625, d4qw4F_, 0.8400, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH CARFILZOMIB
2626, d4qv9F_, 0.8400, 1.89, 0.336, 243, 226, YCP BETA5-C63F MUTANT
2627, d4qluT_, 0.8400, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2628, d4qluF_, 0.8400, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2629, d4qlqF_, 0.8400, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2630, d4nnnT_, 0.8400, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH MG132
2631, d4nnnF_, 0.8400, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH MG132
2632, d3nzjT_, 0.8400, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2633, d3nzjF_, 0.8400, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2634, d1rypU_, 0.8400, 1.89, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2635, d1rypG_, 0.8400, 1.89, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2636, p5vfuIA_, 0.8399, 1.93, 0.336, 239, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2637, p5vftj_, 0.8399, 1.93, 0.336, 239, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2638, d5l55T_, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2639, d5l55F_, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2640, d5fgeT_, 0.8399, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2641, d5fgeF_, 0.8399, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2642, d5d0xT_, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2643, d5d0xF_, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2644, d5d0sT_, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2645, d5d0sF_, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2646, p4y9zT_, 0.8399, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2647, p4y9zF_, 0.8399, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2648, p4y8kT_, 0.8399, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2649, p4y81T_, 0.8399, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2650, p4y81F_, 0.8399, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2651, d4qz1T_, 0.8399, 1.91, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2652, d4qz1F_, 0.8399, 1.91, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2653, d4qv9T_, 0.8399, 1.90, 0.336, 243, 226, YCP BETA5-C63F MUTANT
2654, d4qlqT_, 0.8399, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2655, d4no9T_, 0.8399, 1.91, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2656, d4no9F_, 0.8399, 1.91, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2657, d4hrdF_, 0.8399, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2658, d2ku2B1, 0.8399, 1.82, 0.394, 233, 226, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2659, p5t0hI_, 0.8398, 2.31, 0.352, 250, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2660, p5mpbR_, 0.8398, 1.94, 0.362, 240, 229, 
2661, d5jhsF_, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2662, d5fgiT_, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2663, d5fgiF_, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2664, d5cgfT_, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2665, d5cgfF_, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2666, p4y8oT_, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2667, p4y8oF_, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2668, p4y8kF_, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2669, p4y7xT_, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2670, p4y7xF_, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2671, p4y6zT_, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2672, p4y6zF_, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2673, d4qz5T_, 0.8398, 1.91, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2674, d4qz5F_, 0.8398, 1.90, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2675, d4qz3T_, 0.8398, 1.90, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2676, d4qz3F_, 0.8398, 1.90, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2677, d4qw3T_, 0.8398, 1.90, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2678, d4qw3F_, 0.8398, 1.90, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2679, d4j70F_, 0.8398, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2680, d4fzgT_, 0.8398, 1.90, 0.332, 244, 226, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2681, d4fzgF_, 0.8398, 1.90, 0.332, 244, 226, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2682, p4cr4D_, 0.8398, 1.91, 0.358, 242, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2683, d5jhsT_, 0.8397, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2684, d5fgfT_, 0.8397, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2685, d5fgfF_, 0.8397, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2686, d5d0zT_, 0.8397, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2687, d5d0zF_, 0.8397, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2688, p4y82T_, 0.8397, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2689, p4y82F_, 0.8397, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2690, d4r00T_, 0.8397, 1.90, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2691, d4r00F_, 0.8397, 1.90, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2692, d4qz2F_, 0.8397, 1.91, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2693, d4qwkT_, 0.8397, 1.91, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2694, d4qwkF_, 0.8397, 1.91, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2695, d4ltcF_, 0.8397, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2696, d3hyeF_, 0.8397, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2697, d5fgdF_, 0.8396, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2698, d5dkiT_, 0.8396, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2699, d5dkiF_, 0.8396, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2700, p4zzgG_, 0.8396, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2701, p4y8iT_, 0.8396, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2702, p4y8iF_, 0.8396, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2703, d4qzwT_, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2704, d4qzwF_, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2705, d4qz2T_, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2706, d4qwrT_, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2707, d4qwrF_, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2708, d4qwiT_, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2709, d4qwiF_, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2710, d4qv3T_, 0.8396, 1.90, 0.336, 243, 226, YCP BETA5-M45V MUTANT
2711, d4qv3F_, 0.8396, 1.90, 0.336, 243, 226, YCP BETA5-M45V MUTANT
2712, d4no6T_, 0.8396, 1.91, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2713, d4no6F_, 0.8396, 1.91, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2714, d4intF_, 0.8396, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2715, d3un8F_, 0.8396, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2716, d3mg0T_, 0.8396, 1.90, 0.332, 244, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2717, d3mg0F_, 0.8396, 1.90, 0.336, 244, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2718, d3hyeT_, 0.8396, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2719, d5l52T_, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2720, d5l52F_, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2721, d5fgdT_, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2722, d5cz4T_, 0.8395, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2723, d5cz4F_, 0.8395, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2724, d4z1lT_, 0.8395, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2725, d4z1lF_, 0.8395, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2726, p4y8lT_, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2727, p4y8lF_, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2728, p4y70T_, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2729, p4y70F_, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2730, d4qvvT_, 0.8395, 1.90, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2731, d4qvvF_, 0.8395, 1.90, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2732, d4no8T_, 0.8395, 1.91, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2733, d4no8F_, 0.8395, 1.91, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2734, d4j70T_, 0.8395, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2735, d4hnpT_, 0.8395, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2736, d4eu2G_, 0.8395, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2737, d3gptT_, 0.8395, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2738, d3gptF_, 0.8395, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2739, p5nifG_, 0.8394, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2740, p5cgiT_, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2741, p5cgiF_, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2742, p4y8qT_, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2743, p4y8qF_, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2744, p4y8jT_, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2745, p4y8jF_, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2746, p4y80T_, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2747, p4y80F_, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2748, p4y7wT_, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2749, p4y7wF_, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2750, d4hrdT_, 0.8394, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2751, d4hrcF_, 0.8394, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2752, d3un8T_, 0.8394, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2753, d3nzwF_, 0.8394, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2754, p4ya3F_, 0.8393, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2755, p4ya0F_, 0.8393, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2756, d4q1sT_, 0.8393, 1.92, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2757, d4inrF_, 0.8393, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2758, d3tddT_, 0.8393, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2759, d3tddF_, 0.8393, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2760, d3nzwT_, 0.8393, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2761, d5fhsT_, 0.8392, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2762, d5fhsF_, 0.8392, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2763, d5cz8F_, 0.8392, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2764, p4zzgU_, 0.8392, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2765, p4ya3T_, 0.8392, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2766, p4ya0T_, 0.8392, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2767, d4qxjT_, 0.8392, 1.92, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2768, d4qxjF_, 0.8392, 1.91, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2769, d4qwgF_, 0.8392, 1.92, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2770, d4ltcT_, 0.8392, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2771, d4lqiF_, 0.8392, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2772, d4intT_, 0.8392, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2773, d4inrT_, 0.8392, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2774, d3mg4F_, 0.8392, 1.90, 0.332, 244, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2775, d3d29T_, 0.8392, 1.91, 0.336, 244, 226, PROTEASOME INHIBITION BY FELLUTAMIDE B
2776, d3d29F_, 0.8392, 1.91, 0.336, 244, 226, PROTEASOME INHIBITION BY FELLUTAMIDE B
2777, p5vfqCA_, 0.8391, 1.94, 0.336, 239, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2778, p5nifU_, 0.8391, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2779, d5cz8T_, 0.8391, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2780, d5cz5T_, 0.8391, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2781, d5cz5F_, 0.8391, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2782, d4qwsT_, 0.8391, 1.92, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2783, d4qwsF_, 0.8391, 1.92, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2784, d4qwjF_, 0.8391, 1.92, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2785, d4qwgT_, 0.8391, 1.92, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2786, d4qlvT_, 0.8391, 1.91, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2787, d4qlvF_, 0.8391, 1.91, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2788, d4lqiT_, 0.8391, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2789, d3dy3F_, 0.8391, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2790, p4y7yT_, 0.8390, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2791, p4y7yF_, 0.8390, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2792, p4y78T_, 0.8390, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2793, p4y78F_, 0.8390, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2794, d4qwjT_, 0.8390, 1.92, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2795, d4jsqT_, 0.8390, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2796, d4jsqF_, 0.8390, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2797, d4inuF_, 0.8390, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2798, d3nzxT_, 0.8390, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2799, d3nzxF_, 0.8390, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2800, d3gpwT_, 0.8390, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2801, d3gpwF_, 0.8390, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2802, d3dy3T_, 0.8390, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2803, d2fnyF_, 0.8390, 1.91, 0.332, 244, 226,  
2804, d4qzxT_, 0.8389, 1.92, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2805, d4qzxF_, 0.8389, 1.92, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2806, d2fnyT_, 0.8389, 1.91, 0.332, 244, 226,  
2807, d1g0uF_, 0.8389, 1.90, 0.336, 242, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2808, p5mp9G_, 0.8388, 1.89, 0.336, 243, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2809, d4inuT_, 0.8388, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2810, p4gk7F_, 0.8388, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2811, d4g4sG_, 0.8388, 1.91, 0.336, 246, 226, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2812, d3gpjT_, 0.8388, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2813, d3gpjF_, 0.8388, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2814, d3e47T_, 0.8388, 1.92, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2815, d3e47F_, 0.8388, 1.92, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2816, d4jt0T_, 0.8387, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2817, d4jt0F_, 0.8387, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2818, d4jsuT_, 0.8387, 1.91, 0.336, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2819, d4jsuF_, 0.8387, 1.91, 0.336, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2820, p4gk7T_, 0.8387, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2821, d3bdmT_, 0.8387, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2822, d2fakT_, 0.8387, 1.91, 0.341, 244, 226, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2823, d2fakF_, 0.8387, 1.91, 0.341, 244, 226, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2824, d1g65F_, 0.8387, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2825, p6epfC_, 0.8386, 2.46, 0.361, 249, 233, GROUND STATE 26S PROTEASOME (GS1)
2826, p5vfpBA_, 0.8386, 1.93, 0.336, 239, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2827, d4hrcT_, 0.8386, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2828, d4fzcT_, 0.8386, 1.91, 0.332, 244, 226, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2829, d4fzcF_, 0.8386, 1.91, 0.332, 244, 226, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2830, d3dy4T_, 0.8386, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2831, d3dy4F_, 0.8386, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2832, d3bdmF_, 0.8386, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2833, d2zcyT_, 0.8386, 1.92, 0.336, 244, 226, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2834, d2zcyF_, 0.8386, 1.92, 0.336, 244, 226, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2835, d2gplF_, 0.8386, 1.92, 0.332, 244, 226, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2836, d1jd2F_, 0.8386, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2837, d1g65T_, 0.8386, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2838, d1g0uT_, 0.8386, 1.91, 0.336, 242, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2839, p4v7oG_, 0.8385, 1.93, 0.341, 244, 226, 
2840, d3okjT_, 0.8385, 1.92, 0.332, 244, 226, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2841, d3okjF_, 0.8385, 1.92, 0.332, 244, 226, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2842, d3mg4T_, 0.8385, 1.91, 0.332, 244, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2843, d3l5qL_, 0.8385, 1.93, 0.341, 244, 226,  
2844, d2gplT_, 0.8385, 1.92, 0.332, 244, 226, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2845, p4v7oU_, 0.8384, 1.93, 0.341, 244, 226, 
2846, p4v7oCB_, 0.8384, 1.93, 0.341, 244, 226, 
2847, p3un4T_, 0.8384, 1.92, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2848, p3un4F_, 0.8384, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2849, d3shjT_, 0.8384, 1.91, 0.332, 244, 226, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2850, d3shjF_, 0.8384, 1.91, 0.332, 244, 226, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2851, d3l5qX_, 0.8384, 1.93, 0.341, 244, 226,  
2852, d2ku2C1, 0.8384, 1.82, 0.396, 233, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2853, d1vsyU_, 0.8384, 1.93, 0.341, 244, 226,  
2854, p5m32T_, 0.8383, 1.95, 0.291, 240, 227, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2855, p4v7oOA_, 0.8383, 1.93, 0.341, 244, 226, 
2856, d1vsyG_, 0.8383, 1.93, 0.341, 244, 226,  
2857, p5vfrj_, 0.8382, 1.94, 0.336, 239, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2858, d4eu2U_, 0.8382, 1.92, 0.341, 244, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2859, d1jd21_, 0.8382, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2860, p5m32B_, 0.8381, 2.06, 0.354, 234, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2861, d1z7qU1, 0.8381, 1.92, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2862, d1z7qG1, 0.8381, 1.92, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2863, p5vfoM_, 0.8379, 1.98, 0.286, 240, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2864, d3mg8F_, 0.8379, 1.86, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2865, d2f16F_, 0.8378, 1.93, 0.341, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2866, d2f16T_, 0.8377, 1.93, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2867, d3oevF_, 0.8375, 1.87, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2868, d3oeuF_, 0.8375, 1.87, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2869, d3mg7F_, 0.8375, 1.87, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2870, d3oevT_, 0.8374, 1.87, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2871, d3mg8T_, 0.8374, 1.87, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2872, p5wviCA_, 0.8373, 2.31, 0.356, 245, 233, 
2873, d3mg6T_, 0.8373, 1.87, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2874, d3oeuT_, 0.8372, 1.87, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2875, d3mg7T_, 0.8372, 1.87, 0.333, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2876, d4eu2O_, 0.8371, 1.83, 0.307, 241, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2877, d3mg6F_, 0.8371, 1.87, 0.333, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2878, p5m32F_, 0.8370, 1.88, 0.292, 232, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2879, p5vfqG_, 0.8369, 1.98, 0.286, 240, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2880, p5t0jI_, 0.8368, 2.04, 0.352, 250, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2881, d3sdkU_, 0.8364, 1.84, 0.311, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2882, p5wviBA_, 0.8363, 1.91, 0.326, 243, 227, 
2883, p5nifA_, 0.8363, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2884, p4zzgA_, 0.8363, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2885, d3mg4U_, 0.8363, 1.84, 0.307, 243, 225, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2886, p5vfpG_, 0.8362, 2.00, 0.286, 240, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2887, p5t0hK_, 0.8362, 1.80, 0.329, 228, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2888, d3mg7U_, 0.8362, 1.86, 0.311, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2889, p3jcpPA_, 0.8362, 1.93, 0.341, 244, 226, 
2890, d5d0wU_, 0.8361, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2891, p6epdC_, 0.8360, 2.06, 0.361, 249, 230, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
2892, d5d0wG_, 0.8360, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2893, d4qv9U_, 0.8360, 1.86, 0.307, 241, 225, YCP BETA5-C63F MUTANT
2894, d4qv9G_, 0.8360, 1.86, 0.307, 241, 225, YCP BETA5-C63F MUTANT
2895, d4ya4U_, 0.8359, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2896, d4ya4G_, 0.8359, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2897, d3mg6U_, 0.8359, 1.85, 0.311, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2898, p3jcpP_, 0.8359, 1.94, 0.341, 244, 226, 
2899, d5l5bU_, 0.8358, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2900, d5l5bG_, 0.8358, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2901, d5fggU_, 0.8358, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2902, d5czaU_, 0.8358, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2903, d5czaG_, 0.8358, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2904, p5a5bE_, 0.8358, 2.23, 0.328, 243, 229, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2905, d4y8rU_, 0.8358, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2906, d4qv3U_, 0.8358, 1.86, 0.307, 241, 225, YCP BETA5-M45V MUTANT
2907, d4qv3G_, 0.8358, 1.86, 0.307, 241, 225, YCP BETA5-M45V MUTANT
2908, p4cr3E_, 0.8358, 2.23, 0.328, 243, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2909, d5l55U_, 0.8357, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2910, p5gjrX_, 0.8357, 1.69, 0.317, 238, 224, 
2911, d5fggG_, 0.8357, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2912, d5fg7U_, 0.8357, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2913, d5fg7G_, 0.8357, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2914, d4y8rG_, 0.8357, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2915, d4no9U_, 0.8357, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2916, d3sdiU_, 0.8357, 1.85, 0.311, 240, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2917, d3mg8U_, 0.8357, 1.86, 0.311, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2918, p5mpag_, 0.8356, 1.95, 0.336, 243, 226, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2919, d5l55G_, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2920, p5gjrLA_, 0.8356, 1.70, 0.317, 238, 224, 
2921, d5cgfU_, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2922, d5cgfG_, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2923, d5ahjU_, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2924, d5ahjG_, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2925, d4ya1U_, 0.8356, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2926, d4ya1G_, 0.8356, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2927, d4quyU_, 0.8356, 1.86, 0.307, 241, 225, YCP BETA5-A49S-MUTANT
2928, d4no9G_, 0.8356, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2929, d4nnnU_, 0.8356, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH MG132
2930, d4eu2A_, 0.8356, 1.86, 0.307, 241, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2931, d3wxrO_, 0.8356, 1.86, 0.311, 243, 225, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2932, p5cggU_, 0.8355, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2933, p5cggG_, 0.8355, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2934, d4quyG_, 0.8355, 1.86, 0.307, 241, 225, YCP BETA5-A49S-MUTANT
2935, d3un8U_, 0.8355, 1.86, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2936, p5vfuX_, 0.8354, 1.91, 0.296, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2937, p5vftM_, 0.8354, 1.91, 0.296, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2938, p5gjqG_, 0.8354, 1.69, 0.317, 238, 224, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2939, d5fgaU_, 0.8354, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2940, d5fgaG_, 0.8354, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2941, d5bxlU_, 0.8354, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2942, d5bxlG_, 0.8354, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2943, d4qwlU_, 0.8354, 1.86, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2944, d4qv7U_, 0.8354, 1.87, 0.307, 241, 225, YCP BETA5-A50V MUTANT
2945, d4nnnG_, 0.8354, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH MG132
2946, d4g4sA_, 0.8354, 2.02, 0.310, 241, 226, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2947, d3sdkF_, 0.8354, 1.84, 0.335, 236, 224, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2948, d1g0uU_, 0.8354, 1.86, 0.307, 240, 225, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2949, p5vfsG_, 0.8353, 1.91, 0.296, 240, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2950, p5vfom_, 0.8353, 1.90, 0.292, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2951, d5l5rU_, 0.8353, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2952, d5l5rG_, 0.8353, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2953, d5l52U_, 0.8353, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2954, d5jhrU_, 0.8353, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2955, p5dsvH_, 0.8353, 1.78, 0.290, 239, 224, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2956, d5d0sU_, 0.8353, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2957, d5d0sG_, 0.8353, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2958, d4qwlG_, 0.8353, 1.86, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2959, d4qv7G_, 0.8353, 1.87, 0.307, 241, 225, YCP BETA5-A50V MUTANT
2960, d4no8U_, 0.8353, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2961, d4no8G_, 0.8353, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2962, d4hnpU_, 0.8353, 1.86, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2963, d3oevG_, 0.8353, 1.86, 0.307, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2964, p5vfoL_, 0.8352, 1.70, 0.317, 238, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2965, d5l5uU_, 0.8352, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2966, d5l52G_, 0.8352, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2967, d5jhrG_, 0.8352, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2968, d5bxnU_, 0.8352, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2969, d5bxnG_, 0.8352, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2970, d4qwuU_, 0.8352, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2971, d4qwuG_, 0.8352, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2972, d4qv1U_, 0.8352, 1.87, 0.307, 241, 225, YCP BETA5-M45A MUTANT
2973, d4qv1G_, 0.8352, 1.87, 0.307, 241, 225, YCP BETA5-M45A MUTANT
2974, d4no1U_, 0.8352, 1.87, 0.307, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2975, d4ltcU_, 0.8352, 1.86, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2976, d4j70U_, 0.8352, 1.87, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2977, d3oevU_, 0.8352, 1.87, 0.311, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2978, p6gopU_, 0.8351, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2979, p5nifO_, 0.8351, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2980, d5l5uG_, 0.8351, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2981, p4zzgO_, 0.8351, 1.88, 0.307, 242, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2982, d4z1lU_, 0.8351, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2983, p4y8hU_, 0.8351, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2984, p4y8hG_, 0.8351, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2985, d4qz6U_, 0.8351, 1.86, 0.311, 241, 225, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2986, d4qv6U_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-A49V MUTANT
2987, d4qv5U_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-M45I MUTANT
2988, d4qv5G_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-M45I MUTANT
2989, d4qv4U_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-M45T MUTANT
2990, d4qv0U_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2991, d4qv0G_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2992, d4no1G_, 0.8351, 1.87, 0.307, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2993, p3jcpJA_, 0.8351, 1.87, 0.307, 243, 225, 
2994, p3jcpJ_, 0.8351, 1.87, 0.307, 243, 225, 
2995, d2ku1B1, 0.8351, 1.90, 0.400, 233, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2996, p6gopG_, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2997, p5vfrM_, 0.8350, 2.01, 0.286, 240, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2998, p5t0gJ_, 0.8350, 1.99, 0.332, 239, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2999, d4z1lG_, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3000, d4y9yU_, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3001, d4y9yG_, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3002, d4y8mU_, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3003, d4y8mG_, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3004, d4r17U_, 0.8350, 1.87, 0.307, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3005, d4r17G_, 0.8350, 1.88, 0.307, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3006, d4qzzU_, 0.8350, 1.87, 0.307, 241, 225, YCP IN COMPLEX WITH OMURALIDE
3007, d4qzzG_, 0.8350, 1.87, 0.307, 241, 225, YCP IN COMPLEX WITH OMURALIDE
3008, d4qz6G_, 0.8350, 1.86, 0.311, 241, 225, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3009, d4qz0U_, 0.8350, 1.86, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3010, d4qv8U_, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT
3011, d4qv8G_, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT
3012, d4qv6G_, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-A49V MUTANT
3013, d4qv4G_, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-M45T MUTANT
3014, d4q1sU_, 0.8350, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3015, d4hrcU_, 0.8350, 1.86, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3016, d3oeuU_, 0.8350, 1.98, 0.310, 243, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3017, d3gpjU_, 0.8350, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3018, d3gpjG_, 0.8350, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3019, d1rypO_, 0.8350, 1.87, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3020, p5m32G_, 0.8349, 1.99, 0.358, 233, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3021, d5l6aU_, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3022, d5l6aG_, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3023, d5fgfU_, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3024, d5fgfG_, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3025, d5fg9U_, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3026, d5fg9G_, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3027, d5d0zU_, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3028, d5d0zG_, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3029, p4ya7U_, 0.8349, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3030, p4ya7G_, 0.8349, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3031, p4y8pU_, 0.8349, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3032, p4y8pG_, 0.8349, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3033, d4r00U_, 0.8349, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3034, d4r00G_, 0.8349, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3035, d4qz0G_, 0.8349, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3036, d4qvnU_, 0.8349, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3037, d4qvnG_, 0.8349, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3038, d4hrdU_, 0.8349, 1.86, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3039, d3sdkT_, 0.8349, 1.85, 0.335, 236, 224, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3040, p1fntU_, 0.8349, 1.97, 0.336, 240, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3041, p5vfqFA_, 0.8348, 1.90, 0.296, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3042, d5cz9U_, 0.8348, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3043, d5cz9G_, 0.8348, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3044, p4x6zO_, 0.8348, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3045, d4j70G_, 0.8348, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3046, p3un4U_, 0.8348, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3047, d3tddU_, 0.8348, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3048, d3tddG_, 0.8348, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3049, d1g65U_, 0.8348, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3050, p1fntG_, 0.8348, 1.97, 0.336, 240, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3051, d5jhsU_, 0.8347, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3052, d5fhsU_, 0.8347, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3053, d5fhsG_, 0.8347, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3054, d5cz8U_, 0.8347, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3055, p4y9zU_, 0.8347, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3056, p4y9zG_, 0.8347, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3057, d4qz5U_, 0.8347, 1.87, 0.307, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3058, d4qz5G_, 0.8347, 1.87, 0.307, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3059, d4qw1U_, 0.8347, 1.87, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3060, d4qw1G_, 0.8347, 1.87, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3061, d4qvlU_, 0.8347, 1.87, 0.307, 241, 225, YCP IN COMPLEX WITH BORTEZOMIB
3062, d4jsuU_, 0.8347, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3063, d4jsuG_, 0.8347, 1.87, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3064, p3un4G_, 0.8347, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3065, d3nzjU_, 0.8347, 1.87, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3066, d3mg7G_, 0.8347, 1.88, 0.307, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3067, d3gpwU_, 0.8347, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3068, d3gptU_, 0.8347, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3069, d1g0uG_, 0.8347, 1.87, 0.307, 240, 225, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3070, p5vfpEA_, 0.8346, 1.90, 0.292, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3071, p5t0cY_, 0.8346, 2.04, 0.295, 240, 227, 
3072, p5t0cEB_, 0.8346, 2.04, 0.295, 240, 227, 
3073, d5l6bU_, 0.8346, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3074, d5l6bG_, 0.8346, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3075, d5jhsG_, 0.8346, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3076, d5cz8G_, 0.8346, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3077, p4ya2U_, 0.8346, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3078, p4ya2G_, 0.8346, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3079, p4y8tU_, 0.8346, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3080, p4y8sU_, 0.8346, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3081, p4y8sG_, 0.8346, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3082, d4qz3U_, 0.8346, 1.87, 0.311, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3083, d4qz3G_, 0.8346, 1.87, 0.311, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3084, d4qw7U_, 0.8346, 1.87, 0.307, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3085, d4qw5U_, 0.8346, 1.87, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3086, d4qw5G_, 0.8346, 1.87, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3087, d4qvlG_, 0.8346, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH BORTEZOMIB
3088, d4no6U_, 0.8346, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3089, d4jt0U_, 0.8346, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3090, d4jsqU_, 0.8346, 1.87, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3091, d3un8G_, 0.8346, 1.87, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3092, d3nzxU_, 0.8346, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3093, d3nzjG_, 0.8346, 1.87, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3094, d3mg4G_, 0.8346, 1.87, 0.307, 243, 225, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3095, d3mg0U_, 0.8346, 1.87, 0.311, 243, 225, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3096, d3gpwG_, 0.8346, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3097, d3gptG_, 0.8346, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3098, d3bdmU_, 0.8346, 1.89, 0.307, 243, 225, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3099, d3bdmG_, 0.8346, 1.89, 0.307, 243, 225, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3100, d1rypA_, 0.8346, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3101, d5lttU_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3102, d5lttG_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3103, d5l5aU_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3104, d5l5aG_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3105, d5d0vU_, 0.8345, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3106, d5d0vG_, 0.8345, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3107, d5cz7U_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3108, d5cz7G_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3109, d5cz6U_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3110, d5cz6G_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3111, p4y8tG_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3112, p4y8kU_, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3113, p4y8gU_, 0.8345, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3114, p4y8gG_, 0.8345, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3115, p4y75U_, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3116, p4y75G_, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3117, d4qw7G_, 0.8345, 1.87, 0.307, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3118, d4qw6U_, 0.8345, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3119, d4qvyU_, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3120, d4qvyG_, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3121, d4qvpU_, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3122, d4qvpG_, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3123, d4quxU_, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-A49T-MUTANT
3124, d4quxG_, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-A49T-MUTANT
3125, d4qltU_, 0.8345, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3126, d4qltG_, 0.8345, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3127, d4no6G_, 0.8345, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3128, d4lqiU_, 0.8345, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3129, d4jt0G_, 0.8345, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3130, d4jsqG_, 0.8345, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3131, d4intU_, 0.8345, 1.87, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3132, d4inrU_, 0.8345, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3133, d4fzgU_, 0.8345, 1.87, 0.311, 243, 225, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3134, d3shjU_, 0.8345, 1.88, 0.311, 243, 225, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3135, d3sdkG_, 0.8345, 1.88, 0.307, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3136, d3nzxG_, 0.8345, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3137, p5mpbD_, 0.8344, 1.99, 0.358, 240, 229, 
3138, d5l63U_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3139, d5l63G_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3140, d5l61U_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3141, d5l61G_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3142, d5l5hU_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3143, d5l5hG_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3144, p5l4gT_, 0.8344, 1.70, 0.317, 238, 224, 
3145, p5cgiU_, 0.8344, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3146, p4y8lU_, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3147, p4y8lG_, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3148, p4y8kG_, 0.8344, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3149, p4y77U_, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3150, p4y70U_, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3151, p4v7oO_, 0.8344, 1.88, 0.307, 243, 225, 
3152, p4v7oIA_, 0.8344, 1.88, 0.307, 243, 225, 
3153, p4v7oA_, 0.8344, 1.88, 0.307, 243, 225, 
3154, d4qz4U_, 0.8344, 1.87, 0.311, 241, 225, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3155, d4qz4G_, 0.8344, 1.87, 0.307, 241, 225, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3156, d4qw6G_, 0.8344, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3157, d4lqiG_, 0.8344, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3158, d3shjG_, 0.8344, 1.88, 0.311, 243, 225, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3159, d3nzwU_, 0.8344, 1.89, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3160, d3mg6G_, 0.8344, 1.88, 0.307, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3161, d3l5qC_, 0.8344, 1.88, 0.307, 243, 225,  
3162, d3l5qA_, 0.8344, 1.88, 0.307, 243, 225,  
3163, d3hyeU_, 0.8344, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3164, d1vsyA_, 0.8344, 1.88, 0.307, 243, 225,  
3165, p5vfrl_, 0.8343, 1.73, 0.317, 238, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3166, d5l67U_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3167, d5l67G_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3168, d5l65U_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3169, d5l65G_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3170, d5l5oU_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3171, d5l5oG_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3172, d5l5fU_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3173, d5l5dU_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3174, d5l5dG_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3175, d5fgeU_, 0.8343, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3176, d5fgeG_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3177, p5cgiG_, 0.8343, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3178, p5cghU_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3179, p4ya9U_, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3180, p4ya9G_, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3181, p4y8uU_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3182, p4y8uG_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3183, p4y7wU_, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3184, p4y77G_, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3185, p4y70G_, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3186, p4v7oWA_, 0.8343, 1.88, 0.307, 243, 225, 
3187, d4r02U_, 0.8343, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3188, d4qzwU_, 0.8343, 1.88, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3189, d4qwrU_, 0.8343, 1.88, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3190, d4qwjU_, 0.8343, 1.87, 0.307, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3191, d4qwjG_, 0.8343, 1.87, 0.307, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3192, d4qluU_, 0.8343, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3193, d4nnwU_, 0.8343, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3194, d4nnwG_, 0.8343, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3195, d4fzgG_, 0.8343, 1.87, 0.311, 243, 225, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3196, d3wxrA_, 0.8343, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3197, d3okjU_, 0.8343, 1.89, 0.307, 243, 225, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3198, d3nzwG_, 0.8343, 1.89, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3199, d3hyeG_, 0.8343, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3200, d3e47U_, 0.8343, 1.87, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3201, d2fnyU_, 0.8343, 1.87, 0.311, 243, 225,  
3202, d1vsyO_, 0.8343, 1.88, 0.307, 243, 225,  
3203, d1jd22_, 0.8343, 1.89, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3204, p5vfsFA_, 0.8342, 1.93, 0.296, 240, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3205, d5l6cU_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3206, d5l66U_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3207, d5l66G_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3208, d5l64U_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3209, d5l64G_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3210, d5l62U_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3211, d5l62G_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3212, d5l5wU_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3213, d5l5pU_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3214, d5l5pG_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3215, d5l5fG_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3216, d5l54U_, 0.8342, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3217, d5l54G_, 0.8342, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3218, p5cghG_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3219, p4y8jU_, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3220, p4y7yU_, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3221, p4y7yG_, 0.8342, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3222, p4y7wG_, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3223, d4qzxU_, 0.8342, 1.88, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3224, d4qzwG_, 0.8342, 1.88, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3225, d4qwrG_, 0.8342, 1.88, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3226, d4qvwU_, 0.8342, 1.88, 0.307, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3227, d4qvwG_, 0.8342, 1.88, 0.307, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3228, d4qluG_, 0.8342, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3229, d4qlsU_, 0.8342, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3230, d4qlsG_, 0.8342, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3231, d3oeuG_, 0.8342, 1.88, 0.307, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3232, p6epdB_, 0.8341, 2.18, 0.603, 234, 232, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
3233, d5l6cG_, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3234, d5l5xU_, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3235, d5l5wG_, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3236, d5l5eU_, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3237, d5l5eG_, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3238, d5d0tU_, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3239, d5cz5U_, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3240, p4y8qU_, 0.8341, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3241, p4y8jG_, 0.8341, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3242, p4y82U_, 0.8341, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3243, d4qzxG_, 0.8341, 1.88, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3244, d4qz7U_, 0.8341, 1.88, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3245, d4qz7G_, 0.8341, 1.88, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3246, d4qwiU_, 0.8341, 1.88, 0.307, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3247, d4inrG_, 0.8341, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3248, d3okjG_, 0.8341, 1.89, 0.307, 243, 225, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3249, d3e47G_, 0.8341, 1.88, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3250, d3d29U2, 0.8341, 1.90, 0.307, 241, 225, PROTEASOME INHIBITION BY FELLUTAMIDE B
3251, d2fnyG_, 0.8341, 1.88, 0.311, 243, 225,  
3252, d2fakU_, 0.8341, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3253, d5l5xG_, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3254, d5fgiU_, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3255, d5fgiG_, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3256, d5d0tG_, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3257, d5cz5G_, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3258, p4y8qG_, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3259, p4y82G_, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3260, p4y74U_, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3261, p4y74G_, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3262, p4y6vU_, 0.8340, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3263, p4y6vG_, 0.8340, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3264, d4qz2U_, 0.8340, 1.88, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3265, d4qz2G_, 0.8340, 1.88, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3266, d4qwxU_, 0.8340, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3267, d4qwxG_, 0.8340, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3268, d4qwiG_, 0.8340, 1.88, 0.307, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3269, p4qbyU_, 0.8340, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3270, p4qbyG_, 0.8340, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3271, d3d29G2, 0.8340, 1.90, 0.307, 241, 225, PROTEASOME INHIBITION BY FELLUTAMIDE B
3272, d2fakG_, 0.8340, 1.89, 0.307, 243, 225, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3273, d1g65G_, 0.8340, 1.89, 0.307, 243, 225, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3274, p5t0iI_, 0.8339, 2.37, 0.352, 250, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3275, d5m2bU_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3276, d5m2bG_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3277, d5lajU_, 0.8339, 1.89, 0.307, 241, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3278, d5lajG_, 0.8339, 1.89, 0.307, 241, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3279, d5l5tU_, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3280, d5l5tG_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3281, d5l5sU_, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3282, d5l5qU_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3283, d5l5qG_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3284, d5fgdU_, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3285, p4y80U_, 0.8339, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3286, p4y80G_, 0.8339, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3287, p4y6aU_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3288, p4y6aG_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3289, p4y69U_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3290, p4y69G_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3291, d4inuU_, 0.8339, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3292, d4fzcU_, 0.8339, 1.89, 0.311, 243, 225, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3293, d3sdiG_, 0.8339, 1.89, 0.307, 240, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3294, d2gplU_, 0.8339, 1.89, 0.311, 243, 225, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3295, d2f16U_, 0.8339, 1.88, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3296, p5vfrL_, 0.8338, 1.72, 0.317, 238, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3297, p5mpaG_, 0.8338, 1.97, 0.336, 243, 226, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3298, d5l5zU_, 0.8338, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3299, d5l5vU_, 0.8338, 1.89, 0.307, 241, 225,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3300, d5l5vG_, 0.8338, 1.89, 0.307, 241, 225,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3301, d5l5sG_, 0.8338, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3302, d5fgdG_, 0.8338, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3303, d5dkjU_, 0.8338, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3304, p4y84U_, 0.8338, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3305, p4y7xU_, 0.8338, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3306, p4y7xG_, 0.8338, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3307, d4r18U_, 0.8338, 1.89, 0.307, 241, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3308, d4qwkU_, 0.8338, 1.88, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3309, d4qwfU_, 0.8338, 1.88, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3310, d4qvqU_, 0.8338, 1.89, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3311, d4qlvU_, 0.8338, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3312, d4qlqU_, 0.8338, 1.89, 0.311, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3313, d4ltcG_, 0.8338, 1.89, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3314, d4intG_, 0.8338, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3315, d4fzcG_, 0.8338, 1.89, 0.311, 243, 225, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3316, d5l5zG_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3317, d5l5jU_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3318, d5l5jG_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3319, d5dkjG_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3320, d5bouU_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3321, d5bouG_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3322, p4y8nU_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3323, p4y8nG_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3324, p4y84G_, 0.8337, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3325, d4rurU_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3326, d4r18G_, 0.8337, 1.89, 0.307, 241, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3327, d4qwkG_, 0.8337, 1.88, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3328, d4qwfG_, 0.8337, 1.88, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3329, d4qvqG_, 0.8337, 1.89, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3330, d4qlvG_, 0.8337, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3331, d4qlqG_, 0.8337, 1.89, 0.311, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3332, d4inuG_, 0.8337, 1.89, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3333, d3dy3G_, 0.8337, 1.91, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3334, d2gplG_, 0.8337, 1.89, 0.311, 243, 225, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3335, d2f16G_, 0.8337, 1.89, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3336, p5t0gM_, 0.8336, 2.05, 0.295, 240, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3337, d5l68U_, 0.8336, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3338, d5l68G_, 0.8336, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3339, d5l5iU_, 0.8336, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3340, d5l5iG_, 0.8336, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3341, p4y6zU_, 0.8336, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3342, d4rurG_, 0.8336, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3343, d4qw0U_, 0.8336, 1.89, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3344, d4qw0G_, 0.8336, 1.89, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3345, d4qvvU_, 0.8336, 1.89, 0.307, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3346, d3mg8G_, 0.8336, 1.90, 0.307, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3347, d3dy3U_, 0.8336, 1.91, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3348, p6avoG_, 0.8335, 1.73, 0.317, 234, 224, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3349, p5vfqF_, 0.8335, 1.73, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3350, p5vfqEA_, 0.8335, 1.73, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3351, d5d0xU_, 0.8335, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3352, p4ya5U_, 0.8335, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3353, p4y8iU_, 0.8335, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3354, p4y8iG_, 0.8335, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3355, p4y6zG_, 0.8335, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3356, d4qxjU_, 0.8335, 1.88, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3357, d4qxjG_, 0.8335, 1.88, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3358, d4qw4U_, 0.8335, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH CARFILZOMIB
3359, d4qvvG_, 0.8335, 1.89, 0.307, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3360, d4q1sG_, 0.8335, 1.90, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3361, p4gk7U_, 0.8335, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3362, d5l5yU_, 0.8334, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3363, d5d0xG_, 0.8334, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3364, p4ya5G_, 0.8334, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3365, p4y78U_, 0.8334, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3366, p4y78G_, 0.8334, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3367, d4qz1U_, 0.8334, 1.88, 0.307, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3368, d4qw4G_, 0.8334, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH CARFILZOMIB
3369, d3dy4U_, 0.8334, 1.91, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3370, d1iruT_, 0.8334, 1.74, 0.317, 238, 224, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3371, d1iruF_, 0.8334, 1.74, 0.317, 238, 224, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3372, p6avoL_, 0.8333, 1.73, 0.317, 234, 224, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3373, d5laiU_, 0.8333, 1.90, 0.307, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3374, d5laiG_, 0.8333, 1.90, 0.307, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3375, d5l60U_, 0.8333, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3376, d5l60G_, 0.8333, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3377, d5l5yG_, 0.8333, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3378, p4x6zA_, 0.8333, 1.90, 0.307, 242, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3379, d4qz1G_, 0.8333, 1.88, 0.307, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3380, p4gk7G_, 0.8333, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3381, d3dy4G_, 0.8333, 1.91, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3382, p5vfsEA_, 0.8332, 1.72, 0.317, 238, 224, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3383, p5l4gF_, 0.8332, 1.72, 0.317, 238, 224, 
3384, d4qvmU_, 0.8332, 1.89, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3385, d4qvmG_, 0.8332, 1.89, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3386, d3wxrG1, 0.8332, 1.87, 0.330, 236, 224, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3387, d2zcyU_, 0.8332, 1.92, 0.307, 243, 225, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3388, d2zcyG_, 0.8332, 1.92, 0.307, 243, 225, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3389, p6epeA_, 0.8331, 2.09, 0.354, 246, 229, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3390, p5vfsF_, 0.8331, 1.72, 0.317, 238, 224, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3391, p5vfol_, 0.8331, 1.74, 0.317, 238, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3392, d5l69U_, 0.8331, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3393, d5l69G_, 0.8331, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3394, d5cz4U_, 0.8331, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3395, p4ya3U_, 0.8331, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3396, p4ya3G_, 0.8331, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3397, d4hnpG_, 0.8331, 1.90, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3398, d3unfS_, 0.8331, 1.72, 0.312, 238, 224, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3399, d3unfE_, 0.8331, 1.72, 0.312, 238, 224, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3400, p3unbu_, 0.8331, 1.73, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3401, d3unbS_, 0.8331, 1.73, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3402, d5cz4G_, 0.8330, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3403, p4y81U_, 0.8330, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3404, p4y81G_, 0.8330, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3405, d4qwsU_, 0.8330, 1.89, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3406, d4qwsG_, 0.8329, 1.89, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3407, d4hrdG_, 0.8329, 1.90, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3408, p5fghU_, 0.8328, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3409, p5fghG_, 0.8328, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3410, p4y8oU_, 0.8328, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3411, p4y8oG_, 0.8328, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3412, p5vfuLA_, 0.8327, 1.95, 0.296, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3413, p5vftm_, 0.8327, 1.95, 0.296, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3414, p4ya0U_, 0.8327, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3415, p4ya0G_, 0.8327, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3416, p3unhS_, 0.8327, 1.73, 0.312, 238, 224, MOUSE 20S IMMUNOPROTEASOME
3417, p3unhE_, 0.8327, 1.73, 0.312, 238, 224, MOUSE 20S IMMUNOPROTEASOME
3418, p3j9iU_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3419, p3j9iT_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3420, p3j9iS_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3421, p3j9iR_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3422, p3j9iQ_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3423, p3j9iP_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3424, p3j9iO_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3425, p3j9iG_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3426, p3j9iF_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3427, p3j9iE_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3428, p3j9iD_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3429, p3j9iC_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3430, p3j9iB_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3431, p3j9iA_, 0.8326, 1.67, 0.407, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3432, d1jd2G_, 0.8326, 1.91, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3433, p5vfpF_, 0.8325, 1.74, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3434, p5vfpDA_, 0.8325, 1.75, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3435, d4r02G_, 0.8325, 1.91, 0.307, 241, 225, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3436, d4hrcG_, 0.8325, 1.90, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3437, p5vfrm_, 0.8324, 1.93, 0.292, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3438, d4r3oF_, 0.8324, 1.74, 0.317, 238, 224, HUMAN CONSTITUTIVE 20S PROTEASOME
3439, d4qw3U_, 0.8324, 1.90, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3440, d4qw3G_, 0.8324, 1.90, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3441, p5dsvJ_, 0.8323, 1.94, 0.290, 239, 224, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3442, d4r67T_, 0.8323, 1.75, 0.317, 238, 224, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3443, p4r67h_, 0.8323, 1.75, 0.317, 238, 224, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3444, d4r67F_, 0.8323, 1.75, 0.317, 238, 224, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3445, d4cr2G_, 0.8323, 2.15, 0.339, 245, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3446, d5dkiU_, 0.8322, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3447, d5dkiG_, 0.8322, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3448, d4r3oT_, 0.8322, 1.75, 0.317, 238, 224, HUMAN CONSTITUTIVE 20S PROTEASOME
3449, p5mp9a_, 0.8319, 1.99, 0.305, 241, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3450, d3wxrU1, 0.8319, 1.88, 0.330, 236, 224, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3451, p5mp9A_, 0.8318, 1.97, 0.305, 241, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3452, p5lf0E_, 0.8318, 1.70, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3453, d4qwgU_, 0.8318, 1.91, 0.311, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3454, d4qwgG_, 0.8318, 1.91, 0.311, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3455, d5lf4E_, 0.8316, 1.69, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3456, p5lf0S_, 0.8316, 1.70, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3457, p5t0jM_, 0.8315, 1.91, 0.296, 240, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3458, p5lf6E_, 0.8315, 1.70, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3459, d5lf4S_, 0.8315, 1.69, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3460, p3uneu_, 0.8315, 1.76, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME
3461, d3mg0G_, 0.8315, 1.93, 0.307, 243, 225, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3462, d5lexS_, 0.8314, 1.70, 0.318, 235, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3463, d5le5S_, 0.8313, 1.70, 0.318, 237, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3464, d5lf7S_, 0.8312, 1.70, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3465, p5lf6S_, 0.8312, 1.70, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3466, p5leyE_, 0.8312, 1.70, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3467, d5lf1S_, 0.8311, 1.70, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3468, p5vfuW_, 0.8310, 1.75, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3469, p5vftL_, 0.8310, 1.74, 0.317, 238, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3470, d5lf7E_, 0.8310, 1.71, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3471, d5lf3S_, 0.8310, 1.71, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3472, d5lexE_, 0.8310, 1.71, 0.318, 233, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3473, p3uneE_, 0.8310, 1.76, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME
3474, p3unbg_, 0.8310, 1.77, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3475, d5lf3E_, 0.8309, 1.71, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3476, d5lf1E_, 0.8309, 1.71, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3477, p5leyS_, 0.8309, 1.71, 0.318, 235, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3478, p3uneS_, 0.8308, 1.76, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME
3479, p5vfuKA_, 0.8307, 1.77, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3480, d5le5E_, 0.8307, 1.71, 0.318, 233, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3481, p5vftl_, 0.8306, 1.77, 0.317, 238, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3482, p5lezS_, 0.8306, 1.71, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3483, p3uneg_, 0.8306, 1.76, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME
3484, d1ya7F_, 0.8306, 1.64, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3485, p5wvkBA_, 0.8305, 1.99, 0.332, 244, 226, 
3486, p5lezE_, 0.8304, 1.71, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3487, d3unbE_, 0.8303, 1.78, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3488, p3jcoPA_, 0.8302, 2.02, 0.341, 244, 226, 
3489, p3jcoP_, 0.8302, 2.02, 0.341, 244, 226, 
3490, p5mpbU_, 0.8301, 2.02, 0.332, 243, 226, 
3491, p5a5bG_, 0.8300, 2.07, 0.336, 245, 226, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3492, p4cr3G_, 0.8300, 2.07, 0.336, 245, 226, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3493, p3jcoJA_, 0.8300, 1.95, 0.307, 243, 225, 
3494, d1yauF_, 0.8300, 1.55, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3495, p5a0qP_, 0.8298, 1.11, 0.631, 214, 214, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3496, p5a0qB_, 0.8298, 1.11, 0.631, 214, 214, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3497, p3jcoJ_, 0.8298, 1.95, 0.307, 243, 225, 
3498, p5wvkU_, 0.8295, 2.14, 0.335, 244, 227, 
3499, p5t0hJ_, 0.8295, 2.03, 0.332, 239, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3500, p5t0cX_, 0.8295, 1.78, 0.317, 238, 224, 
3501, p5t0cDB_, 0.8295, 1.78, 0.317, 238, 224, 
3502, p5t0hM_, 0.8294, 2.12, 0.295, 240, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3503, d1yauA_, 0.8294, 1.56, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3504, d1ya7G_, 0.8294, 1.66, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3505, p5mpcG_, 0.8293, 2.18, 0.335, 243, 227, 
3506, d1yauG_, 0.8292, 1.57, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3507, p5mpaa_, 0.8291, 1.93, 0.311, 241, 225, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3508, d1yauC_, 0.8291, 1.56, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3509, d1ya7C_, 0.8291, 1.66, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3510, d2ku2G1, 0.8290, 1.77, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3511, d3jseG_, 0.8289, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3512, d2ku1D1, 0.8289, 1.91, 0.404, 233, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3513, d3jseF_, 0.8288, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3514, d3jseB_, 0.8287, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3515, d5lexG_, 0.8286, 1.87, 0.368, 241, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3516, d1yauB_, 0.8286, 1.57, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3517, p6epcC_, 0.8285, 2.69, 0.363, 249, 234, GROUND STATE 26S PROTEASOME (GS2)
3518, d3jseD_, 0.8285, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3519, d3jseC_, 0.8285, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3520, d3jseA_, 0.8285, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3521, d2ku2F1, 0.8285, 1.82, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3522, d2ku2D1, 0.8285, 1.81, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3523, d2ku1F1, 0.8285, 1.81, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3524, p5mpcU_, 0.8284, 2.32, 0.338, 243, 228, 
3525, d3jseE_, 0.8284, 1.67, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3526, d2ku1C1, 0.8283, 1.85, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3527, d1ya7B_, 0.8282, 1.67, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3528, p5wviI_, 0.8280, 1.96, 0.350, 231, 226, 
3529, p5ln3G_, 0.8280, 2.06, 0.291, 242, 227, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3530, d1ya7D_, 0.8278, 1.68, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3531, d1ya7A_, 0.8278, 1.68, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3532, d5lf3G_, 0.8277, 1.88, 0.368, 241, 223, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3533, d1yauD_, 0.8277, 1.59, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3534, p5mpaf_, 0.8276, 1.64, 0.285, 231, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3535, p5mpcR_, 0.8275, 2.06, 0.363, 240, 226, 
3536, d2ku2E1, 0.8275, 1.68, 0.403, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3537, d1yarG_, 0.8275, 1.53, 0.416, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3538, d1yarF_, 0.8274, 1.55, 0.411, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3539, d1yarC_, 0.8274, 1.53, 0.416, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3540, d5lf7G_, 0.8272, 1.89, 0.368, 241, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3541, d5le5G_, 0.8272, 1.89, 0.368, 241, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3542, d2ku1E1, 0.8271, 1.70, 0.403, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3543, d5lf1G_, 0.8270, 1.89, 0.368, 241, 223, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3544, d1yarD_, 0.8270, 1.53, 0.416, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3545, d5lf4G_, 0.8269, 1.89, 0.368, 241, 223, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3546, d2ku1G1, 0.8269, 1.71, 0.403, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3547, p6epfD_, 0.8268, 2.17, 0.326, 246, 230, GROUND STATE 26S PROTEASOME (GS1)
3548, p5m32E_, 0.8266, 2.01, 0.311, 234, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3549, p5wvkV_, 0.8265, 1.98, 0.311, 243, 225, 
3550, d4cr2A_, 0.8265, 2.04, 0.305, 243, 226, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3551, d1yarB_, 0.8265, 1.55, 0.416, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3552, d4g4sF_, 0.8263, 1.66, 0.285, 234, 221, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3553, p6epeB_, 0.8261, 2.00, 0.612, 234, 224, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3554, p1fntO_, 0.8261, 2.01, 0.307, 238, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3555, p5mpbG_, 0.8260, 2.06, 0.336, 243, 226, 
3556, d3jrmG_, 0.8260, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3557, d3jrmB_, 0.8260, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3558, d3jrmA_, 0.8260, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3559, d3jrmD_, 0.8259, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3560, d3jrmC_, 0.8259, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3561, p1fntA_, 0.8259, 2.02, 0.307, 238, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3562, p5vy3Y_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3563, p5vy3W_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3564, p5vy3U_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3565, p5vy3S_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3566, p5vy3Q_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3567, p5vy3O_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3568, p5vy3M_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3569, p5vy3K_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3570, p5vy3I_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3571, p5vy3G_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3572, p5vy3E_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3573, p5vy3C_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3574, p5vy3A_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3575, p5vy30_, 0.8258, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3576, d3jrmF_, 0.8258, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3577, d1z7qO1, 0.8258, 2.19, 0.300, 243, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3578, d1z7qA1, 0.8258, 2.19, 0.300, 243, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3579, d1yarA_, 0.8257, 1.56, 0.416, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3580, p4cr4G_, 0.8256, 2.22, 0.335, 245, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3581, d3jrmE_, 0.8256, 1.71, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3582, d1yauE_, 0.8255, 1.63, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3583, p4zzgT_, 0.8252, 1.84, 0.284, 232, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3584, p5vy4Y_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3585, p5vy4W_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3586, p5vy4U_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3587, p5vy4S_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3588, p5vy4Q_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3589, p5vy4O_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3590, p5vy4M_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3591, p5vy4K_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3592, p5vy4I_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3593, p5vy4G_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3594, p5vy4E_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3595, p5vy4C_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3596, p5vy4AA_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3597, p5vy4A_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3598, p5vy40_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3599, p5mp9F_, 0.8249, 1.82, 0.284, 233, 222, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3600, d3mg8S_, 0.8249, 1.85, 0.284, 233, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3601, p5nifT_, 0.8248, 1.85, 0.284, 232, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3602, d3sdkS_, 0.8248, 1.85, 0.284, 233, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3603, d3dy3E_, 0.8248, 1.68, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3604, d3dy3S_, 0.8247, 1.68, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3605, d4hnpS_, 0.8246, 1.68, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3606, p4zzgF_, 0.8245, 1.68, 0.285, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3607, d3sdkE_, 0.8245, 1.85, 0.284, 233, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3608, d4intE_, 0.8244, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3609, d4fzgS_, 0.8244, 1.69, 0.285, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3610, d4fzgE_, 0.8244, 1.69, 0.285, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3611, d3bdmS_, 0.8244, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3612, d4intS_, 0.8243, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3613, d4hnpE_, 0.8243, 1.68, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3614, d3sdiE_, 0.8243, 1.85, 0.284, 230, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3615, d3mg6S_, 0.8243, 1.86, 0.284, 233, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3616, p3jtlG_, 0.8243, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3617, p3jtlC_, 0.8243, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3618, p3jtlB_, 0.8243, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3619, d3bdmE_, 0.8243, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3620, p4gk7S_, 0.8242, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3621, p4gk7E_, 0.8242, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3622, p3jtlD_, 0.8242, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3623, p3jtlA_, 0.8242, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3624, d3gpjS_, 0.8242, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3625, d3gpjE_, 0.8242, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3626, d4hrdS_, 0.8241, 1.68, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3627, p3jtlF_, 0.8241, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3628, d3d29S_, 0.8241, 1.69, 0.285, 233, 221, PROTEASOME INHIBITION BY FELLUTAMIDE B
3629, d3d29E_, 0.8241, 1.69, 0.285, 233, 221, PROTEASOME INHIBITION BY FELLUTAMIDE B
3630, d2zcyS_, 0.8241, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3631, d2zcyE_, 0.8241, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3632, p6bdfY_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3633, p6bdfW_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3634, p6bdfU_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3635, p6bdfS_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3636, p6bdfQ_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3637, p6bdfO_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3638, p6bdfM_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3639, p6bdfK_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3640, p6bdfI_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3641, p6bdfG_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3642, p6bdfE_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3643, p6bdfC_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3644, p6bdfA_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3645, p6bdf0_, 0.8240, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3646, p5nifF_, 0.8240, 1.69, 0.285, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3647, d4fzcS_, 0.8240, 1.69, 0.285, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3648, d4fzcE_, 0.8240, 1.69, 0.285, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3649, p3jtlE_, 0.8240, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3650, d3dy4S_, 0.8240, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3651, d3dy4E_, 0.8240, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3652, d1yarE_, 0.8240, 1.59, 0.416, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3653, d1ya7E_, 0.8240, 1.74, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3654, p6epfG_, 0.8239, 2.15, 0.288, 245, 226, GROUND STATE 26S PROTEASOME (GS1)
3655, d4hrdE_, 0.8239, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3656, d3nzjS_, 0.8238, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3657, d3mg7S_, 0.8238, 1.87, 0.284, 233, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3658, d1pmaO_, 0.8238, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3659, d1pmaD_, 0.8238, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3660, d4lqiS_, 0.8237, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3661, d4lqiE_, 0.8237, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3662, d3un8E_, 0.8237, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3663, d3nzjE_, 0.8237, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3664, p5wviAA_, 0.8236, 2.00, 0.350, 231, 226, 
3665, d4eu2F_, 0.8236, 1.70, 0.285, 232, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3666, d3un8S_, 0.8236, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3667, d3mg6E_, 0.8236, 1.87, 0.284, 233, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3668, d1z7qT1, 0.8236, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3669, d1z7qF1, 0.8236, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3670, d5lajS_, 0.8234, 1.70, 0.285, 231, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3671, d5lajE_, 0.8234, 1.70, 0.285, 231, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3672, d3oevE_, 0.8234, 1.87, 0.284, 233, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3673, d3oeuS_, 0.8234, 1.87, 0.284, 233, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3674, d3oeuE_, 0.8234, 1.70, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3675, d1pmaN_, 0.8234, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3676, d1pmaH_, 0.8234, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3677, d4j70E_, 0.8233, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3678, d1pmaJ_, 0.8233, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3679, d1pmaF_, 0.8233, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3680, p5t0gL_, 0.8232, 1.85, 0.317, 238, 224, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3681, d5l5uS_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3682, d5l5uE_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3683, d5dkjS_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3684, d5dkjE_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3685, d4r18S_, 0.8232, 1.70, 0.285, 231, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3686, d4r18E_, 0.8232, 1.70, 0.285, 231, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3687, d4jt0E_, 0.8232, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3688, d4jsqS_, 0.8232, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3689, d4jsqE_, 0.8232, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3690, d4j70S_, 0.8232, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3691, d1pmaL_, 0.8232, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3692, d1pmaG_, 0.8232, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3693, d1pmaE_, 0.8232, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3694, d5l6cS_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3695, d5l6cE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3696, d5l67S_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3697, d5l67E_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3698, d5l62S_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3699, d5l62E_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3700, d5l61S_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3701, d5l61E_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3702, d5l5zS_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3703, d5l5zE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3704, d5l5tS_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3705, d5l5tE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3706, d5l5sS_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3707, d5l5sE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3708, d5l5pS_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3709, d5l5pE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3710, d4jt0S_, 0.8231, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3711, d4jsuS_, 0.8231, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3712, d4jsuE_, 0.8231, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3713, p3un4S_, 0.8231, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3714, p3un4E_, 0.8231, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3715, d3mg8E_, 0.8231, 1.71, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3716, d3mg7E_, 0.8231, 1.87, 0.284, 233, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3717, d3mg0S_, 0.8231, 1.70, 0.285, 233, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3718, d3mg0E_, 0.8231, 1.70, 0.285, 233, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3719, d1pmaM_, 0.8231, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3720, d1pmaI_, 0.8231, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3721, d1pmaC_, 0.8231, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3722, d5lttS_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3723, d5lttE_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3724, d5l69S_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3725, d5l69E_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3726, d5l60S_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3727, d5l60E_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3728, d5l5vS_, 0.8230, 1.70, 0.285, 231, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3729, d5l5vE_, 0.8230, 1.70, 0.285, 231, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3730, d5l5qS_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3731, d5l5qE_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3732, d5l5jS_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3733, d5l5jE_, 0.8230, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3734, d5cz7S_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3735, d5cz7E_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3736, d4qw0S_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3737, d4qw0E_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3738, d4qvyS_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3739, d4qvyE_, 0.8230, 1.71, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3740, d4q1sE_, 0.8230, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3741, d3c92U1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3742, d3c92T1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3743, d3c92S1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3744, d3c92R1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3745, d3c92Q1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3746, d3c92P1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3747, d3c92O1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3748, d3c92G1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3749, d3c92F1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3750, d3c92E1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3751, d3c92D1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3752, d3c92C1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3753, d3c92B1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3754, d3c92A1, 0.8230, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3755, d1pmaA_, 0.8230, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3756, p1fntF_, 0.8230, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3757, d5l6bS_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3758, d5l6bE_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3759, d5l64S_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3760, d5l64E_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3761, d5l63S_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3762, d5l63E_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3763, d5l5xS_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3764, d5l5xE_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3765, d5l5wS_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3766, d5l5wE_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3767, d5l5oS_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3768, d5l5oE_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3769, d5l5iS_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3770, d5l5iE_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3771, d5l5hS_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3772, d5l5hE_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3773, d5fgaS_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3774, d5fgaE_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3775, d5d0tE_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3776, d5cz6S_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3777, d5cz6E_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3778, p4x6zF_, 0.8229, 1.71, 0.285, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3779, d4qzzS_, 0.8229, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH OMURALIDE
3780, d4qzzE_, 0.8229, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH OMURALIDE
3781, d4inrE_, 0.8229, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3782, d4hrcE_, 0.8229, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3783, d1pmaK_, 0.8229, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3784, p1fntT_, 0.8229, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3785, p6gopS_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3786, p6gopE_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3787, d5l6aS_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3788, d5l6aE_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3789, d5l68S_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3790, d5l68E_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3791, d5l66S_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3792, d5l66E_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3793, d5l65S_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3794, d5l65E_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3795, d5l5yS_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3796, d5l5yE_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3797, d5l5fS_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3798, d5l5fE_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3799, d5l5eS_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3800, d5l5eE_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3801, d5l5aS_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3802, d5l5aE_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3803, d5dkiS_, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3804, d5dkiE_, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3805, d5d0tS_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3806, d4qz6S_, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3807, d4qz6E_, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3808, d4qvvS_, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3809, d4qvvE_, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3810, d4qvlE_, 0.8228, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH BORTEZOMIB
3811, d3nzwS_, 0.8228, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3812, d3nzwE_, 0.8228, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3813, d2fakE_, 0.8228, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3814, d1rypF_, 0.8228, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3815, d5l5rS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3816, d5l5dS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3817, d5l5dE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3818, d5l5bS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3819, p5fghS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3820, p5fghE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3821, d5fgfS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3822, d5fgfE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3823, d5fg9S_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3824, d5fg9E_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3825, d5d0xS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3826, d5d0xE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3827, d5czaS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3828, d5czaE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3829, d5cgfS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3830, d5cgfE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3831, p4x6zT_, 0.8227, 1.71, 0.285, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3832, d4r00S_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3833, d4r00E_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3834, d4qvlS_, 0.8227, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH BORTEZOMIB
3835, d4qv6S_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-A49V MUTANT
3836, d4qv6E_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-A49V MUTANT
3837, d4qv0S_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3838, d4qv0E_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3839, d4ltcE_, 0.8227, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3840, d3shjE_, 0.8227, 1.71, 0.285, 233, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3841, d3hyeE_, 0.8227, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3842, d2fakS_, 0.8227, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3843, d5m2bS_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3844, d5m2bE_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3845, d5l5rE_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3846, d5l5bE_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3847, d5fg7S_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3848, d5fg7E_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3849, d5bxlS_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3850, d5bxlE_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3851, d5bouS_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3852, d5bouE_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3853, p4y9zS_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3854, p4y9zE_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3855, p4y8uS_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3856, p4y8uE_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3857, d4y8rS_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3858, d4y8rE_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3859, p4y70S_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3860, p4y70E_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3861, p4y69S_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3862, p4y69E_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3863, d4qz5S_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3864, d4qz5E_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3865, d4qz3S_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3866, d4qz3E_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3867, d4qvwS_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3868, d4qvwE_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3869, d4qvpS_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3870, d4qvpE_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3871, d4qv8S_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT
3872, d4qv8E_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT
3873, d4quyS_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT
3874, d4quyE_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT
3875, d4quxS_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49T-MUTANT
3876, d4quxE_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49T-MUTANT
3877, d4nnnS_, 0.8226, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH MG132
3878, d4nnnE_, 0.8226, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH MG132
3879, d4inrS_, 0.8226, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3880, d3wxrF_, 0.8226, 1.71, 0.285, 232, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3881, d3shjS_, 0.8226, 1.71, 0.285, 233, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3882, d3hyeS_, 0.8226, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3883, d3gpwS_, 0.8226, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3884, d3gpwE_, 0.8226, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3885, d3gptE_, 0.8226, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3886, d2gplS_, 0.8226, 1.71, 0.285, 233, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3887, d2gplE_, 0.8226, 1.71, 0.285, 233, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3888, p5mp9f_, 0.8225, 1.70, 0.285, 231, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3889, p5ln3D_, 0.8225, 2.22, 0.309, 232, 230, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3890, d5cz9S_, 0.8225, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3891, d5cz9E_, 0.8225, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3892, d4y9yS_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3893, d4y9yE_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3894, d4y8mS_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3895, d4y8mE_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3896, p4y8jS_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3897, p4y8jE_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3898, p4y7wS_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3899, p4y7wE_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3900, p4y6aS_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3901, p4y6aE_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3902, d4qwuS_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3903, d4qwuE_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3904, d4qvmS_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3905, d4qvmE_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3906, d4qv9S_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT
3907, d4qv9E_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT
3908, d4qv7S_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-A50V MUTANT
3909, d4qv7E_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-A50V MUTANT
3910, d4ltcS_, 0.8225, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3911, d3nzxS_, 0.8225, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3912, d3nzxE_, 0.8225, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3913, d3mg4E_, 0.8225, 1.71, 0.285, 233, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3914, p3jcpOA_, 0.8225, 1.72, 0.285, 233, 221, 
3915, p3jcpO_, 0.8225, 1.72, 0.285, 233, 221, 
3916, d3gptS_, 0.8225, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3917, d3e47E_, 0.8225, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3918, d5fggS_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3919, d5fggE_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3920, d5fgeS_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3921, d5fgeE_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3922, p5cghS_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3923, p5cghE_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3924, p5cggS_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3925, p5cggE_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3926, d5bxnS_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3927, d5bxnE_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3928, d4z1lE_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3929, p4ya7S_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3930, p4ya7E_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3931, p4ya5S_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3932, p4ya5E_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3933, d4ya4S_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3934, d4ya4E_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3935, d4ya1S_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3936, d4ya1E_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3937, p4y8nS_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3938, p4y8nE_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3939, p4y80S_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3940, p4y80E_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3941, p4y7yS_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3942, p4y7yE_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3943, p4y74S_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3944, p4y74E_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3945, p4y6vS_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3946, p4y6vE_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3947, d4rurS_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3948, d4rurE_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3949, d4qwjS_, 0.8224, 1.71, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3950, d4qwjE_, 0.8224, 1.71, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3951, d4qvqE_, 0.8224, 1.71, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3952, d4qv1S_, 0.8224, 1.72, 0.285, 231, 221, YCP BETA5-M45A MUTANT
3953, d4qv1E_, 0.8224, 1.72, 0.285, 231, 221, YCP BETA5-M45A MUTANT
3954, d4nnwS_, 0.8224, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3955, d4nnwE_, 0.8224, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3956, d3e47S_, 0.8224, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3957, p5vfoJ_, 0.8223, 2.04, 0.338, 239, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3958, d5laiS_, 0.8223, 1.71, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3959, d5laiE_, 0.8223, 1.71, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3960, d5jhsS_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3961, d5jhsE_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3962, d5jhrS_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3963, d5jhrE_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3964, d5fhsS_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3965, d5fhsE_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3966, d5fgiS_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3967, d5fgiE_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3968, d5fgdS_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3969, d5fgdE_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3970, d5d0wS_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3971, d5d0wE_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3972, d5cz8S_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3973, d5cz8E_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3974, p5a0qS_, 0.8223, 1.30, 0.349, 215, 215, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3975, p5a0qE_, 0.8223, 1.30, 0.349, 215, 215, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3976, d4z1lS_, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3977, p4y8iS_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3978, p4y8iE_, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3979, d4r02E_, 0.8223, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3980, d4qwkS_, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3981, d4qwkE_, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3982, d4qwiS_, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3983, d4qwiE_, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3984, d4qw7E_, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3985, d4qw4E_, 0.8223, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH CARFILZOMIB
3986, d4qw1S_, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3987, d4qw1E_, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3988, d4qvqS_, 0.8223, 1.71, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3989, d4qvnS_, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3990, d4qvnE_, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3991, d2fnyE_, 0.8223, 1.72, 0.285, 233, 221,  
3992, d1g65E_, 0.8223, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3993, d5d0vS_, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3994, d5d0vE_, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3995, d5d0sS_, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3996, d5d0sE_, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3997, d5cz4S_, 0.8222, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3998, p4ya0S_, 0.8222, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3999, p4ya0E_, 0.8222, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4000, p4y8pS_, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4001, p4y8pE_, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4002, p4y8lS_, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4003, p4y8lE_, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4004, d4r17S_, 0.8222, 1.72, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4005, d4r17E_, 0.8222, 1.72, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4006, d4r02S_, 0.8222, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4007, d4qzwS_, 0.8222, 1.72, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4008, d4qzwE_, 0.8222, 1.72, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4009, d4qz4S_, 0.8222, 1.72, 0.285, 231, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4010, d4qz4E_, 0.8222, 1.72, 0.285, 231, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4011, d4qwrS_, 0.8222, 1.72, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4012, d4qwrE_, 0.8222, 1.72, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4013, d4qw7S_, 0.8222, 1.72, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4014, d4qw4S_, 0.8222, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH CARFILZOMIB
4015, d4qv3E_, 0.8222, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT
4016, d3tddS_, 0.8222, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4017, d3tddE_, 0.8222, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4018, d3c91U1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4019, d3c91T1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4020, d3c91S1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4021, d3c91R1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4022, d3c91Q1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4023, d3c91P1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4024, d3c91O1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4025, d3c91G1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4026, d3c91F1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4027, d3c91E1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4028, d3c91D1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4029, d3c91C1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4030, d3c91B1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4031, d3c91A1, 0.8222, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4032, d2fnyS_, 0.8222, 1.72, 0.285, 233, 221,  
4033, d5cz4E_, 0.8221, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4034, p4ya9S_, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4035, p4ya9E_, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4036, p4ya3S_, 0.8221, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4037, p4ya3E_, 0.8221, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4038, p4y78S_, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4039, p4y78E_, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4040, p4y77S_, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4041, p4y77E_, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4042, d4qz7E_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4043, d4qwlE_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4044, d4qw6S_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4045, d4qw6E_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4046, d4qw5S_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4047, d4qw5E_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4048, d4qw3S_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4049, d4qw3E_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4050, d4qv4S_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45T MUTANT
4051, d4qv4E_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45T MUTANT
4052, d4qv3S_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT
4053, d4no9S_, 0.8221, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4054, d4no9E_, 0.8221, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4055, d4no1S_, 0.8221, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4056, d4no1E_, 0.8221, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4057, d4eu2T_, 0.8221, 1.72, 0.285, 232, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4058, d2f16E_, 0.8221, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4059, d5d0zS_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4060, d5d0zE_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4061, d5cz5S_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4062, d5cz5E_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4063, p4y8qS_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4064, p4y8qE_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4065, p4y8oS_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4066, p4y8oE_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4067, p4y8kS_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4068, p4y8kE_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4069, p4y82S_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4070, p4y82E_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4071, p4y7xS_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4072, p4y7xE_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4073, p4y75S_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4074, p4y75E_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4075, p4y6zS_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4076, p4y6zE_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4077, d4qz7S_, 0.8220, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4078, d4qwlS_, 0.8220, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4079, d2f16S_, 0.8220, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4080, p5cgiS_, 0.8219, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4081, p5cgiE_, 0.8219, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4082, p4y81S_, 0.8219, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4083, p4y81E_, 0.8219, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4084, d4qwfS_, 0.8219, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4085, d4qwfE_, 0.8219, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4086, d4no8S_, 0.8219, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4087, d4no8E_, 0.8219, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4088, d4hrcS_, 0.8219, 1.73, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4089, d1rypT_, 0.8219, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4090, p6epfE_, 0.8218, 2.15, 0.323, 233, 226, GROUND STATE 26S PROTEASOME (GS1)
4091, d5l52S_, 0.8218, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4092, d5l52E_, 0.8218, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4093, p4y8tS_, 0.8218, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4094, p4y8tE_, 0.8218, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4095, d4qxjS_, 0.8218, 1.72, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4096, d4qxjE_, 0.8218, 1.72, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4097, d4qwxE_, 0.8218, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4098, d4qv5S_, 0.8218, 1.73, 0.285, 231, 221, YCP BETA5-M45I MUTANT
4099, d4qv5E_, 0.8218, 1.73, 0.285, 231, 221, YCP BETA5-M45I MUTANT
4100, d4inuE_, 0.8218, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4101, d5l55E_, 0.8217, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4102, p4y8sS_, 0.8217, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4103, d4qzxS_, 0.8217, 1.72, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4104, d4qzxE_, 0.8217, 1.72, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4105, d4qz0S_, 0.8217, 1.73, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4106, d4qz0E_, 0.8217, 1.73, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4107, d4qwxS_, 0.8217, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4108, d4qlqS_, 0.8217, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4109, d4qlqE_, 0.8217, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4110, d5l55S_, 0.8216, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4111, p4y8sE_, 0.8216, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4112, d4qz2S_, 0.8216, 1.73, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4113, d4qz2E_, 0.8216, 1.73, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4114, d4qz1S_, 0.8216, 1.73, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4115, d4qz1E_, 0.8216, 1.73, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4116, d4qwsS_, 0.8216, 1.73, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4117, d4qwsE_, 0.8216, 1.73, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4118, d4q1sS_, 0.8216, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4119, d3wxrT_, 0.8216, 1.73, 0.285, 232, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4120, d3oevS_, 0.8216, 1.73, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4121, d3mg4S_, 0.8216, 1.74, 0.285, 233, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4122, d1g0uE_, 0.8216, 1.72, 0.285, 230, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4123, d4qwgS_, 0.8215, 1.73, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4124, d4qwgE_, 0.8215, 1.73, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4125, d5ahjE_, 0.8214, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4126, d4inuS_, 0.8214, 1.73, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4127, d3okjS_, 0.8214, 1.73, 0.285, 233, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4128, d3okjE_, 0.8214, 1.73, 0.285, 233, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4129, d1g65S_, 0.8214, 1.73, 0.285, 233, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4130, p6epeC_, 0.8213, 2.30, 0.339, 249, 230, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4131, d5l54S_, 0.8213, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4132, d5l54E_, 0.8213, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4133, d5ahjS_, 0.8213, 1.74, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4134, p4y8hS_, 0.8213, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4135, p4y8hE_, 0.8213, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4136, p4y8gS_, 0.8213, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4137, p4y84S_, 0.8213, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4138, p4y84E_, 0.8213, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4139, d4qlsE_, 0.8213, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4140, d4no6S_, 0.8213, 1.74, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4141, d4no6E_, 0.8213, 1.74, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4142, d3sdiS_, 0.8213, 1.73, 0.285, 230, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4143, p5mpaF_, 0.8212, 1.87, 0.284, 233, 222, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4144, p4y8gE_, 0.8212, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4145, d4qlsS_, 0.8212, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4146, p5vfqD_, 0.8211, 2.05, 0.338, 239, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4147, p4ya2S_, 0.8210, 1.74, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4148, p4ya2E_, 0.8210, 1.74, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4149, d4qltS_, 0.8210, 1.74, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4150, d4qltE_, 0.8210, 1.74, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4151, p4qbyS_, 0.8210, 1.74, 0.285, 231, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4152, p4qbyE_, 0.8210, 1.74, 0.285, 231, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4153, d4qluS_, 0.8209, 1.74, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4154, d4qluE_, 0.8209, 1.74, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4155, p5a5bF_, 0.8208, 1.88, 0.284, 233, 222, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4156, p4cr3F_, 0.8208, 1.88, 0.284, 233, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4157, p4v7oT_, 0.8206, 1.76, 0.285, 234, 221, 
4158, p4v7oBB_, 0.8206, 1.76, 0.285, 234, 221, 
4159, d4qlvS_, 0.8206, 1.74, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4160, d4qlvE_, 0.8206, 1.74, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4161, d3l5qW_, 0.8206, 1.76, 0.285, 234, 221,  
4162, d1vsyT_, 0.8206, 1.76, 0.285, 234, 221,  
4163, p4v7oNA_, 0.8205, 1.76, 0.285, 234, 221, 
4164, p4v7oF_, 0.8205, 1.76, 0.285, 234, 221, 
4165, d3l5qK_, 0.8205, 1.76, 0.285, 234, 221,  
4166, d1vsyF_, 0.8205, 1.76, 0.285, 234, 221,  
4167, p5vfrJ_, 0.8203, 2.06, 0.338, 239, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4168, p5wvkT_, 0.8200, 1.84, 0.284, 233, 222, 
4169, d1jd2E_, 0.8198, 1.75, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4170, p5mpbF_, 0.8197, 1.92, 0.284, 231, 222, 
4171, p4cr4A_, 0.8197, 2.23, 0.304, 243, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4172, d1g0uS_, 0.8194, 1.76, 0.285, 230, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4173, p6epeG_, 0.8193, 2.18, 0.292, 245, 226, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4174, p6epfF_, 0.8185, 1.98, 0.308, 238, 224, GROUND STATE 26S PROTEASOME (GS1)
4175, p5mpbA_, 0.8185, 2.07, 0.307, 241, 225, 
4176, d5lexU_, 0.8185, 2.00, 0.367, 235, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4177, p5t0hL_, 0.8184, 1.98, 0.317, 238, 224, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4178, d1jd2Z_, 0.8183, 1.77, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4179, d5lf3U_, 0.8182, 1.99, 0.367, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4180, d5lf7U_, 0.8180, 1.99, 0.367, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4181, p5fmgP_, 0.8180, 1.26, 0.528, 212, 212, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4182, p5fmgB_, 0.8180, 1.26, 0.528, 212, 212, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4183, p5fmgS_, 0.8179, 1.60, 0.332, 217, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4184, p5fmgE_, 0.8179, 1.60, 0.332, 217, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4185, d5lf1U_, 0.8177, 2.00, 0.367, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4186, p5lf6U_, 0.8175, 2.00, 0.367, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4187, p5t0jL_, 0.8174, 1.94, 0.317, 238, 224, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4188, p5mpcO_, 0.8173, 2.07, 0.311, 241, 225, 
4189, d5lf4U_, 0.8171, 2.00, 0.367, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4190, p6epeF_, 0.8169, 2.05, 0.308, 238, 224, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4191, p5mpbT_, 0.8166, 1.91, 0.284, 233, 222, 
4192, p5wviX_, 0.8155, 2.22, 0.341, 245, 226, 
4193, p5t0iK_, 0.8154, 2.08, 0.320, 228, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4194, p6epcG_, 0.8150, 2.47, 0.284, 245, 229, GROUND STATE 26S PROTEASOME (GS2)
4195, p5dsvC_, 0.8149, 1.81, 0.297, 234, 219, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4196, p3jcoOA_, 0.8147, 1.84, 0.281, 233, 221, 
4197, p3jcoO_, 0.8147, 1.84, 0.281, 233, 221, 
4198, p6epcF_, 0.8140, 2.17, 0.307, 238, 225, GROUND STATE 26S PROTEASOME (GS2)
4199, p6epcE_, 0.8137, 2.24, 0.323, 233, 226, GROUND STATE 26S PROTEASOME (GS2)
4200, d4g4sD_, 0.8127, 1.53, 0.379, 220, 214, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4201, p6epdG_, 0.8122, 2.56, 0.281, 245, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4202, p5mpcA_, 0.8113, 2.16, 0.304, 241, 224, 
4203, d5le5U_, 0.8109, 1.87, 0.372, 232, 218, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4204, p4v7oR_, 0.8104, 1.61, 0.358, 227, 215, 
4205, p4v7oLA_, 0.8104, 1.61, 0.358, 227, 215, 
4206, d3l5qU_, 0.8104, 1.61, 0.358, 227, 215,  
4207, d1vsyD_, 0.8104, 1.61, 0.358, 227, 215,  
4208, p4v7oZA_, 0.8103, 1.61, 0.358, 227, 215, 
4209, p4v7oD_, 0.8103, 1.61, 0.358, 227, 215, 
4210, d3l5qI_, 0.8103, 1.61, 0.358, 227, 215,  
4211, d1vsyR_, 0.8103, 1.61, 0.358, 227, 215,  
4212, d4cr2F_, 0.8099, 2.04, 0.284, 233, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4213, p4v7oE_, 0.8091, 1.59, 0.318, 227, 214, 
4214, p4v7oAB_, 0.8091, 1.59, 0.318, 227, 214, 
4215, p3ipmF_, 0.8091, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4216, p3ipmE_, 0.8091, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4217, p3ipmD_, 0.8091, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4218, p3ipmC_, 0.8091, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4219, p3ipmB_, 0.8091, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4220, p3ipmA_, 0.8091, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4221, p5vfpAA_, 0.8090, 1.77, 0.344, 232, 218, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4222, p4v7oMA_, 0.8090, 1.59, 0.318, 227, 214, 
4223, p3ipmG_, 0.8090, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4224, p4v7oS_, 0.8089, 1.60, 0.318, 227, 214, 
4225, p5vfqBA_, 0.8088, 1.78, 0.344, 232, 218, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4226, p5vfoi_, 0.8085, 1.79, 0.344, 232, 218, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4227, p5l4gA_, 0.8082, 1.68, 0.349, 221, 215, 
4228, p5gjqB_, 0.8077, 1.72, 0.349, 221, 215, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4229, p5l4gO_, 0.8076, 1.68, 0.349, 221, 215, 
4230, p5vfri_, 0.8075, 1.79, 0.344, 232, 218, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4231, p5gjqh_, 0.8075, 1.68, 0.349, 221, 215, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4232, p5gjrS_, 0.8074, 1.71, 0.349, 221, 215, 
4233, p5gjrGA_, 0.8073, 1.70, 0.349, 221, 215, 
4234, p5t0iM_, 0.8070, 2.40, 0.295, 240, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4235, p5mpcF_, 0.8057, 2.09, 0.284, 231, 222, 
4236, p3unhU_, 0.8055, 1.72, 0.349, 220, 215, MOUSE 20S IMMUNOPROTEASOME
4237, p3unhG_, 0.8055, 1.72, 0.349, 220, 215, MOUSE 20S IMMUNOPROTEASOME
4238, p5mpbE_, 0.8053, 1.69, 0.321, 228, 215, 
4239, p5a5bC_, 0.8051, 2.00, 0.355, 226, 220, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4240, p4cr3C_, 0.8051, 2.00, 0.355, 226, 220, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4241, p5a5bA_, 0.8050, 2.35, 0.305, 243, 226, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4242, p4cr3A_, 0.8050, 2.35, 0.305, 243, 226, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4243, p5fmgQ_, 0.8047, 1.61, 0.347, 220, 213, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4244, p5fmgC_, 0.8047, 1.61, 0.347, 220, 213, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4245, p5t0jH_, 0.8045, 2.23, 0.596, 232, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4246, p4cr4F_, 0.8044, 2.09, 0.284, 233, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4247, p5fmgO_, 0.8041, 1.82, 0.312, 219, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4248, p5fmgA_, 0.8041, 1.82, 0.312, 219, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4249, p6epcD_, 0.8036, 2.49, 0.323, 246, 229, GROUND STATE 26S PROTEASOME (GS2)
4250, p5vfrG_, 0.8011, 1.77, 0.349, 220, 215, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4251, p6epeE_, 0.8007, 2.57, 0.320, 233, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4252, p5vfoG_, 0.8001, 1.80, 0.349, 220, 215, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4253, p5vfqA_, 0.8000, 1.79, 0.349, 220, 215, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4254, p5fmgT_, 0.7999, 1.61, 0.329, 219, 213, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4255, p5fmgF_, 0.7999, 1.61, 0.329, 219, 213, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4256, p5vfqZ_, 0.7996, 1.80, 0.349, 220, 215, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4257, p5vfog_, 0.7996, 1.80, 0.349, 220, 215, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4258, p5wvkX_, 0.7995, 2.16, 0.352, 225, 219, 
4259, p5wvkQ_, 0.7994, 2.18, 0.350, 225, 220, 
4260, p5vfsZ_, 0.7994, 1.82, 0.349, 220, 215, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4261, p5vfsA_, 0.7992, 1.82, 0.349, 220, 215, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4262, p5vfpA_, 0.7990, 1.81, 0.349, 220, 215, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4263, p5vfrg_, 0.7988, 1.81, 0.349, 220, 215, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4264, p5t0cYA_, 0.7979, 1.83, 0.349, 220, 215, 
4265, p5t0cS_, 0.7979, 1.83, 0.349, 220, 215, 
4266, p5vfpY_, 0.7976, 1.83, 0.349, 220, 215, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4267, p5m32U_, 0.7975, 1.75, 0.350, 218, 214, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4268, p5vfuR_, 0.7968, 1.86, 0.349, 220, 215, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4269, p5vftG_, 0.7968, 1.86, 0.349, 220, 215, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4270, p6avoR_, 0.7958, 1.84, 0.352, 217, 213, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4271, p6avoK_, 0.7950, 1.85, 0.352, 217, 213, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4272, p5t0gG_, 0.7947, 1.86, 0.349, 220, 215, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4273, p5vfuFA_, 0.7938, 1.92, 0.349, 220, 215, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4274, p5vftg_, 0.7938, 1.92, 0.349, 220, 215, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4275, p6epdE_, 0.7937, 2.60, 0.322, 233, 227, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4276, p5t0jG_, 0.7926, 1.86, 0.344, 220, 215, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4277, p5a0qR_, 0.7922, 1.62, 0.341, 214, 211, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4278, p5a0qD_, 0.7922, 1.62, 0.341, 214, 211, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4279, p6epdF_, 0.7916, 2.35, 0.308, 238, 224, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4280, p5mpcD_, 0.7916, 1.82, 0.362, 224, 213, 
4281, p5wviZ_, 0.7911, 2.12, 0.285, 233, 221, 
4282, p5wviG_, 0.7910, 2.12, 0.285, 233, 221, 
4283, p5ln3C_, 0.7904, 2.03, 0.349, 225, 218, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4284, p6epdD_, 0.7864, 2.69, 0.330, 246, 230, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4285, p5fmgR_, 0.7864, 1.64, 0.388, 215, 209, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4286, p5fmgD_, 0.7864, 1.64, 0.388, 215, 209, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4287, p5fmgU_, 0.7855, 2.13, 0.231, 219, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4288, p5fmgG_, 0.7855, 2.13, 0.231, 219, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4289, p6epfA_, 0.7850, 1.96, 0.344, 222, 215, GROUND STATE 26S PROTEASOME (GS1)
4290, p5t0hG_, 0.7839, 2.02, 0.349, 220, 215, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4291, p5t0jK_, 0.7834, 1.73, 0.318, 212, 211, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4292, p6epcA_, 0.7824, 1.91, 0.349, 219, 212, GROUND STATE 26S PROTEASOME (GS2)
4293, p5lezG_, 0.7822, 1.78, 0.357, 218, 210, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4294, p5wviNA_, 0.7821, 2.14, 0.352, 222, 216, 
4295, p5m32S_, 0.7820, 1.78, 0.308, 218, 211, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4296, p5lf0G_, 0.7817, 1.78, 0.357, 218, 210, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4297, p5leyG_, 0.7817, 1.79, 0.357, 218, 210, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4298, p6epdA_, 0.7814, 2.08, 0.340, 223, 215, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4299, p5lf6G_, 0.7808, 1.80, 0.357, 218, 210, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4300, p5t0iG_, 0.7803, 2.04, 0.340, 220, 215, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4301, d5ts0G_, 0.7799, 2.11, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4302, p5mpaA_, 0.7797, 1.90, 0.292, 224, 212, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4303, p5mpbO_, 0.7796, 1.95, 0.296, 225, 213, 
4304, p5a0qU_, 0.7782, 1.66, 0.304, 209, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4305, p5a0qG_, 0.7782, 1.66, 0.304, 209, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4306, p5t0iL_, 0.7781, 1.84, 0.316, 221, 212, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4307, d5trgP_, 0.7778, 2.08, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4308, d5trsA_, 0.7759, 2.11, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4309, p6epeD_, 0.7754, 2.02, 0.324, 229, 213, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4310, d5thoS_, 0.7751, 2.29, 0.181, 221, 216, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4311, d5trgA_, 0.7748, 2.06, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4312, d5trrA_, 0.7743, 2.07, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4313, d5tryA_, 0.7742, 2.08, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4314, d5thoG_, 0.7741, 2.09, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4315, d5trsP_, 0.7739, 2.17, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4316, d5ts0A_, 0.7734, 2.09, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4317, d5thoA_, 0.7734, 2.09, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4318, d5trsC_, 0.7730, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4319, p5wviH_, 0.7729, 1.57, 0.335, 214, 206, 
4320, d5ts0T_, 0.7729, 2.11, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4321, d5tryQ_, 0.7728, 2.12, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4322, d5trrP_, 0.7728, 2.21, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4323, d3mi0F_, 0.7728, 2.33, 0.182, 220, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4324, d3mfeI_, 0.7727, 2.03, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4325, d5trsD_, 0.7726, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4326, d5ts0U_, 0.7724, 2.05, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4327, d5ts0Q_, 0.7724, 2.12, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4328, d3mkaA_, 0.7724, 2.37, 0.181, 222, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4329, d5tryS_, 0.7723, 2.19, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4330, d5tryF_, 0.7721, 2.11, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4331, p5lf0U_, 0.7720, 1.90, 0.356, 212, 208, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4332, p5lezU_, 0.7720, 1.90, 0.356, 212, 208, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4333, d3mkaU_, 0.7719, 2.39, 0.181, 221, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4334, d3h6iQ_, 0.7719, 2.22, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4335, p2fhgW_, 0.7717, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4336, p5leyU_, 0.7716, 1.91, 0.356, 212, 208, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4337, p2fhgQ_, 0.7716, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4338, p2fhgI_, 0.7716, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4339, p2fhgA_, 0.7716, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4340, p2fhgU_, 0.7715, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4341, p2fhgO_, 0.7715, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4342, p2fhgM_, 0.7715, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4343, p2fhgD_, 0.7715, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4344, p2fhgB_, 0.7715, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4345, p2fhg1_, 0.7715, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4346, d5ts0B_, 0.7714, 2.02, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4347, p2fhgS_, 0.7714, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4348, p2fhgK_, 0.7714, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4349, d5ts0E_, 0.7713, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4350, d5trrS_, 0.7713, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4351, d5trgS_, 0.7713, 2.15, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4352, d5trgO_, 0.7713, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4353, d5thoE_, 0.7712, 2.13, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4354, d5ts0P_, 0.7711, 2.15, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4355, d5ts0C_, 0.7711, 2.08, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4356, d5trsU_, 0.7710, 2.01, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4357, d5trrU_, 0.7710, 2.01, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4358, d5trrT_, 0.7710, 2.07, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4359, d3mfeK_, 0.7710, 2.01, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4360, d5trrE_, 0.7709, 2.08, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4361, d5thoO_, 0.7708, 2.15, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4362, d3mkaF_, 0.7708, 2.30, 0.182, 221, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4363, d3mkaM_, 0.7707, 2.49, 0.181, 224, 216, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4364, d5trsS_, 0.7705, 2.16, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4365, d5trsE_, 0.7705, 2.09, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4366, d2fhhW_, 0.7705, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4367, d2fhhO_, 0.7705, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4368, d2fhhD_, 0.7705, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4369, d5ts0D_, 0.7704, 2.09, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4370, d5trgU_, 0.7704, 2.02, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4371, d2fhhU_, 0.7704, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4372, d2fhhM_, 0.7704, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4373, d2fhhA_, 0.7704, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4374, d5ts0R_, 0.7703, 2.10, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4375, d5tryP_, 0.7703, 2.12, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4376, d2fhhY_, 0.7703, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4377, d2fhhS_, 0.7703, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4378, d2fhhK_, 0.7703, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4379, d2fhhI_, 0.7703, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4380, d2fhhF_, 0.7703, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4381, d2fhhB_, 0.7703, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4382, p5wviY_, 0.7702, 2.07, 0.291, 225, 213, 
4383, d5tryU_, 0.7702, 2.02, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4384, d3hfaB_, 0.7702, 1.91, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4385, d3h6iF_, 0.7702, 2.10, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4386, d2fhhQ_, 0.7702, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4387, d2fhh1_, 0.7702, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4388, d5trsB_, 0.7700, 2.04, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4389, d5ts0S_, 0.7699, 2.18, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4390, d5trsT_, 0.7699, 2.10, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4391, d5trrC_, 0.7699, 2.08, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4392, d5trgE_, 0.7698, 2.15, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4393, d5trrO_, 0.7697, 2.11, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4394, d5thoU_, 0.7697, 2.04, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4395, d5thoF_, 0.7696, 2.11, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4396, d5tryE_, 0.7695, 2.11, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4397, d5tryD_, 0.7695, 2.11, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4398, d5thoT_, 0.7695, 2.10, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4399, d5thoR_, 0.7695, 2.11, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4400, d3mkaS_, 0.7695, 2.34, 0.187, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4401, d5thoC_, 0.7694, 2.11, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4402, d5tryR_, 0.7692, 2.11, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4403, d3mkaB_, 0.7692, 2.36, 0.182, 220, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4404, d3h6fQ_, 0.7691, 2.20, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4405, d5trgT_, 0.7690, 2.12, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4406, d3mfeB_, 0.7689, 2.05, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4407, d5trsO_, 0.7688, 2.13, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4408, d5trrG_, 0.7688, 2.05, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4409, d5trrD_, 0.7687, 2.06, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4410, d5thoP_, 0.7686, 2.14, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4411, p5lzpD_, 0.7685, 2.13, 0.184, 217, 212, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4412, d3mkaW_, 0.7685, 2.22, 0.184, 221, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4413, d3mkaK_, 0.7685, 2.39, 0.182, 221, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4414, d3h6fW_, 0.7685, 2.17, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4415, d3h6iW_, 0.7684, 2.19, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4416, d3h6fF_, 0.7683, 2.07, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4417, d2h6jB1, 0.7683, 2.30, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4418, d5trgQ_, 0.7682, 2.15, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4419, d5trgD_, 0.7682, 2.28, 0.183, 223, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4420, d3h6iK_, 0.7682, 2.25, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4421, d5trsG_, 0.7681, 2.07, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4422, d5thoQ_, 0.7681, 2.09, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4423, d5tryT_, 0.7680, 2.06, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4424, d5tryC_, 0.7680, 2.05, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4425, d3mkaO_, 0.7679, 2.31, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4426, d2h6jA1, 0.7679, 2.31, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4427, d1q5qC_, 0.7679, 2.29, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4428, d3h6iA_, 0.7678, 2.08, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4429, d1q5qF_, 0.7678, 2.29, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4430, d1q5qE_, 0.7678, 2.29, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4431, d1q5qD_, 0.7678, 2.29, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4432, d1q5qB_, 0.7678, 2.29, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4433, d1q5qA_, 0.7678, 2.29, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4434, d5ts0O_, 0.7677, 2.08, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4435, d2h6jG1, 0.7677, 2.31, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4436, d1q5qG_, 0.7677, 2.29, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4437, d5tryG_, 0.7676, 2.07, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4438, d5trsQ_, 0.7676, 2.09, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4439, d2h6jF1, 0.7676, 2.31, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4440, d2h6jD1, 0.7676, 2.31, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4441, d2h6jE1, 0.7675, 2.31, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4442, d2h6jC1, 0.7675, 2.31, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4443, d1q5rF_, 0.7675, 2.32, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4444, d1q5rE_, 0.7675, 2.32, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4445, d1q5rD_, 0.7675, 2.32, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4446, d1q5rB_, 0.7675, 2.32, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4447, d1q5rA_, 0.7675, 2.32, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4448, d1q5rG_, 0.7674, 2.32, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4449, d1q5rC_, 0.7674, 2.32, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4450, d3mkaQ_, 0.7673, 2.29, 0.183, 222, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4451, p5mpcT_, 0.7670, 1.79, 0.269, 213, 208, 
4452, d3h6fK_, 0.7670, 2.01, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4453, d5trrB_, 0.7669, 2.03, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4454, d5trgB_, 0.7668, 2.03, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4455, d5trgG_, 0.7667, 2.09, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4456, d3mfeS_, 0.7667, 2.03, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4457, d3mkaY_, 0.7666, 2.24, 0.183, 224, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4458, d5thoD_, 0.7665, 2.10, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4459, d3h6i1_, 0.7665, 2.02, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4460, d3krdF_, 0.7664, 2.11, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4461, d3h6iI_, 0.7663, 2.02, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4462, d3h6f1_, 0.7663, 2.02, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4463, d3mkaD_, 0.7662, 2.30, 0.183, 222, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4464, d5trgC_, 0.7660, 2.11, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4465, d5thoB_, 0.7660, 2.05, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4466, d3h6iM_, 0.7659, 2.17, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4467, d3mi0U_, 0.7658, 2.19, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4468, d3h6iU_, 0.7658, 2.05, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4469, d5tryB_, 0.7656, 2.05, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4470, d5trsR_, 0.7656, 2.13, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4471, d3h6fA_, 0.7653, 2.04, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4472, d3mka1_, 0.7652, 2.41, 0.183, 219, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4473, d5trgF_, 0.7651, 2.06, 0.181, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4474, d3mi0O_, 0.7651, 2.20, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4475, d5trrQ_, 0.7649, 2.07, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4476, p5ln3A_, 0.7649, 2.12, 0.349, 219, 212, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4477, d3mi0M_, 0.7649, 2.19, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4478, d3mi0K_, 0.7648, 2.24, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4479, d5trsF_, 0.7646, 2.13, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4480, d3krdY_, 0.7645, 2.18, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4481, d3h6fS_, 0.7645, 2.07, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4482, d3mi0S_, 0.7643, 2.25, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4483, p5vfpD_, 0.7640, 1.97, 0.325, 219, 209, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4484, d3h6iO_, 0.7639, 2.08, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4485, d3mi01_, 0.7637, 2.15, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4486, d3h6fO_, 0.7637, 2.09, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4487, d3h6iS_, 0.7636, 2.08, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4488, d5trrR_, 0.7635, 2.08, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4489, d5ts0F_, 0.7634, 2.09, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4490, d3hfaA_, 0.7634, 2.03, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4491, d3h6fI_, 0.7634, 2.01, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4492, d3mi0Y_, 0.7633, 2.30, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4493, p5lzp2_, 0.7632, 2.10, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4494, d3krdI_, 0.7632, 2.14, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4495, p5lzp4_, 0.7631, 2.10, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4496, d5tryO_, 0.7630, 2.15, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4497, p5lzp0_, 0.7630, 2.10, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4498, p5lzp6_, 0.7629, 2.10, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4499, p5lzpY_, 0.7628, 2.10, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4500, p5lzp8_, 0.7627, 2.10, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4501, p5lzpW_, 0.7626, 2.10, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4502, d3mfeY_, 0.7626, 1.98, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4503, d3hfaS_, 0.7626, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4504, d3hfa1_, 0.7626, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4505, d3hfaW_, 0.7625, 2.04, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4506, d3hfaQ_, 0.7624, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4507, d5trgR_, 0.7623, 2.10, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4508, d3krdS_, 0.7623, 2.12, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4509, d3hfaO_, 0.7623, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4510, d3hfaM_, 0.7623, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4511, d3mi0W_, 0.7622, 2.31, 0.190, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4512, d3hfaU_, 0.7622, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4513, d3hfaK_, 0.7622, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4514, d3hfaI_, 0.7622, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4515, d3hfaF_, 0.7622, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4516, d3h6iB_, 0.7622, 2.06, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4517, d5trrF_, 0.7621, 2.10, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4518, d3krdW_, 0.7619, 2.11, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4519, d3h6fM_, 0.7619, 2.18, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4520, d3h6fD_, 0.7619, 2.03, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4521, d3mi0A_, 0.7618, 2.17, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4522, d3krd1_, 0.7618, 2.13, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4523, d3hfaY_, 0.7618, 2.07, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4524, p5lzpH_, 0.7616, 2.16, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4525, p5lzpJ_, 0.7615, 2.13, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4526, d3mi0I_, 0.7614, 2.34, 0.180, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4527, d3h6fB_, 0.7612, 2.07, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4528, d3mi0Q_, 0.7611, 2.22, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4529, d3mfeA_, 0.7611, 2.06, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4530, d3krdK_, 0.7610, 2.18, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4531, d3krdQ_, 0.7607, 2.10, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4532, d3h6fU_, 0.7606, 2.09, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4533, d3mi0D_, 0.7605, 2.10, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4534, p5lzpS_, 0.7603, 2.21, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4535, d3h6iD_, 0.7602, 2.01, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4536, d3krdO_, 0.7601, 2.14, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4537, d3hfaD_, 0.7601, 2.03, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4538, p5wviF_, 0.7600, 2.03, 0.335, 223, 209, 
4539, d3mfeO_, 0.7591, 2.07, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4540, d3mfe1_, 0.7591, 2.01, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4541, d3h6fY_, 0.7590, 2.03, 0.183, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4542, d3krdU_, 0.7589, 2.12, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4543, d3hf9I_, 0.7587, 1.96, 0.188, 212, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4544, p5lzpQ_, 0.7583, 2.11, 0.187, 214, 209, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4545, d3krdA_, 0.7583, 2.16, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4546, p5t0jJ_, 0.7582, 2.18, 0.325, 222, 212, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4547, p5lzpB_, 0.7582, 2.13, 0.187, 214, 209, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4548, d3mkaI_, 0.7582, 2.26, 0.186, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4549, p5lzpM_, 0.7578, 2.14, 0.187, 214, 209, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4550, p5ln3F_, 0.7575, 1.95, 0.312, 212, 208, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4551, d3krdM_, 0.7575, 2.14, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4552, d3mfeD_, 0.7574, 2.05, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4553, p5wvkAA_, 0.7572, 1.76, 0.268, 210, 205, 
4554, d3krdB_, 0.7569, 2.08, 0.183, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4555, d3krdD_, 0.7567, 2.10, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4556, d3mfeQ_, 0.7564, 2.07, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4557, p3hf9y_, 0.7561, 1.94, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4558, d3h6iY_, 0.7560, 2.10, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4559, p6bgoI_, 0.7559, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4560, p6bgoH_, 0.7559, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4561, p6bgoG_, 0.7559, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4562, p6bgoF_, 0.7559, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4563, p6bgoE_, 0.7559, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4564, p6bgoD_, 0.7559, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4565, p6bgoC_, 0.7559, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4566, p6bglO_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4567, p6bglN_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4568, p6bglM_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4569, p6bglL_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4570, p6bglK_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4571, p6bglJ_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4572, p6bglI_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4573, p6bglH_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4574, p6bglG_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4575, p6bglF_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4576, p6bglE_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4577, p6bglD_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4578, p6bglC_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4579, p6bglA_, 0.7559, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4580, p5wviD_, 0.7559, 2.12, 0.290, 222, 210, 
4581, p3hf9s_, 0.7559, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4582, d3mfeU_, 0.7557, 2.03, 0.188, 212, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4583, p3hf9b_, 0.7555, 1.96, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4584, p3hf9f_, 0.7554, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4585, p3hf9u_, 0.7553, 1.96, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4586, d3hf9K_, 0.7550, 1.99, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4587, p3hf9i_, 0.7548, 1.96, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4588, d3hf9S_, 0.7547, 1.97, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4589, d3hf9B_, 0.7546, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4590, p3hf9k_, 0.7545, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4591, d3mi0B_, 0.7543, 2.24, 0.183, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4592, d3hf9A_, 0.7542, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4593, d3hf9U_, 0.7539, 1.99, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4594, p3hf9w_, 0.7538, 1.97, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4595, d3hf91_, 0.7538, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4596, d3hf9O_, 0.7537, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4597, p3hf9d_, 0.7537, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4598, d3hf9Q_, 0.7533, 1.99, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4599, p3hf9o_, 0.7532, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4600, p3hf9a_, 0.7532, 1.99, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4601, d3hf9Y_, 0.7523, 1.95, 0.185, 210, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4602, p3hf9q_, 0.7523, 2.00, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4603, d3hf93_, 0.7511, 1.96, 0.185, 210, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4604, d3mfeW_, 0.7490, 1.90, 0.191, 209, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4605, p5t0iJ_, 0.7483, 2.30, 0.302, 222, 212, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4606, d3hf9D_, 0.7475, 2.04, 0.185, 210, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4607, p3hf9m_, 0.7438, 1.97, 0.187, 208, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4608, p2fhgF_, 0.7402, 2.08, 0.191, 209, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4609, p2fhgY_, 0.7401, 2.08, 0.191, 209, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4610, p6bgoM_, 0.7379, 1.96, 0.193, 207, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4611, p6bgoL_, 0.7379, 1.96, 0.193, 207, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4612, p6bgoK_, 0.7379, 1.96, 0.193, 207, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4613, p6bgoN_, 0.7378, 1.96, 0.193, 207, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4614, p6bgoJ_, 0.7378, 1.96, 0.193, 207, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4615, p6bgoA_, 0.7378, 1.96, 0.193, 207, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4616, d3hf9M_, 0.7358, 1.87, 0.190, 205, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4617, p6bgoO_, 0.7345, 1.96, 0.194, 206, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4618, p5a0qO_, 0.7270, 1.64, 0.365, 195, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4619, p5a0qA_, 0.7270, 1.64, 0.365, 195, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4620, p5a0qT_, 0.7228, 1.59, 0.339, 195, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4621, p5a0qF_, 0.7227, 1.59, 0.339, 195, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4622, d3h4pl_, 0.7095, 2.20, 0.254, 202, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4623, d3h4pk_, 0.7092, 2.20, 0.254, 202, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4624, d3h4pj_, 0.7090, 2.21, 0.254, 202, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4625, p3h4pe_, 0.7090, 2.07, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4626, p3h4pc_, 0.7088, 2.07, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4627, d3h4pn_, 0.7087, 2.07, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4628, d3h4pi_, 0.7087, 2.07, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4629, p3h4pg_, 0.7087, 2.07, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4630, p3h4pb_, 0.7087, 2.21, 0.254, 202, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4631, p3h4pf_, 0.7086, 2.08, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4632, p3h4pa_, 0.7086, 2.07, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4633, p3h4pd_, 0.7077, 2.09, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4634, d3h4ph_, 0.7074, 2.10, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4635, d3h4pm_, 0.7073, 2.09, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4636, p6bdfZ_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4637, p6bdfX_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4638, p6bdfV_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4639, p6bdfT_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4640, p6bdfR_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4641, p6bdfP_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4642, p6bdfN_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4643, p6bdfL_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4644, p6bdfJ_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4645, p6bdfH_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4646, p6bdfF_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4647, p6bdfD_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4648, p6bdfB_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4649, p6bdf1_, 0.7057, 2.25, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4650, p3j9iZ_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4651, p3j9iY_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4652, p3j9iX_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4653, p3j9iW_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4654, p3j9iV_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4655, p3j9iN_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4656, p3j9iM_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4657, p3j9iL_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4658, p3j9iK_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4659, p3j9iJ_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4660, p3j9iI_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4661, p3j9iH_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4662, p3j9i2_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4663, p3j9i1_, 0.7042, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4664, p5vy4Z_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4665, p5vy4X_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4666, p5vy4V_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4667, p5vy4T_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4668, p5vy4R_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4669, p5vy4P_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4670, p5vy4N_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4671, p5vy4L_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4672, p5vy4J_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4673, p5vy4H_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4674, p5vy4F_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4675, p5vy4D_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4676, p5vy4BA_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4677, p5vy4B_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4678, p5vy41_, 0.7034, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4679, d2h6jN1, 0.7031, 2.64, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4680, d2h6jJ1, 0.7031, 2.65, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4681, d2h6jK1, 0.7030, 2.65, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4682, d2h6jM1, 0.7029, 2.64, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4683, d1yauM_, 0.7029, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4684, p5vy3Z_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4685, p5vy3X_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4686, p5vy3V_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4687, p5vy3T_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4688, p5vy3R_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4689, p5vy3P_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4690, p5vy3N_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4691, p5vy3L_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4692, p5vy3J_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4693, p5vy3H_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4694, p5vy3F_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4695, p5vy3D_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4696, p5vy3B_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4697, p5vy31_, 0.7028, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4698, d3jrmM_, 0.7027, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4699, d3jrmI_, 0.7026, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4700, d2h6jI1, 0.7026, 2.65, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4701, d3jrmK_, 0.7025, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4702, d3jrmH_, 0.7025, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4703, d2h6jL1, 0.7025, 2.65, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4704, d3jrmN_, 0.7024, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4705, d3jrmL_, 0.7024, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4706, d3jseM_, 0.7023, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4707, d2h6jH1, 0.7023, 2.65, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4708, d1yarM_, 0.7023, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4709, d1q5rN_, 0.7023, 3.07, 0.177, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4710, d1q5rM_, 0.7023, 3.07, 0.172, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4711, d1q5rL_, 0.7023, 3.07, 0.177, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4712, d1q5rJ_, 0.7023, 3.07, 0.172, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4713, d1q5rH_, 0.7023, 3.07, 0.177, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4714, d3jseK_, 0.7022, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4715, d1q5rK_, 0.7022, 3.08, 0.177, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4716, d1q5rI_, 0.7022, 3.07, 0.172, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4717, d3jseH_, 0.7020, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4718, d1yauJ_, 0.7020, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4719, d1ya7M_, 0.7020, 2.32, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4720, d3jseN_, 0.7019, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4721, d3jseL_, 0.7019, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4722, d3jrmJ_, 0.7019, 2.39, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4723, d3c92M1, 0.7019, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4724, d3c9211, 0.7019, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4725, d3c91M1, 0.7019, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4726, d3c9111, 0.7019, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4727, d1yauI_, 0.7019, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4728, d1ya7K_, 0.7019, 2.32, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4729, d1ya7I_, 0.7019, 2.32, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4730, d1pmaX_, 0.7019, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4731, d1pmaT_, 0.7019, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4732, d1yauK_, 0.7018, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4733, p3jtlM_, 0.7017, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4734, d3c92W1, 0.7017, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4735, d3c92I1, 0.7017, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4736, d3c91W1, 0.7017, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4737, d3c91I1, 0.7017, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4738, d1yauH_, 0.7017, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4739, d1pmaY_, 0.7017, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4740, d1pmaP_, 0.7017, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4741, p3jtlN_, 0.7016, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4742, p3jtlK_, 0.7016, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4743, p3jtlJ_, 0.7016, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4744, p3jtlI_, 0.7016, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4745, p3jtlH_, 0.7016, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4746, d1yarK_, 0.7016, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4747, d1ya7H_, 0.7016, 2.32, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4748, d1pma2_, 0.7016, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4749, p3jtlL_, 0.7015, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4750, d3c92X1, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4751, d3c92N1, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4752, d3c92J1, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4753, d3c9221, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4754, d3c91X1, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4755, d3c91N1, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4756, d3c91J1, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4757, d3c9121, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4758, d1yarI_, 0.7015, 2.33, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4759, d1ya7J_, 0.7015, 2.33, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4760, d1pmaU_, 0.7015, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4761, d1pmaQ_, 0.7015, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4762, d1yarJ_, 0.7014, 2.33, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4763, d1pmaV_, 0.7014, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4764, d3jseJ_, 0.7013, 2.39, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4765, d3jseI_, 0.7013, 2.39, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4766, d3c92Z1, 0.7013, 2.33, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4767, d3c92L1, 0.7013, 2.33, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4768, d3c91Z1, 0.7013, 2.33, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4769, d3c91L1, 0.7013, 2.33, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4770, d1ya7N_, 0.7013, 2.34, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4771, d1pmaS_, 0.7013, 2.33, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4772, d1pma1_, 0.7013, 2.33, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4773, d3c92V1, 0.7012, 2.33, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4774, d3c92H1, 0.7012, 2.33, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4775, d3c91V1, 0.7012, 2.33, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4776, d3c91H1, 0.7012, 2.33, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4777, d1yauN_, 0.7012, 2.34, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4778, d1yauL_, 0.7012, 2.33, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4779, d1pmaZ_, 0.7012, 2.33, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4780, d1pmaB_, 0.7012, 2.33, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4781, d1yarH_, 0.7011, 2.34, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4782, d1ya7L_, 0.7011, 2.33, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4783, d1pmaW_, 0.7011, 2.33, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4784, d1yarN_, 0.7010, 2.35, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4785, d1yarL_, 0.7010, 2.33, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4786, d3c92Y1, 0.7007, 2.33, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4787, d3c92K1, 0.7007, 2.33, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4788, d3c91Y1, 0.7007, 2.33, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4789, d3c91K1, 0.7007, 2.33, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4790, d1pmaR_, 0.7007, 2.33, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4791, d3mkaG_, 0.7004, 3.11, 0.172, 251, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4792, d3mfeF_, 0.7004, 2.01, 0.198, 212, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4793, d1j2qN_, 0.7000, 2.33, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4794, d1j2qJ_, 0.7000, 2.33, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4795, d1j2qI_, 0.7000, 2.34, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4796, d1j2qH_, 0.7000, 2.34, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4797, d3mkaT_, 0.6999, 3.11, 0.172, 250, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4798, d1j2qM_, 0.6999, 2.34, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4799, d1j2qL_, 0.6999, 2.34, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4800, d1j2qK_, 0.6999, 2.34, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4801, p2z5cC_, 0.6998, 1.23, 0.302, 189, 182, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4802, p2z5cF_, 0.6997, 1.23, 0.302, 189, 182, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4803, d3mkaL_, 0.6995, 3.11, 0.172, 251, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4804, d3mkaJ_, 0.6994, 3.38, 0.170, 252, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4805, d3mkaC_, 0.6994, 3.12, 0.172, 250, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4806, d3mkaN_, 0.6981, 3.35, 0.171, 252, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4807, d3mkaP_, 0.6974, 2.88, 0.175, 250, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4808, d3mkaV_, 0.6972, 2.89, 0.175, 249, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4809, d3mkaH_, 0.6969, 3.01, 0.179, 249, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4810, d3mkaR_, 0.6967, 2.75, 0.176, 246, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4811, d3mka2_, 0.6964, 2.89, 0.175, 246, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4812, d3gpjJ_, 0.6959, 2.05, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4813, d3gpjX_, 0.6958, 2.05, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4814, d3d29J_, 0.6958, 2.06, 0.188, 198, 191, PROTEASOME INHIBITION BY FELLUTAMIDE B
4815, d4intJ_, 0.6957, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4816, d3sdiJ_, 0.6957, 2.06, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4817, d3d29X_, 0.6957, 2.06, 0.188, 198, 191, PROTEASOME INHIBITION BY FELLUTAMIDE B
4818, d3bdmJ_, 0.6957, 2.05, 0.183, 198, 191, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4819, d1g65X_, 0.6957, 2.25, 0.187, 198, 192, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4820, d4intX_, 0.6956, 2.26, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4821, d4inrX_, 0.6956, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4822, d3mkaE_, 0.6956, 2.90, 0.175, 248, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4823, d3bdmX_, 0.6956, 2.05, 0.183, 198, 191, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4824, d1g65J_, 0.6956, 2.06, 0.194, 198, 191, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4825, d4jsqX_, 0.6955, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4826, d4jsqJ_, 0.6955, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4827, d4inrJ_, 0.6955, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4828, d3okjJ_, 0.6955, 2.06, 0.194, 198, 191, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4829, d3nzwX_, 0.6955, 2.06, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4830, d3nzwJ_, 0.6955, 2.06, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4831, d3mfeM_, 0.6955, 1.87, 0.196, 194, 189, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4832, d2zcyX_, 0.6955, 2.06, 0.188, 198, 191, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4833, d2zcyJ_, 0.6955, 2.06, 0.188, 198, 191, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4834, d3okjX_, 0.6954, 2.06, 0.194, 198, 191, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4835, d4jsuX_, 0.6952, 2.07, 0.194, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4836, d4jsuJ_, 0.6952, 2.07, 0.194, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4837, d3nzxX_, 0.6952, 2.07, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4838, d3nzxJ_, 0.6952, 2.07, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4839, d4inuX_, 0.6951, 2.26, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4840, d4inuJ_, 0.6951, 2.26, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4841, d3mg0J_, 0.6950, 2.06, 0.194, 198, 191, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4842, d3mg0X_, 0.6949, 2.07, 0.188, 198, 191, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4843, d3nzjX_, 0.6948, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4844, d3nzjJ_, 0.6948, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4845, d2f16X_, 0.6948, 2.07, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4846, d2f16J_, 0.6948, 2.07, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4847, d4ltcX_, 0.6947, 2.08, 0.194, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4848, d4ltcJ_, 0.6947, 2.08, 0.194, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4849, p3un4X_, 0.6947, 2.08, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4850, p3un4J_, 0.6947, 2.08, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4851, d4q1sJ_, 0.6946, 2.07, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4852, d4hrcX_, 0.6946, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4853, d4hrdJ_, 0.6945, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4854, d3sdiX_, 0.6945, 2.08, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4855, d3hf9W_, 0.6945, 1.82, 0.197, 193, 188, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4856, d5trrI_, 0.6944, 2.52, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4857, d5trgK_, 0.6944, 2.52, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4858, d4jt0X_, 0.6944, 2.27, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4859, d4jt0J_, 0.6944, 2.27, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4860, p4gk7J_, 0.6944, 2.08, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4861, d3wxrY_, 0.6944, 2.28, 0.177, 198, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4862, p4gk7X_, 0.6943, 2.08, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4863, d3gptX_, 0.6943, 2.08, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4864, d3gptJ_, 0.6943, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4865, d3dy3X_, 0.6943, 2.07, 0.183, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4866, d3dy3J_, 0.6943, 2.07, 0.183, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4867, d1g0uX_, 0.6943, 2.28, 0.182, 198, 192, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4868, p5lzpI_, 0.6942, 2.52, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4869, d3un8J_, 0.6942, 2.29, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4870, d3hyeJ_, 0.6942, 2.08, 0.194, 198, 191, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4871, d3gpwJ_, 0.6942, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4872, d2fakX_, 0.6942, 2.09, 0.188, 198, 191, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4873, d2fakJ_, 0.6942, 2.08, 0.194, 198, 191, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4874, d1jd2Q_, 0.6942, 2.09, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4875, d4fzgX_, 0.6941, 2.09, 0.188, 198, 191, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4876, d4fzgJ_, 0.6941, 2.09, 0.188, 198, 191, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4877, d3mi0L_, 0.6941, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4878, d3mg4J_, 0.6941, 2.08, 0.188, 198, 191, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4879, d3hyeX_, 0.6941, 2.08, 0.194, 198, 191, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4880, d3gpwX_, 0.6941, 2.08, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4881, d2gplX_, 0.6941, 2.09, 0.188, 198, 191, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4882, d2gplJ_, 0.6941, 2.08, 0.188, 198, 191, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4883, d1rypK_, 0.6941, 2.09, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4884, d1g0uJ_, 0.6941, 2.08, 0.194, 198, 191, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4885, d5ts0W_, 0.6940, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4886, d5trrW_, 0.6940, 2.52, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4887, d3un8X_, 0.6940, 2.29, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4888, d3dy4X_, 0.6940, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4889, d3dy4J_, 0.6940, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4890, d5trrL_, 0.6939, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4891, d5trgL_, 0.6939, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4892, d4hrcJ_, 0.6939, 2.09, 0.183, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4893, p3ipmM_, 0.6939, 2.40, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4894, p3ipmK_, 0.6939, 2.40, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4895, d1rypY_, 0.6939, 2.10, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4896, d5trgI_, 0.6938, 2.52, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4897, d4lqiX_, 0.6938, 2.09, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4898, d4lqiJ_, 0.6938, 2.09, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4899, d3mg8J_, 0.6938, 2.09, 0.194, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4900, p3ipmL_, 0.6938, 2.40, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4901, p3ipmJ_, 0.6938, 2.40, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4902, p3ipmI_, 0.6938, 2.40, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4903, p3ipmH_, 0.6938, 2.40, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4904, d5trgY_, 0.6937, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4905, d4hnpJ_, 0.6937, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4906, p3ipmN_, 0.6937, 2.40, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4907, d5trsW_, 0.6936, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4908, p5trrb_, 0.6936, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4909, d4hrdX_, 0.6936, 2.09, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4910, d4hnpX_, 0.6936, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4911, d3tddX_, 0.6936, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4912, d3tddJ_, 0.6936, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4913, d1jd2J_, 0.6936, 2.09, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4914, d5trrZ_, 0.6935, 2.53, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4915, d5thoW_, 0.6935, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4916, p5lzpK_, 0.6935, 2.53, 0.173, 222, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4917, p5lzpC_, 0.6935, 2.53, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4918, d4q1sX_, 0.6935, 2.09, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4919, d3shjX_, 0.6935, 2.09, 0.194, 198, 191, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4920, d3shjJ_, 0.6935, 2.10, 0.194, 198, 191, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4921, d3mg6J_, 0.6935, 2.10, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4922, d3e47X_, 0.6935, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4923, d3e47J_, 0.6935, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4924, d5thoL_, 0.6934, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4925, p5lzpE_, 0.6934, 2.53, 0.173, 222, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4926, d2fnyX_, 0.6934, 2.10, 0.188, 198, 191,  
4927, d2fnyJ_, 0.6934, 2.10, 0.188, 198, 191,  
4928, d5ts0K_, 0.6933, 2.55, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4929, d5trrY_, 0.6933, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4930, d5trgX_, 0.6933, 2.54, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4931, d3oevJ_, 0.6933, 2.11, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4932, d5trsY_, 0.6932, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4933, d5trsL_, 0.6932, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4934, d5thoI_, 0.6932, 2.54, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4935, p5lzpR_, 0.6932, 2.53, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4936, d4fzcX_, 0.6932, 2.10, 0.188, 198, 191, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4937, d4fzcJ_, 0.6932, 2.10, 0.188, 198, 191, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4938, d3mg4X_, 0.6932, 2.10, 0.188, 198, 191, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4939, d5ts0I_, 0.6931, 2.54, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4940, p5trra_, 0.6931, 2.55, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4941, d5trgV_, 0.6931, 2.61, 0.173, 223, 197, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4942, p4v7oGB_, 0.6931, 2.29, 0.177, 198, 192, 
4943, d4j70J_, 0.6931, 2.10, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4944, d3sdkJ_, 0.6931, 2.11, 0.194, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4945, d1vsyY_, 0.6931, 2.29, 0.177, 198, 192,  
4946, d5ts0L_, 0.6930, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4947, p5tryb_, 0.6930, 2.56, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4948, d5thoV_, 0.6930, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4949, p4v7oY_, 0.6930, 2.29, 0.177, 198, 192, 
4950, p4v7oK_, 0.6930, 2.29, 0.177, 198, 192, 
4951, d3l5qO_, 0.6930, 2.29, 0.177, 198, 192,  
4952, d3l5q1_, 0.6930, 2.29, 0.177, 198, 192,  
4953, d5tryW_, 0.6929, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4954, p5trya_, 0.6929, 2.55, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4955, d5trsI_, 0.6929, 2.55, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4956, p5trga_, 0.6929, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4957, p5lzpT_, 0.6929, 2.53, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4958, p4v7oSA_, 0.6929, 2.29, 0.177, 198, 192, 
4959, d4j70X_, 0.6929, 2.10, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4960, d3mi0N_, 0.6929, 2.55, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4961, d3mi0J_, 0.6929, 2.55, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4962, d3mi0E_, 0.6929, 2.55, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4963, d3mi02_, 0.6929, 2.55, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4964, d3hfaV_, 0.6929, 2.57, 0.173, 226, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4965, d3hfaG_, 0.6929, 2.57, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4966, d3hfaC_, 0.6929, 2.57, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4967, d1vsyK_, 0.6929, 2.29, 0.177, 198, 192,  
4968, d5tryZ_, 0.6928, 2.54, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4969, d5trrV_, 0.6928, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4970, p5lzpN_, 0.6928, 2.54, 0.173, 221, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4971, d3sdkX_, 0.6928, 2.13, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4972, d3oeuJ_, 0.6928, 2.10, 0.194, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4973, d3mg7J_, 0.6928, 2.12, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4974, d3hfaZ_, 0.6928, 2.58, 0.173, 224, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4975, d3hfaT_, 0.6928, 2.58, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4976, d3hfaP_, 0.6928, 2.58, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4977, d3hfaN_, 0.6928, 2.57, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4978, d3hfaL_, 0.6928, 2.58, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4979, d3hfaE_, 0.6928, 2.58, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4980, d3hfa2_, 0.6928, 2.57, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4981, p5thob_, 0.6927, 2.55, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4982, p5lzpU_, 0.6927, 2.55, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4983, p5lzpG_, 0.6927, 2.55, 0.173, 222, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4984, d3mi0X_, 0.6927, 2.56, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4985, d3hfaX_, 0.6927, 2.58, 0.173, 224, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4986, d3hfaR_, 0.6927, 2.58, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4987, d3hfaJ_, 0.6927, 2.58, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4988, d3hfaH_, 0.6927, 2.58, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4989, p5ts0b_, 0.6926, 2.55, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4990, d5trsK_, 0.6926, 2.56, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4991, p5trsb_, 0.6926, 2.56, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4992, p5trsa_, 0.6926, 2.56, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4993, d5thoY_, 0.6926, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4994, p5lzpO_, 0.6926, 2.55, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4995, p1fntK_, 0.6926, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4996, d5tryL_, 0.6925, 2.55, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4997, d5trsV_, 0.6925, 2.56, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4998, d5thoZ_, 0.6925, 2.55, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4999, d5thoK_, 0.6925, 2.55, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
5000, d3mg6X_, 0.6925, 2.12, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
